Lab-on-a-Chip 시스템의 혈류 역학에 대한 검토: 엔지니어링 관점

Review on Blood Flow Dynamics in Lab-on-a-Chip Systems: An Engineering Perspective

  • Bin-Jie Lai
  • Li-Tao Zhu
  • Zhe Chen*
  • Bo Ouyang*
  • , and 
  • Zheng-Hong Luo*

Abstract

다양한 수송 메커니즘 하에서, “LOC(lab-on-a-chip)” 시스템에서 유동 전단 속도 조건과 밀접한 관련이 있는 혈류 역학은 다양한 수송 현상을 초래하는 것으로 밝혀졌습니다.

본 연구는 적혈구의 동적 혈액 점도 및 탄성 거동과 같은 점탄성 특성의 역할을 통해 LOC 시스템의 혈류 패턴을 조사합니다. 모세관 및 전기삼투압의 주요 매개변수를 통해 LOC 시스템의 혈액 수송 현상에 대한 연구는 실험적, 이론적 및 수많은 수치적 접근 방식을 통해 제공됩니다.

전기 삼투압 점탄성 흐름에 의해 유발되는 교란은 특히 향후 연구 기회를 위해 혈액 및 기타 점탄성 유체를 취급하는 LOC 장치의 혼합 및 분리 기능 향상에 논의되고 적용됩니다. 또한, 본 연구는 보다 정확하고 단순화된 혈류 모델에 대한 요구와 전기역학 효과 하에서 점탄성 유체 흐름에 대한 수치 연구에 대한 강조와 같은 LOC 시스템 하에서 혈류 역학의 수치 모델링의 문제를 식별합니다.

전기역학 현상을 연구하는 동안 제타 전위 조건에 대한 보다 실용적인 가정도 강조됩니다. 본 연구는 모세관 및 전기삼투압에 의해 구동되는 미세유체 시스템의 혈류 역학에 대한 포괄적이고 학제적인 관점을 제공하는 것을 목표로 한다.

KEYWORDS: 

1. Introduction

1.1. Microfluidic Flow in Lab-on-a-Chip (LOC) Systems

Over the past several decades, the ability to control and utilize fluid flow patterns at microscales has gained considerable interest across a myriad of scientific and engineering disciplines, leading to growing interest in scientific research of microfluidics. 

(1) Microfluidics, an interdisciplinary field that straddles physics, engineering, and biotechnology, is dedicated to the behavior, precise control, and manipulation of fluids geometrically constrained to a small, typically submillimeter, scale. 

(2) The engineering community has increasingly focused on microfluidics, exploring different driving forces to enhance working fluid transport, with the aim of accurately and efficiently describing, controlling, designing, and applying microfluidic flow principles and transport phenomena, particularly for miniaturized applications. 

(3) This attention has chiefly been fueled by the potential to revolutionize diagnostic and therapeutic techniques in the biomedical and pharmaceutical sectorsUnder various driving forces in microfluidic flows, intriguing transport phenomena have bolstered confidence in sustainable and efficient applications in fields such as pharmaceutical, biochemical, and environmental science. The “lab-on-a-chip” (LOC) system harnesses microfluidic flow to enable fluid processing and the execution of laboratory tasks on a chip-sized scale. LOC systems have played a vital role in the miniaturization of laboratory operations such as mixing, chemical reaction, separation, flow control, and detection on small devices, where a wide variety of fluids is adapted. Biological fluid flow like blood and other viscoelastic fluids are notably studied among the many working fluids commonly utilized by LOC systems, owing to the optimization in small fluid sample volumed, rapid response times, precise control, and easy manipulation of flow patterns offered by the system under various driving forces. 

(4)The driving forces in blood flow can be categorized as passive or active transport mechanisms and, in some cases, both. Under various transport mechanisms, the unique design of microchannels enables different functionalities in driving, mixing, separating, and diagnosing blood and drug delivery in the blood. 

(5) Understanding and manipulating these driving forces are crucial for optimizing the performance of a LOC system. Such knowledge presents the opportunity to achieve higher efficiency and reliability in addressing cellular level challenges in medical diagnostics, forensic studies, cancer detection, and other fundamental research areas, for applications of point-of-care (POC) devices. 

(6)

1.2. Engineering Approach of Microfluidic Transport Phenomena in LOC Systems

Different transport mechanisms exhibit unique properties at submillimeter length scales in microfluidic devices, leading to significant transport phenomena that differ from those of macroscale flows. An in-depth understanding of these unique transport phenomena under microfluidic systems is often required in fluidic mechanics to fully harness the potential functionality of a LOC system to obtain systematically designed and precisely controlled transport of microfluids under their respective driving force. Fluid mechanics is considered a vital component in chemical engineering, enabling the analysis of fluid behaviors in various unit designs, ranging from large-scale reactors to separation units. Transport phenomena in fluid mechanics provide a conceptual framework for analytically and descriptively explaining why and how experimental results and physiological phenomena occur. The Navier–Stokes (N–S) equation, along with other governing equations, is often adapted to accurately describe fluid dynamics by accounting for pressure, surface properties, velocity, and temperature variations over space and time. In addition, limiting factors and nonidealities for these governing equations should be considered to impose corrections for empirical consistency before physical models are assembled for more accurate controls and efficiency. Microfluidic flow systems often deviate from ideal conditions, requiring adjustments to the standard governing equations. These deviations could arise from factors such as viscous effects, surface interactions, and non-Newtonian fluid properties from different microfluid types and geometrical layouts of microchannels. Addressing these nonidealities supports the refining of theoretical models and prediction accuracy for microfluidic flow behaviors.

The analytical calculation of coupled nonlinear governing equations, which describes the material and energy balances of systems under ideal conditions, often requires considerable computational efforts. However, advancements in computation capabilities, cost reduction, and improved accuracy have made numerical simulations using different numerical and modeling methods a powerful tool for effectively solving these complex coupled equations and modeling various transport phenomena. Computational fluid dynamics (CFD) is a numerical technique used to investigate the spatial and temporal distribution of various flow parameters. It serves as a critical approach to provide insights and reasoning for decision-making regarding the optimal designs involving fluid dynamics, even prior to complex physical model prototyping and experimental procedures. The integration of experimental data, theoretical analysis, and reliable numerical simulations from CFD enables systematic variation of analytical parameters through quantitative analysis, where adjustment to delivery of blood flow and other working fluids in LOC systems can be achieved.

Numerical methods such as the Finite-Difference Method (FDM), Finite-Element-Method (FEM), and Finite-Volume Method (FVM) are heavily employed in CFD and offer diverse approaches to achieve discretization of Eulerian flow equations through filling a mesh of the flow domain. A more in-depth review of numerical methods in CFD and its application for blood flow simulation is provided in Section 2.2.2.

1.3. Scope of the Review

In this Review, we explore and characterize the blood flow phenomena within the LOC systems, utilizing both physiological and engineering modeling approaches. Similar approaches will be taken to discuss capillary-driven flow and electric-osmotic flow (EOF) under electrokinetic phenomena as a passive and active transport scheme, respectively, for blood transport in LOC systems. Such an analysis aims to bridge the gap between physical (experimental) and engineering (analytical) perspectives in studying and manipulating blood flow delivery by different driving forces in LOC systems. Moreover, the Review hopes to benefit the interests of not only blood flow control in LOC devices but also the transport of viscoelastic fluids, which are less studied in the literature compared to that of Newtonian fluids, in LOC systems.

Section 2 examines the complex interplay between viscoelastic properties of blood and blood flow patterns under shear flow in LOC systems, while engineering numerical modeling approaches for blood flow are presented for assistance. Sections 3 and 4 look into the theoretical principles, numerical governing equations, and modeling methodologies for capillary driven flow and EOF in LOC systems as well as their impact on blood flow dynamics through the quantification of key parameters of the two driving forces. Section 5 concludes the characterized blood flow transport processes in LOC systems under these two forces. Additionally, prospective areas of research in improving the functionality of LOC devices employing blood and other viscoelastic fluids and potentially justifying mechanisms underlying microfluidic flow patterns outside of LOC systems are presented. Finally, the challenges encountered in the numerical studies of blood flow under LOC systems are acknowledged, paving the way for further research.

2. Blood Flow Phenomena

ARTICLE SECTIONS

Jump To


2.1. Physiological Blood Flow Behavior

Blood, an essential physiological fluid in the human body, serves the vital role of transporting oxygen and nutrients throughout the body. Additionally, blood is responsible for suspending various blood cells including erythrocytes (red blood cells or RBCs), leukocytes (white blood cells), and thrombocytes (blood platelets) in a plasma medium.Among the cells mentioned above, red blood cells (RBCs) comprise approximately 40–45% of the volume of healthy blood. 

(7) An RBC possesses an inherent elastic property with a biconcave shape of an average diameter of 8 μm and a thickness of 2 μm. This biconcave shape maximizes the surface-to-volume ratio, allowing RBCs to endure significant distortion while maintaining their functionality. 

(8,9) Additionally, the biconcave shape optimizes gas exchange, facilitating efficient uptake of oxygen due to the increased surface area. The inherent elasticity of RBCs allows them to undergo substantial distortion from their original biconcave shape and exhibits high flexibility, particularly in narrow channels.RBC deformability enables the cell to deform from a biconcave shape to a parachute-like configuration, despite minor differences in RBC shape dynamics under shear flow between initial cell locations. As shown in Figure 1(a), RBCs initiating with different resting shapes and orientations displaying display a similar deformation pattern 

(10) in terms of its shape. Shear flow induces an inward bending of the cell at the rear position of the rim to the final bending position, 

(11) resulting in an alignment toward the same position of the flow direction.

Figure 1. Images of varying deformation of RBCs and different dynamic blood flow behaviors. (a) The deforming shape behavior of RBCs at four different initiating positions under the same experimental conditions of a flow from left to right, (10) (b) RBC aggregation, (13) (c) CFL region. (18) Reproduced with permission from ref (10). Copyright 2011 Elsevier. Reproduced with permission from ref (13). Copyright 2022 The Authors, under the terms of the Creative Commons (CC BY 4.0) License https://creativecommons.org/licenses/by/4.0/. Reproduced with permission from ref (18). Copyright 2019 Elsevier.

The flexible property of RBCs enables them to navigate through narrow capillaries and traverse a complex network of blood vessels. The deformability of RBCs depends on various factors, including the channel geometry, RBC concentration, and the elastic properties of the RBC membrane. 

(12) Both flexibility and deformability are vital in the process of oxygen exchange among blood and tissues throughout the body, allowing cells to flow in vessels even smaller than the original cell size prior to deforming.As RBCs serve as major components in blood, their collective dynamics also hugely affect blood rheology. RBCs exhibit an aggregation phenomenon due to cell to cell interactions, such as adhesion forces, among populated cells, inducing unique blood flow patterns and rheological behaviors in microfluidic systems. For blood flow in large vessels between a diameter of 1 and 3 cm, where shear rates are not high, a constant viscosity and Newtonian behavior for blood can be assumed. However, under low shear rate conditions (0.1 s

–1) in smaller vessels such as the arteries and venules, which are within a diameter of 0.2 mm to 1 cm, blood exhibits non-Newtonian properties, such as shear-thinning viscosity and viscoelasticity due to RBC aggregation and deformability. The nonlinear viscoelastic property of blood gives rise to a complex relationship between viscosity and shear rate, primarily influenced by the highly elastic behavior of RBCs. A wide range of research on the transient behavior of the RBC shape and aggregation characteristics under varied flow circumstances has been conducted, aiming to obtain a better understanding of the interaction between blood flow shear forces from confined flows.

For a better understanding of the unique blood flow structures and rheological behaviors in microfluidic systems, some blood flow patterns are introduced in the following section.

2.1.1. RBC Aggregation

RBC aggregation is a vital phenomenon to be considered when designing LOC devices due to its impact on the viscosity of the bulk flow. Under conditions of low shear rate, such as in stagnant or low flow rate regions, RBCs tend to aggregate, forming structures known as rouleaux, resembling stacks of coins as shown in Figure 1(b). 

(13) The aggregation of RBCs increases the viscosity at the aggregated region, 

(14) hence slowing down the overall blood flow. However, when exposed to high shear rates, RBC aggregates disaggregate. As shear rates continue to increase, RBCs tend to deform, elongating and aligning themselves with the direction of the flow. 

(15) Such a dynamic shift in behavior from the cells in response to the shear rate forms the basis of the viscoelastic properties observed in whole blood. In essence, the viscosity of the blood varies according to the shear rate conditions, which are related to the velocity gradient of the system. It is significant to take the intricate relationship between shear rate conditions and the change of blood viscosity due to RBC aggregation into account since various flow driving conditions may induce varied effects on the degree of aggregation.

2.1.2. Fåhræus-Lindqvist Effect

The Fåhræus–Lindqvist (FL) effect describes the gradual decrease in the apparent viscosity of blood as the channel diameter decreases. 

(16) This effect is attributed to the migration of RBCs toward the central region in the microchannel, where the flow rate is higher, due to the presence of higher pressure and asymmetric distribution of shear forces. This migration of RBCs, typically observed at blood vessels less than 0.3 mm, toward the higher flow rate region contributes to the change in blood viscosity, which becomes dependent on the channel size. Simultaneously, the increase of the RBC concentration in the central region of the microchannel results in the formation of a less viscous region close to the microchannel wall. This region called the Cell-Free Layer (CFL), is primarily composed of plasma. 

(17) The combination of the FL effect and the following CFL formation provides a unique phenomenon that is often utilized in passive and active plasma separation mechanisms, involving branched and constriction channels for various applications in plasma separation using microfluidic systems.

2.1.3. Cell-Free Layer Formation

In microfluidic blood flow, RBCs form aggregates at the microchannel core and result in a region that is mostly devoid of RBCs near the microchannel walls, as shown in Figure 1(c). 

(18) The region is known as the cell-free layer (CFL). The CFL region is often known to possess a lower viscosity compared to other regions within the blood flow due to the lower viscosity value of plasma when compared to that of the aggregated RBCs. Therefore, a thicker CFL region composed of plasma correlates to a reduced apparent whole blood viscosity. 

(19) A thicker CFL region is often established following the RBC aggregation at the microchannel core under conditions of decreasing the tube diameter. Apart from the dependence on the RBC concentration in the microchannel core, the CFL thickness is also affected by the volume concentration of RBCs, or hematocrit, in whole blood, as well as the deformability of RBCs. Given the influence CFL thickness has on blood flow rheological parameters such as blood flow rate, which is strongly dependent on whole blood viscosity, investigating CFL thickness under shear flow is crucial for LOC systems accounting for blood flow.

2.1.4. Plasma Skimming in Bifurcation Networks

The uneven arrangement of RBCs in bifurcating microchannels, commonly termed skimming bifurcation, arises from the axial migration of RBCs within flowing streams. This uneven distribution contributes to variations in viscosity across differing sizes of bifurcating channels but offers a stabilizing effect. Notably, higher flow rates in microchannels are associated with increased hematocrit levels, resulting in higher viscosity compared with those with lower flow rates. Parametric investigations on bifurcation angle, 

(20) thickness of the CFL, 

(21) and RBC dynamics, including aggregation and deformation, 

(22) may alter the varying viscosity of blood and its flow behavior within microchannels.

2.2. Modeling on Blood Flow Dynamics

2.2.1. Blood Properties and Mathematical Models of Blood Rheology

Under different shear rate conditions in blood flow, the elastic characteristics and dynamic changes of the RBC induce a complex velocity and stress relationship, resulting in the incompatibility of blood flow characterization through standard presumptions of constant viscosity used for Newtonian fluid flow. Blood flow is categorized as a viscoelastic non-Newtonian fluid flow where constitutive equations governing this type of flow take into consideration the nonlinear viscometric properties of blood. To mathematically characterize the evolving blood viscosity and the relationship between the elasticity of RBC and the shear blood flow, respectively, across space and time of the system, a stress tensor (τ) defined by constitutive models is often coupled in the Navier–Stokes equation to account for the collective impact of the constant dynamic viscosity (η) and the elasticity from RBCs on blood flow.The dynamic viscosity of blood is heavily dependent on the shear stress applied to the cell and various parameters from the blood such as hematocrit value, plasma viscosity, mechanical properties of the RBC membrane, and red blood cell aggregation rate. The apparent blood viscosity is considered convenient for the characterization of the relationship between the evolving blood viscosity and shear rate, which can be defined by Casson’s law, as shown in eq 1.

𝜇=𝜏0𝛾˙+2𝜂𝜏0𝛾˙⎯⎯⎯⎯⎯⎯⎯√+𝜂�=�0�˙+2��0�˙+�

(1)where τ

0 is the yield stress–stress required to initiate blood flow motion, η is the Casson rheological constant, and γ̇ is the shear rate. The value of Casson’s law parameters under blood with normal hematocrit level can be defined as τ

0 = 0.0056 Pa and η = 0.0035 Pa·s. 

(23) With the known property of blood and Casson’s law parameters, an approximation can be made to the dynamic viscosity under various flow condition domains. The Power Law model is often employed to characterize the dynamic viscosity in relation to the shear rate, since precise solutions exist for specific geometries and flow circumstances, acting as a fundamental standard for definition. The Carreau and Carreau–Yasuda models can be advantageous over the Power Law model due to their ability to evaluate the dynamic viscosity at low to zero shear rate conditions. However, none of the above-mentioned models consider the memory or other elastic behavior of blood and its RBCs. Some other commonly used mathematical models and their constants for the non-Newtonian viscosity property characterization of blood are listed in Table 1 below. 

(24−26)Table 1. Comparison of Various Non-Newtonian Models for Blood Viscosity 

(24−26)

ModelNon-Newtonian ViscosityParameters
Power Law(2)n = 0.61, k = 0.42
Carreau(3)μ0 = 0.056 Pa·s, μ = 0.00345 Pa·s, λ = 3.1736 s, m = 2.406, a = 0.254
Walburn–Schneck(4)C1 = 0.000797 Pa·s, C2 = 0.0608 Pa·s, C3 = 0.00499, C4 = 14.585 g–1, TPMA = 25 g/L
Carreau–Yasuda(5)μ0 = 0.056 Pa·s, μ = 0.00345 Pa·s, λ = 1.902 s, n = 0.22, a = 1.25
Quemada(6)μp = 0.0012 Pa·s, k = 2.07, k0 = 4.33, γ̇c = 1.88 s–1

The blood rheology is commonly known to be influenced by two key physiological factors, namely, the hematocrit value (H

t) and the fibrinogen concentration (c

f), with an average value of 42% and 0.252 gd·L

–1, respectively. Particularly in low shear conditions, the presence of varying fibrinogen concentrations affects the tendency for aggregation and rouleaux formation, while the occurrence of aggregation is contingent upon specific levels of hematocrit. 

(27) The study from Apostolidis et al. 

(28) modifies the Casson model through emphasizing its reliance on hematocrit and fibrinogen concentration parameter values, owing to the extensive knowledge of the two physiological blood parameters.The viscoelastic response of blood is heavily dependent on the elasticity of the RBC, which is defined by the relationship between the deformation and stress relaxation from RBCs under a specific location of shear flow as a function of the velocity field. The stress tensor is usually characterized by constitutive equations such as the Upper-Convected Maxwell Model 

(29) and the Oldroyd-B model 

(30) to track the molecule effects under shear from different driving forces. The prominent non-Newtonian features, such as shear thinning and yield stress, have played a vital role in the characterization of blood rheology, particularly with respect to the evaluation of yield stress under low shear conditions. The nature of stress measurement in blood, typically on the order of 1 mPa, is challenging due to its low magnitude. The occurrence of the CFL complicates the measurement further due to the significant decrease in apparent viscosity near the wall over time and a consequential disparity in viscosity compared to the bulk region.In addition to shear thinning viscosity and yield stress, the formation of aggregation (rouleaux) from RBCs under low shear rates also contributes to the viscoelasticity under transient flow 

(31) and thixotropy 

(32) of whole blood. Given the difficulty in evaluating viscoelastic behavior of blood under low strain magnitudes and limitations in generalized Newtonian models, the utilization of viscoelastic models is advocated to encompass elasticity and delineate non-shear components within the stress tensor. Extending from the Oldroyd-B model, Anand et al. 

(33) developed a viscoelastic model framework for adapting elasticity within blood samples and predicting non-shear stress components. However, to also address the thixotropic effects, the model developed by Horner et al. 

(34) serves as a more comprehensive approach than the viscoelastic model from Anand et al. Thixotropy 

(32) typically occurs from the structural change of the rouleaux, where low shear rate conditions induce rouleaux formation. Correspondingly, elasticity increases, while elasticity is more representative of the isolated RBCs, under high shear rate conditions. The model of Horner et al. 

(34) considers the contribution of rouleaux to shear stress, taking into account factors such as the characteristic time for Brownian aggregation, shear-induced aggregation, and shear-induced breakage. Subsequent advancements in the model from Horner et al. often revolve around refining the three aforementioned key terms for a more substantial characterization of rouleaux dynamics. Notably, this has led to the recently developed mHAWB model 

(35) and other model iterations to enhance the accuracy of elastic and viscoelastic contributions to blood rheology, including the recently improved model suggested by Armstrong et al. 

(36)

2.2.2. Numerical Methods (FDM, FEM, FVM)

Numerical simulation has become increasingly more significant in analyzing the geometry, boundary layers of flow, and nonlinearity of hyperbolic viscoelastic flow constitutive equations. CFD is a powerful and efficient tool utilizing numerical methods to solve the governing hydrodynamic equations, such as the Navier–Stokes (N–S) equation, continuity equation, and energy conservation equation, for qualitative evaluation of fluid motion dynamics under different parameters. CFD overcomes the challenge of analytically solving nonlinear forms of differential equations by employing numerical methods such as the Finite-Difference Method (FDM), Finite-Element Method (FEM), and Finite-Volume Method (FVM) to discretize and solve the partial differential equations (PDEs), allowing for qualitative reproduction of transport phenomena and experimental observations. Different numerical methods are chosen to cope with various transport systems for optimization of the accuracy of the result and control of error during the discretization process.FDM is a straightforward approach to discretizing PDEs, replacing the continuum representation of equations with a set of finite-difference equations, which is typically applied to structured grids for efficient implementation in CFD programs. 

(37) However, FDM is often limited to simple geometries such as rectangular or block-shaped geometries and struggles with curved boundaries. In contrast, FEM divides the fluid domain into small finite grids or elements, approximating PDEs through a local description of physics. 

(38) All elements contribute to a large, sparse matrix solver. However, FEM may not always provide accurate results for systems involving significant deformation and aggregation of particles like RBCs due to large distortion of grids. 

(39) FVM evaluates PDEs following the conservation laws and discretizes the selected flow domain into small but finite size control volumes, with each grid at the center of a finite volume. 

(40) The divergence theorem allows the conversion of volume integrals of PDEs with divergence terms into surface integrals of surface fluxes across cell boundaries. Due to its conservation property, FVM offers efficient outcomes when dealing with PDEs that embody mass, momentum, and energy conservation principles. Furthermore, widely accessible software packages like the OpenFOAM toolbox 

(41) include a viscoelastic solver, making it an attractive option for viscoelastic fluid flow modeling. 

(42)

2.2.3. Modeling Methods of Blood Flow Dynamics

The complexity in the blood flow simulation arises from deformability and aggregation that RBCs exhibit during their interaction with neighboring cells under different shear rate conditions induced by blood flow. Numerical models coupled with simulation programs have been applied as a groundbreaking method to predict such unique rheological behavior exhibited by RBCs and whole blood. The conventional approach of a single-phase flow simulation is often applied to blood flow simulations within large vessels possessing a moderate shear rate. However, such a method assumes the properties of plasma, RBCs and other cellular components to be evenly distributed as average density and viscosity in blood, resulting in the inability to simulate the mechanical dynamics, such as RBC aggregation under high-shear flow field, inherent in RBCs. To accurately describe the asymmetric distribution of RBC and blood flow, multiphase flow simulation, where numerical simulations of blood flows are often modeled as two immiscible phases, RBCs and blood plasma, is proposed. A common assumption is that RBCs exhibit non-Newtonian behavior while the plasma is treated as a continuous Newtonian phase.Numerous multiphase numerical models have been proposed to simulate the influence of RBCs on blood flow dynamics by different assumptions. In large-scale simulations (above the millimeter range), continuum-based methods are wildly used due to their lower computational demands. 

(43) Eulerian multiphase flow simulations offer the solution of a set of conservation equations for each separate phase and couple the phases through common pressure and interphase exchange coefficients. Xu et al. 

(44) utilized the combined finite-discrete element method (FDEM) to replicate the dynamic behavior and distortion of RBCs subjected to fluidic forces, utilizing the Johnson–Kendall–Roberts model 

(45) to define the adhesive forces of cell-to-cell interactions. The iterative direct-forcing immersed boundary method (IBM) is commonly employed in simulations of the fluid–cell interface of blood. This method effectively captures the intricacies of the thin and flexible RBC membranes within various external flow fields. 

(46) The study by Xu et al. 

(44) also adopts this approach to bridge the fluid dynamics and RBC deformation through IBM. Yoon and You utilized the Maxwell model to define the viscosity of the RBC membrane. 

(47) It was discovered that the Maxwell model could represent the stress relaxation and unloading processes of the cell. Furthermore, the reduced flexibility of an RBC under particular situations such as infection is specified, which was unattainable by the Kelvin–Voigt model 

(48) when compared to the Maxwell model in the literature. The Yeoh hyperplastic material model was also adapted to predict the nonlinear elasticity property of RBCs with FEM employed to discretize the RBC membrane using shell-type elements. Gracka et al. 

(49) developed a numerical CFD model with a finite-volume parallel solver for multiphase blood flow simulation, where an updated Maxwell viscoelasticity model and a Discrete Phase Model are adopted. In the study, the adapted IBM, based on unstructured grids, simulates the flow behavior and shape change of the RBCs through fluid-structure coupling. It was found that the hybrid Euler–Lagrange (E–L) approach 

(50) for the development of the multiphase model offered better results in the simulated CFL region in the microchannels.To study the dynamics of individual behaviors of RBCs and the consequent non-Newtonian blood flow, cell-shape-resolved computational models are often adapted. The use of the boundary integral method has become prevalent in minimizing computational expenses, particularly in the exclusive determination of fluid velocity on the surfaces of RBCs, incorporating the option of employing IBM or particle-based techniques. The cell-shaped-resolved method has enabled an examination of cell to cell interactions within complex ambient or pulsatile flow conditions 

(51) surrounding RBC membranes. Recently, Rydquist et al. 

(52) have looked to integrate statistical information from macroscale simulations to obtain a comprehensive overview of RBC behavior within the immediate proximity of the flow through introduction of respective models characterizing membrane shape definition, tension, bending stresses of RBC membranes.At a macroscopic scale, continuum models have conventionally been adapted for assessing blood flow dynamics through the application of elasticity theory and fluid dynamics. However, particle-based methods are known for their simplicity and adaptability in modeling complex multiscale fluid structures. Meshless methods, such as the boundary element method (BEM), smoothed particle hydrodynamics (SPH), and dissipative particle dynamics (DPD), are often used in particle-based characterization of RBCs and the surrounding fluid. By representing the fluid as discrete particles, meshless methods provide insights into the status and movement of the multiphase fluid. These methods allow for the investigation of cellular structures and microscopic interactions that affect blood rheology. Non-confronting mesh methods like IBM can also be used to couple a fluid solver such as FEM, FVM, or the Lattice Boltzmann Method (LBM) through membrane representation of RBCs. In comparison to conventional CFD methods, LBM has been viewed as a favorable numerical approach for solving the N–S equations and the simulation of multiphase flows. LBM exhibits the notable advantage of being amenable to high-performance parallel computing environments due to its inherently local dynamics. In contrast to DPD and SPH where RBC membranes are modeled as physically interconnected particles, LBM employs the IBM to account for the deformation dynamics of RBCs 

(53,54) under shear flows in complex channel geometries. 

(54,55) However, it is essential to acknowledge that the utilization of LBM in simulating RBC flows often entails a significant computational overhead, being a primary challenge in this context. Krüger et al. 

(56) proposed utilizing LBM as a fluid solver, IBM to couple the fluid and FEM to compute the response of membranes to deformation under immersed fluids. This approach decouples the fluid and membranes but necessitates significant computational effort due to the requirements of both meshes and particles.Despite the accuracy of current blood flow models, simulating complex conditions remains challenging because of the high computational load and cost. Balachandran Nair et al. 

(57) suggested a reduced order model of RBC under the framework of DEM, where the RBC is represented by overlapping constituent rigid spheres. The Morse potential force is adapted to account for the RBC aggregation exhibited by cell to cell interactions among RBCs at different distances. Based upon the IBM, the reduced-order RBC model is adapted to simulate blood flow transport for validation under both single and multiple RBCs with a resolved CFD-DEM solver. 

(58) In the resolved CFD-DEM model, particle sizes are larger than the grid size for a more accurate computation of the surrounding flow field. A continuous forcing approach is taken to describe the momentum source of the governing equation prior to discretization, which is different from a Direct Forcing Method (DFM). 

(59) As no body-conforming moving mesh is required, the continuous forcing approach offers lower complexity and reduced cost when compared to the DFM. Piquet et al. 

(60) highlighted the high complexity of the DFM due to its reliance on calculating an additional immersed boundary flux for the velocity field to ensure its divergence-free condition.The fluid–structure interaction (FSI) method has been advocated to connect the dynamic interplay of RBC membranes and fluid plasma within blood flow such as the coupling of continuum–particle interactions. However, such methodology is generally adapted for anatomical configurations such as arteries 

(61,62) and capillaries, 

(63) where both the structural components and the fluid domain undergo substantial deformation due to the moving boundaries. Due to the scope of the Review being blood flow simulation within microchannels of LOC devices without deformable boundaries, the Review of the FSI method will not be further carried out.In general, three numerical methods are broadly used: mesh-based, particle-based, and hybrid mesh–particle techniques, based on the spatial scale and the fundamental numerical approach, mesh-based methods tend to neglect the effects of individual particles, assuming a continuum and being efficient in terms of time and cost. However, the particle-based approach highlights more of the microscopic and mesoscopic level, where the influence of individual RBCs is considered. A review from Freund et al. 

(64) addressed the three numerical methodologies and their respective modeling approaches of RBC dynamics. Given the complex mechanics and the diverse levels of study concerning numerical simulations of blood and cellular flow, a broad spectrum of numerical methods for blood has been subjected to extensive review. 

(64−70) Ye at al. 

(65) offered an extensive review of the application of the DPD, SPH, and LBM for numerical simulations of RBC, while Rathnayaka et al. 

(67) conducted a review of the particle-based numerical modeling for liquid marbles through drawing parallels to the transport of RBCs in microchannels. A comparative analysis between conventional CFD methods and particle-based approaches for cellular and blood flow dynamic simulation can be found under the review by Arabghahestani et al. 

(66) Literature by Li et al. 

(68) and Beris et al. 

(69) offer an overview of both continuum-based models at micro/macroscales and multiscale particle-based models encompassing various length and temporal dimensions. Furthermore, these reviews deliberate upon the potential of coupling continuum-particle methods for blood plasma and RBC modeling. Arciero et al. 

(70) investigated various modeling approaches encompassing cellular interactions, such as cell to cell or plasma interactions and the individual cellular phases. A concise overview of the reviews is provided in Table 2 for reference.

Table 2. List of Reviews for Numerical Approaches Employed in Blood Flow Simulation

ReferenceNumerical methods
Li et al. (2013) (68)Continuum-based modeling (BIM), particle-based modeling (LBM, LB-FE, SPH, DPD)
Freund (2014) (64)RBC dynamic modeling (continuum-based modeling, complementary discrete microstructure modeling), blood flow dynamic modeling (FDM, IBM, LBM, particle-mesh methods, coupled boundary integral and mesh-based methods, DPD)
Ye et al. (2016) (65)DPD, SPH, LBM, coupled IBM-Smoothed DPD
Arciero et al. (2017) (70)LBM, IBM, DPD, conventional CFD Methods (FDM, FVM, FEM)
Arabghahestani et al. (2019) (66)Particle-based methods (LBM, DPD, direct simulation Monte Carlo, molecular dynamics), SPH, conventional CFD methods (FDM, FVM, FEM)
Beris et al. (2021) (69)DPD, smoothed DPD, IBM, LBM, BIM
Rathnayaka (2022) (67)SPH, CG, LBM

3. Capillary Driven Blood Flow in LOC Systems

ARTICLE SECTIONS

Jump To


3.1. Capillary Driven Flow Phenomena

Capillary driven (CD) flow is a pivotal mechanism in passive microfluidic flow systems 

(9) such as the blood circulation system and LOC systems. 

(71) CD flow is essentially the movement of a liquid to flow against drag forces, where the capillary effect exerts a force on the liquid at the borders, causing a liquid–air meniscus to flow despite gravity or other drag forces. A capillary pressure drops across the liquid–air interface with surface tension in the capillary radius and contact angle. The capillary effect depends heavily on the interaction between the different properties of surface materials. Different values of contact angles can be manipulated and obtained under varying levels of surface wettability treatments to manipulate the surface properties, resulting in different CD blood delivery rates for medical diagnostic device microchannels. CD flow techniques are appealing for many LOC devices, because they require no external energy. However, due to the passive property of liquid propulsion by capillary forces and the long-term instability of surface treatments on channel walls, the adaptability of CD flow in geometrically complex LOC devices may be limited.

3.2. Theoretical and Numerical Modeling of Capillary Driven Blood Flow

3.2.1. Theoretical Basis and Assumptions of Microfluidic Flow

The study of transport phenomena regarding either blood flow driven by capillary forces or externally applied forces under microfluid systems all demands a comprehensive recognition of the significant differences in flow dynamics between microscale and macroscale. The fundamental assumptions and principles behind fluid transport at the microscale are discussed in this section. Such a comprehension will lay the groundwork for the following analysis of the theoretical basis of capillary forces and their role in blood transport in LOC systems.

At the macroscale, fluid dynamics are often strongly influenced by gravity due to considerable fluid mass. However, the high surface to volume ratio at the microscale shifts the balance toward surface forces (e.g., surface tension and viscous forces), much larger than the inertial force. This difference gives rise to transport phenomena unique to microscale fluid transport, such as the prevalence of laminar flow due to a very low Reynolds number (generally lower than 1). Moreover, the fluid in a microfluidic system is often assumed to be incompressible due to the small flow velocity, indicating constant fluid density in both space and time.Microfluidic flow behaviors are governed by the fundamental principles of mass and momentum conservation, which are encapsulated in the continuity equation and the Navier–Stokes (N–S) equation. The continuity equation describes the conservation of mass, while the N–S equation captures the spatial and temporal variations in velocity, pressure, and other physical parameters. Under the assumption of the negligible influence of gravity in microfluidic systems, the continuity equation and the Eulerian representation of the incompressible N–S equation can be expressed as follows:

∇·𝐮⇀=0∇·�⇀=0

(7)

−∇𝑝+𝜇∇2𝐮⇀+∇·𝝉⇀−𝐅⇀=0−∇�+�∇2�⇀+∇·�⇀−�⇀=0

(8)Here, p is the pressure, u is the fluid viscosity, 

𝝉⇀�⇀ represents the stress tensor, and F is the body force exerted by external forces if present.

3.2.2. Theoretical Basis and Modeling of Capillary Force in LOC Systems

The capillary force is often the major driving force to manipulate and transport blood without an externally applied force in LOC systems. Forces induced by the capillary effect impact the free surface of fluids and are represented not directly in the Navier–Stokes equations but through the pressure boundary conditions of the pressure term p. For hydrophilic surfaces, the liquid generally induces a contact angle between 0° and 30°, encouraging the spread and attraction of fluid under a positive cos θ condition. For this condition, the pressure drop becomes positive and generates a spontaneous flow forward. A hydrophobic solid surface repels the fluid, inducing minimal contact. Generally, hydrophobic solids exhibit a contact angle larger than 90°, inducing a negative value of cos θ. Such a value will result in a negative pressure drop and a flow in the opposite direction. The induced contact angle is often utilized to measure the wall exposure of various surface treatments on channel walls where different wettability gradients and surface tension effects for CD flows are established. Contact angles between different interfaces are obtainable through standard values or experimental methods for reference. 

(72)For the characterization of the induced force by the capillary effect, the Young–Laplace (Y–L) equation 

(73) is widely employed. In the equation, the capillary is considered a pressure boundary condition between the two interphases. Through the Y–L equation, the capillary pressure force can be determined, and subsequently, the continuity and momentum balance equations can be solved to obtain the blood filling rate. Kim et al. 

(74) studied the effects of concentration and exposure time of a nonionic surfactant, Silwet L-77, on the performance of a polydimethylsiloxane (PDMS) microchannel in terms of plasma and blood self-separation. The study characterized the capillary pressure force by incorporating the Y–L equation and further evaluated the effects of the changing contact angle due to different levels of applied channel wall surface treatments. The expression of the Y–L equation utilized by Kim et al. 

(74) is as follows:

𝑃=−𝜎(cos𝜃b+cos𝜃tℎ+cos𝜃l+cos𝜃r𝑤)�=−�(cos⁡�b+cos⁡�tℎ+cos⁡�l+cos⁡�r�)

(9)where σ is the surface tension of the liquid and θ

bθ

tθ

l, and θ

r are the contact angle values between the liquid and the bottom, top, left, and right walls, respectively. A numerical simulation through Coventor software is performed to evaluate the dynamic changes in the filling rate within the microchannel. The simulation results for the blood filling rate in the microchannel are expressed at a specific time stamp, shown in Figure 2. The results portray an increasing instantaneous filling rate of blood in the microchannel following the decrease in contact angle induced by a higher concentration of the nonionic surfactant treated to the microchannel wall.

Figure 2. Numerical simulation of filling rate of capillary driven blood flow under various contact angle conditions at a specific timestamp. (74) Reproduced with permission from ref (74). Copyright 2010 Elsevier.

When in contact with hydrophilic or hydrophobic surfaces, blood forms a meniscus with a contact angle due to surface tension. The Lucas–Washburn (L–W) equation 

(75) is one of the pioneering theoretical definitions for the position of the meniscus over time. In addition, the L–W equation provides the possibility for research to obtain the velocity of the blood formed meniscus through the derivation of the meniscus position. The L–W equation 

(75) can be shown below:

𝐿(𝑡)=𝑅𝜎cos(𝜃)𝑡2𝜇⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯√�(�)=��⁡cos(�)�2�

(10)Here L(t) represents the distance of the liquid driven by the capillary forces. However, the generalized L–W equation solely assumes the constant physical properties from a Newtonian fluid rather than considering the non-Newtonian fluid behavior of blood. Cito et al. 

(76) constructed an enhanced version of the L–W equation incorporating the power law to consider the RBC aggregation and the FL effect. The non-Newtonian fluid apparent viscosity under the Power Law model is defined as

𝜇=𝑘·(𝛾˙)𝑛−1�=�·(�˙)�−1

(11)where γ̇ is the strain rate tensor defined as 

𝛾˙=12𝛾˙𝑖𝑗𝛾˙𝑗𝑖⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯√�˙=12�˙���˙��. The stress tensor term τ is computed as τ = μγ̇

ij. The updated L–W equation by Cito 

(76) is expressed as

𝐿(𝑡)=𝑅[(𝑛+13𝑛+1)(𝜎cos(𝜃)𝑅𝑘)1/𝑛𝑡]𝑛/𝑛+1�(�)=�[(�+13�+1)(�⁡cos(�)��)1/��]�/�+1

(12)where k is the flow consistency index and n is the power law index, respectively. The power law index, from the Power Law model, characterizes the extent of the non-Newtonian behavior of blood. Both the consistency and power law index rely on blood properties such as hematocrit, the appearance of the FL effect, the formation of RBC aggregates, etc. The updated L–W equation computes the location and velocity of blood flow caused by capillary forces at specified time points within the LOC devices, taking into account the effects of blood flow characteristics such as RBC aggregation and the FL effect on dynamic blood viscosity.Apart from the blood flow behaviors triggered by inherent blood properties, unique flow conditions driven by capillary forces that are portrayed under different microchannel geometries also hold crucial implications for CD blood delivery. Berthier et al. 

(77) studied the spontaneous Concus–Finn condition, the condition to initiate the spontaneous capillary flow within a V-groove microchannel, as shown in Figure 3(a) both experimentally and numerically. Through experimental studies, the spontaneous Concus–Finn filament development of capillary driven blood flow is observed, as shown in Figure 3(b), while the dynamic development of blood flow is numerically simulated through CFD simulation.

Figure 3. (a) Sketch of the cross-section of Berthier’s V-groove microchannel, (b) experimental view of blood in the V-groove microchannel, (78) (c) illustration of the dynamic change of the extension of filament from FLOW 3D under capillary flow at three increasing time intervals. (78) Reproduced with permission from ref (78). Copyright 2014 Elsevier.

Berthier et al. 

(77) characterized the contact angle needed for the initiation of the capillary driving force at a zero-inlet pressure, through the half-angle (α) of the V-groove geometry layout, and its relation to the Concus–Finn filament as shown below:

𝜃<𝜋2−𝛼sin𝛼1+2(ℎ2/𝑤)sin𝛼<cos𝜃{�<�2−�sin⁡�1+2(ℎ2/�)⁡sin⁡�<cos⁡�

(13)Three possible regimes were concluded based on the contact angle value for the initiation of flow and development of Concus–Finn filament:

𝜃>𝜃1𝜃1>𝜃>𝜃0𝜃0no SCFSCF without a Concus−Finn filamentSCF without a Concus−Finn filament{�>�1no SCF�1>�>�0SCF without a Concus−Finn filament�0SCF without a Concus−Finn filament

(14)Under Newton’s Law, the force balance with low Reynolds and Capillary numbers results in the neglect of inertial terms. The force balance between the capillary forces and the viscous force induced by the channel wall is proposed to derive the analytical fluid velocity. This relation between the two forces offers insights into the average flow velocity and the penetration distance function dependent on time. The apparent blood viscosity is defined by Berthier et al. 

(78) through Casson’s law, 

(23) given in eq 1. The research used the FLOW-3D program from Flow Science Inc. software, which solves transient, free-surface problems using the FDM in multiple dimensions. The Volume of Fluid (VOF) method 

(79) is utilized to locate and track the dynamic extension of filament throughout the advancing interface within the channel ahead of the main flow at three progressing time stamps, as depicted in Figure 3(c).

4. Electro-osmotic Flow (EOF) in LOC Systems

ARTICLE SECTIONS

Jump To


The utilization of external forces, such as electric fields, has significantly broadened the possibility of manipulating microfluidic flow in LOC systems. 

(80) Externally applied electric field forces induce a fluid flow from the movement of ions in fluid terms as the “electro-osmotic flow” (EOF).Unique transport phenomena, such as enhanced flow velocity and flow instability, induced by non-Newtonian fluids, particularly viscoelastic fluids, under EOF, have sparked considerable interest in microfluidic devices with simple or complicated geometries within channels. 

(81) However, compared to the study of Newtonian fluids and even other electro-osmotic viscoelastic fluid flows, the literature focusing on the theoretical and numerical modeling of electro-osmotic blood flow is limited due to the complexity of blood properties. Consequently, to obtain a more comprehensive understanding of the complex blood flow behavior under EOF, theoretical and numerical studies of the transport phenomena in the EOF section will be based on the studies of different viscoelastic fluids under EOF rather than that of blood specifically. Despite this limitation, we believe these studies offer valuable insights that can help understand the complex behavior of blood flow under EOF.

4.1. EOF Phenomena

Electro-osmotic flow occurs at the interface between the microchannel wall and bulk phase solution. When in contact with the bulk phase, solution ions are absorbed or dissociated at the solid–liquid interface, resulting in the formation of a charge layer, as shown in Figure 4. This charged channel surface wall interacts with both negative and positive ions in the bulk sample, causing repulsion and attraction forces to create a thin layer of immobilized counterions, known as the Stern layer. The induced electric potential from the wall gradually decreases with an increase in the distance from the wall. The Stern layer potential, commonly termed the zeta potential, controls the intensity of the electrostatic interactions between mobile counterions and, consequently, the drag force from the applied electric field. Next to the Stern layer is the diffuse mobile layer, mainly composed of a mobile counterion. These two layers constitute the “electrical double layer” (EDL), the thickness of which is directly proportional to the ionic strength (concentration) of the bulk fluid. The relationship between the two parameters is characterized by a Debye length (λ

D), expressed as

𝜆𝐷=𝜖𝑘B𝑇2(𝑍𝑒)2𝑐0⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯√��=��B�2(��)2�0

(15)where ϵ is the permittivity of the electrolyte solution, k

B is the Boltzmann constant, T is the electron temperature, Z is the integer valence number, e is the elementary charge, and c

0 is the ionic density.

Figure 4. Schematic diagram of an electro-osmotic flow in a microchannel with negative surface charge. (82) Reproduced with permission from ref (82). Copyright 2012 Woodhead Publishing.

When an electric field is applied perpendicular to the EDL, viscous drag is generated due to the movement of excess ions in the EDL. Electro-osmotic forces can be attributed to the externally applied electric potential (ϕ) and the zeta potential, the system wall induced potential by charged walls (ψ). As illustrated in Figure 4, the majority of ions in the bulk phase have a uniform velocity profile, except for a shear rate condition confined within an extremely thin Stern layer. Therefore, EOF displays a unique characteristic of a “near flat” or plug flow velocity profile, different from the parabolic flow typically induced by pressure-driven microfluidic flow (Hagen–Poiseuille flow). The plug-shaped velocity profile of the EOF possesses a high shear rate above the Stern layer.Overall, the EOF velocity magnitude is typically proportional to the Debye Length (λ

D), zeta potential, and magnitude of the externally applied electric field, while a more viscous liquid reduces the EOF velocity.

4.2. Modeling on Electro-osmotic Viscoelastic Fluid Flow

4.2.1. Theoretical Basis of EOF Mechanisms

The EOF of an incompressible viscoelastic fluid is commonly governed by the continuity and incompressible N–S equations, as shown in eqs 7 and 8, where the stress tensor and the electrostatic force term are coupled. The electro-osmotic body force term F, representing the body force exerted by the externally applied electric force, is defined as 

𝐹⇀=𝑝𝐸𝐸⇀�⇀=���⇀, where ρ

E and 

𝐸⇀�⇀ are the net electric charge density and the applied external electric field, respectively.Numerous models are established to theoretically study the externally applied electric potential and the system wall induced potential by charged walls. The following Laplace equation, expressed as eq 16, is generally adapted and solved to calculate the externally applied potential (ϕ).

∇2𝜙=0∇2�=0

(16)Ion diffusion under applied electric fields, together with mass transport resulting from convection and diffusion, transports ionic solutions in bulk flow under electrokinetic processes. The Nernst–Planck equation can describe these transport methods, including convection, diffusion, and electro-diffusion. Therefore, the Nernst–Planck equation is used to determine the distribution of the ions within the electrolyte. The electric potential induced by the charged channel walls follows the Poisson–Nernst–Plank (PNP) equation, which can be written as eq 17.

∇·[𝐷𝑖∇𝑛𝑖−𝑢⇀𝑛𝑖+𝑛𝑖𝐷𝑖𝑧𝑖𝑒𝑘𝑏𝑇∇(𝜙+𝜓)]=0∇·[��∇��−�⇀��+����������∇(�+�)]=0

(17)where D

in

i, and z

i are the diffusion coefficient, ionic concentration, and ionic valence of the ionic species I, respectively. However, due to the high nonlinearity and numerical stiffness introduced by different lengths and time scales from the PNP equations, the Poisson–Boltzmann (PB) model is often considered the major simplified method of the PNP equation to characterize the potential distribution of the EDL region in microchannels. In the PB model, it is assumed that the ionic species in the fluid follow the Boltzmann distribution. This model is typically valid for steady-state problems where charge transport can be considered negligible, the EDLs do not overlap with each other, and the intrinsic potentials are low. It provides a simplified representation of the potential distribution in the EDL region. The PB equation governing the EDL electric potential distribution is described as

∇2𝜓=(2𝑒𝑧𝑛0𝜀𝜀0)sinh(𝑧𝑒𝜓𝑘b𝑇)∇2�=(2���0��0)⁡sinh(����b�)

(18)where n

0 is the ion bulk concentration, z is the ionic valence, and ε

0 is the electric permittivity in the vacuum. Under low electric potential conditions, an even further simplified model to illustrate the EOF phenomena is the Debye–Hückel (DH) model. The DH model is derived by obtaining a charge density term by expanding the exponential term of the Boltzmann equation in a Taylor series.

4.2.2. EOF Modeling for Viscoelastic Fluids

Many studies through numerical modeling were performed to obtain a deeper understanding of the effect exhibited by externally applied electric fields on viscoelastic flow in microchannels under various geometrical designs. Bello et al. 

(83) found that methylcellulose solution, a non-Newtonian polymer solution, resulted in stronger electro-osmotic mobility in experiments when compared to the predictions by the Helmholtz–Smoluchowski equation, which is commonly used to define the velocity of EOF of a Newtonian fluid. Being one of the pioneers to identify the discrepancies between the EOF of Newtonian and non-Newtonian fluids, Bello et al. attributed such discrepancies to the presence of a very high shear rate in the EDL, resulting in a change in the orientation of the polymer molecules. Park and Lee 

(84) utilized the FVM to solve the PB equation for the characterization of the electric field induced force. In the study, the concept of fractional calculus for the Oldroyd-B model was adapted to illustrate the elastic and memory effects of viscoelastic fluids in a straight microchannel They observed that fluid elasticity and increased ratio of viscoelastic fluid contribution to overall fluid viscosity had a significant impact on the volumetric flow rate and sensitivity of velocity to electric field strength compared to Newtonian fluids. Afonso et al. 

(85) derived an analytical expression for EOF of viscoelastic fluid between parallel plates using the DH model to account for a zeta potential condition below 25 mV. The study established the understanding of the electro-osmotic viscoelastic fluid flow under low zeta potential conditions. Apart from the electrokinetic forces, pressure forces can also be coupled with EOF to generate a unique fluid flow behavior within the microchannel. Sousa et al. 

(86) analytically studied the flow of a standard viscoelastic solution by combining the pressure gradient force with an externally applied electric force. It was found that, at a near wall skimming layer and the outer layer away from the wall, macromolecules migrating away from surface walls in viscoelastic fluids are observed. In the study, the Phan-Thien Tanner (PTT) constitutive model is utilized to characterize the viscoelastic properties of the solution. The approach is found to be valid when the EDL is much thinner than the skimming layer under an enhanced flow rate. Zhao and Yang 

(87) solved the PB equation and Carreau model for the characterization of the EOF mechanism and non-Newtonian fluid respectively through the FEM. The numerical results depict that, different from the EOF of Newtonian fluids, non-Newtonian fluids led to an increase of electro-osmotic mobility for shear thinning fluids but the opposite for shear thickening fluids.Like other fluid transport driving forces, EOF within unique geometrical layouts also portrays unique transport phenomena. Pimenta and Alves 

(88) utilized the FVM to perform numerical simulations of the EOF of viscoelastic fluids considering the PB equation and the Oldroyd-B model, in a cross-slot and flow-focusing microdevices. It was found that electroelastic instabilities are formed due to the development of large stresses inside the EDL with streamlined curvature at geometry corners. Bezerra et al. 

(89) used the FDM to numerically analyze the vortex formation and flow instability from an electro-osmotic non-Newtonian fluid flow in a microchannel with a nozzle geometry and parallel wall geometry setting. The PNP equation is utilized to characterize the charge motion in the EOF and the PTT model for non-Newtonian flow characterization. A constriction geometry is commonly utilized in blood flow adapted in LOC systems due to the change in blood flow behavior under narrow dimensions in a microchannel. Ji et al. 

(90) recently studied the EOF of viscoelastic fluid in a constriction microchannel connected by two relatively big reservoirs on both ends (as seen in Figure 5) filled with the polyacrylamide polymer solution, a viscoelastic fluid, and an incompressible monovalent binary electrolyte solution KCl.

Figure 5. Schematic diagram of a negatively charged constriction microchannel connected to two reservoirs at both ends. An electro-osmotic flow is induced in the system by the induced potential difference between the anode and cathode. (90) Reproduced with permission from ref (90). Copyright 2021 The Authors, under the terms of the Creative Commons (CC BY 4.0) License https://creativecommons.org/licenses/by/4.0/.

In studying the EOF of viscoelastic fluids, the Oldroyd-B model is often utilized to characterize the polymeric stress tensor and the deformation rate of the fluid. The Oldroyd-B model is expressed as follows:

𝜏=𝜂p𝜆(𝐜−𝐈)�=�p�(�−�)

(19)where η

p, λ, c, and I represent the polymer dynamic viscosity, polymer relaxation time, symmetric conformation tensor of the polymer molecules, and the identity matrix, respectively.A log-conformation tensor approach is taken to prevent convergence difficulty induced by the viscoelastic properties. The conformation tensor (c) in the polymeric stress tensor term is redefined by a new tensor (Θ) based on the natural logarithm of the c. The new tensor is defined as

Θ=ln(𝐜)=𝐑ln(𝚲)𝐑Θ=ln(�)=�⁡ln(�)�

(20)in which Λ is the diagonal matrix and R is the orthogonal matrix.Under the new conformation tensor, the induced EOF of a viscoelastic fluid is governed by the continuity and N–S equations adapting the Oldroyd-B model, which is expressed as

∂𝚯∂𝑡+𝐮·∇𝚯=𝛀Θ−ΘΩ+2𝐁+1𝜆(eΘ−𝐈)∂�∂�+�·∇�=�Θ−ΘΩ+2�+1�(eΘ−�)

(21)where Ω and B represent the anti-symmetric matrix and the symmetric traceless matrix of the decomposition of the velocity gradient tensor ∇u, respectively. The conformation tensor can be recovered by c = exp(Θ). The PB model and Laplace equation are utilized to characterize the charged channel wall induced potential and the externally applied potential.The governing equations are numerically solved through the FVM by RheoTool, 

(42) an open-source viscoelastic EOF solver on the OpenFOAM platform. A SIMPLEC (Semi-Implicit Method for Pressure Linked Equations-Consistent) algorithm was applied to solve the velocity-pressure coupling. The pressure field and velocity field were computed by the PCG (Preconditioned Conjugate Gradient) solver and the PBiCG (Preconditioned Biconjugate Gradient) solver, respectively.Ranging magnitudes of an applied electric field or fluid concentration induce both different streamlines and velocity magnitudes at various locations and times of the microchannel. In the study performed by Ji et al., 

(90) notable fluctuation of streamlines and vortex formation is formed at the upper stream entrance of the constriction as shown in Figure 6(a) and (b), respectively, due to the increase of electrokinetic effect, which is seen as a result of the increase in polymeric stress (τ

xx). 

(90) The contraction geometry enhances the EOF velocity within the constriction channel under high E

app condition (600 V/cm). Such phenomena can be attributed to the dependence of electro-osmotic viscoelastic fluid flow on the system wall surface and bulk fluid properties. 

(91)

Figure 6. Schematic diagram of vortex formation and streamlines of EOF depicting flow instability at (a) 1.71 s and (b) 1.75 s. Spatial distribution of the elastic normal stress at (c) high Eapp condition. Streamline of an electro-osmotic flow under Eapp of 600 V/cm (90) for (d) non-Newtonian and (e) Newtonian fluid through a constriction geometry. Reproduced with permission from ref (90). Copyright 2021 The Authors, under the terms of the Creative Commons (CC BY 4.0) License https://creativecommons.org/licenses/by/4.0/.

As elastic normal stress exceeds the local shear stress, flow instability and vortex formation occur. The induced elastic stress under EOF not only enhances the instability of the flow but often generates an irregular secondary flow leading to strong disturbance. 

(92) It is also vital to consider the effect of the constriction layout of microchannels on the alteration of the field strength within the system. The contraction geometry enhances a larger electric field strength compared with other locations of the channel outside the constriction region, resulting in a higher velocity gradient and stronger extension on the polymer within the viscoelastic solution. Following the high shear flow condition, a higher magnitude of stretch for polymer molecules in viscoelastic fluids exhibits larger elastic stresses and enhancement of vortex formation at the region. 

(93)As shown in Figure 6(c), significant elastic normal stress occurs at the inlet of the constriction microchannel. Such occurrence of a polymeric flow can be attributed to the dominating elongational flow, giving rise to high deformation of the polymers within the viscoelastic fluid flow, resulting in higher elastic stress from the polymers. Such phenomena at the entrance result in the difference in velocity streamline as circled in Figure 6(d) compared to that of the Newtonian fluid at the constriction entrance in Figure 6(e). 

(90) The difference between the Newtonian and polymer solution at the exit, as circled in Figure 6(d) and (e), can be attributed to the extrudate swell effect of polymers 

(94) within the viscoelastic fluid flow. The extrudate swell effect illustrates that, as polymers emerge from the constriction exit, they tend to contract in the flow direction and grow in the normal direction, resulting in an extrudate diameter greater than the channel size. The deformation of polymers within the polymeric flow at both the entrance and exit of the contraction channel facilitates the change in shear stress conditions of the flow, leading to the alteration in streamlines of flows for each region.

4.3. EOF Applications in LOC Systems

4.3.1. Mixing in LOC Systems

Rather than relying on the micromixing controlled by molecular diffusion under low Reynolds number conditions, active mixers actively leverage convective instability and vortex formation induced by electro-osmotic flows from alternating current (AC) or direct current (DC) electric fields. Such adaptation is recognized as significant breakthroughs for promotion of fluid mixing in chemical and biological applications such as drug delivery, medical diagnostics, chemical synthesis, and so on. 

(95)Many researchers proposed novel designs of electro-osmosis micromixers coupled with numerical simulations in conjunction with experimental findings to increase their understanding of the role of flow instability and vortex formation in the mixing process under electrokinetic phenomena. Matsubara and Narumi 

(96) numerically modeled the mixing process in a microchannel with four electrodes on each side of the microchannel wall, which generated a disruption through unstable electro-osmotic vortices. It was found that particle mixing was sensitive to both the convection effect induced by the main and secondary vortex within the micromixer and the change in oscillation frequency caused by the supplied AC voltage when the Reynolds number was varied. Qaderi et al. 

(97) adapted the PNP equation to numerically study the effect of the geometry and zeta potential configuration of the microchannel on the mixing process with a combined electro-osmotic pressure driven flow. It was reported that the application of heterogeneous zeta potential configuration enhances the mixing efficiency by around 23% while the height of the hurdles increases the mixing efficiency at most 48.1%. Cho et al. 

(98) utilized the PB model and Laplace equation to numerically simulate the electro-osmotic non-Newtonian fluid mixing process within a wavy and block layout of microchannel walls. The Power Law model is adapted to describe the fluid rheological characteristic. It was found that shear-thinning fluids possess a higher volumetric flow rate, which could result in poorer mixing efficiency compared to that of Newtonian fluids. Numerous studies have revealed that flow instability and vortex generation, in particular secondary vortices produced by barriers or greater magnitudes of heterogeneous zeta potential distribution, enhance mixing by increasing bulk flow velocity and reducing flow distance.To better understand the mechanism of disturbance formed in the system due to externally applied forces, known as electrokinetic instability, literature often utilize the Rayleigh (Ra) number, 

(1) as described below:

𝑅𝑎𝑣=𝑢ev𝑢eo=(𝛾−1𝛾+1)2𝑊𝛿2𝐸el2𝐻2𝜁𝛿Ra�=�ev�eo=(�−1�+1)2��2�el2�2��

(22)where γ is the conductivity ratio of the two streams and can be written as 

𝛾=𝜎el,H𝜎el,L�=�el,H�el,L. The Ra number characterizes the ratio between electroviscous and electro-osmotic flow. A high Ra

v value often results in good mixing. It is evident that fluid properties such as the conductivity (σ) of the two streams play a key role in the formation of disturbances to enhance mixing in microsystems. At the same time, electrokinetic parameters like the zeta potential (ζ) in the Ra number is critical in the characterization of electro-osmotic velocity and a slip boundary condition at the microchannel wall.To understand the mixing result along the channel, the concentration field can be defined and simulated under the assumption of steady state conditions and constant diffusion coefficient for each of the working fluid within the system through the convection–diffusion equation as below:

∂𝑐𝒊∂𝑡+∇⇀(𝑐𝑖𝑢⇀−𝐷𝑖∇⇀𝑐𝒊)=0∂��∂�+∇⇀(���⇀−��∇⇀��)=0

(23)where c

i is the species concentration of species i and D

i is the diffusion coefficient of the corresponding species.The standard deviation of concentration (σ

sd) can be adapted to evaluate the mixing quality of the system. 

(97) The standard deviation for concentration at a specific portion of the channel may be calculated using the equation below:

𝜎sd=∫10(𝐶∗(𝑦∗)−𝐶m)2d𝑦∗∫10d𝑦∗⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯�sd=∫01(�*(�*)−�m)2d�*∫01d�*

(24)where C*(y*) and C

m are the non-dimensional concentration profile and the mean concentration at the portion, respectively. C* is the non-dimensional concentration and can be calculated as 

𝐶∗=𝐶𝐶ref�*=��ref, where C

ref is the reference concentration defined as the bulk solution concentration. The mean concentration profile can be calculated as 

𝐶m=∫10(𝐶∗(𝑦∗)d𝑦∗∫10d𝑦∗�m=∫01(�*(�*)d�*∫01d�*. With the standard deviation of concentration, the mixing efficiency 

(97) can then be calculated as below:

𝜀𝑥=1−𝜎sd𝜎sd,0��=1−�sd�sd,0

(25)where σ

sd,0 is the standard derivation of the case of no mixing. The value of the mixing efficiency is typically utilized in conjunction with the simulated flow field and concentration field to explore the effect of geometrical and electrokinetic parameters on the optimization of the mixing results.

5. Summary

ARTICLE SECTIONS

Jump To


5.1. Conclusion

Viscoelastic fluids such as blood flow in LOC systems are an essential topic to proceed with diagnostic analysis and research through microdevices in the biomedical and pharmaceutical industries. The complex blood flow behavior is tightly controlled by the viscoelastic characteristics of blood such as the dynamic viscosity and the elastic property of RBCs under various shear rate conditions. Furthermore, the flow behaviors under varied driving forces promote an array of microfluidic transport phenomena that are critical to the management of blood flow and other adapted viscoelastic fluids in LOC systems. This review addressed the blood flow phenomena, the complicated interplay between shear rate and blood flow behaviors, and their numerical modeling under LOC systems through the lens of the viscoelasticity characteristic. Furthermore, a theoretical understanding of capillary forces and externally applied electric forces leads to an in-depth investigation of the relationship between blood flow patterns and the key parameters of the two driving forces, the latter of which is introduced through the lens of viscoelastic fluids, coupling numerical modeling to improve the knowledge of blood flow manipulation in LOC systems. The flow disturbances triggered by the EOF of viscoelastic fluids and their impact on blood flow patterns have been deeply investigated due to their important role and applications in LOC devices. Continuous advancements of various numerical modeling methods with experimental findings through more efficient and less computationally heavy methods have served as an encouraging sign of establishing more accurate illustrations of the mechanisms for multiphase blood and other viscoelastic fluid flow transport phenomena driven by various forces. Such progress is fundamental for the manipulation of unique transport phenomena, such as the generated disturbances, to optimize functionalities offered by microdevices in LOC systems.

The following section will provide further insights into the employment of studied blood transport phenomena to improve the functionality of micro devices adapting LOC technology. A discussion of the novel roles that external driving forces play in microfluidic flow behaviors is also provided. Limitations in the computational modeling of blood flow and electrokinetic phenomena in LOC systems will also be emphasized, which may provide valuable insights for future research endeavors. These discussions aim to provide guidance and opportunities for new paths in the ongoing development of LOC devices that adapt blood flow.

5.2. Future Directions

5.2.1. Electro-osmosis Mixing in LOC Systems

Despite substantial research, mixing results through flow instability and vortex formation phenomena induced by electro-osmotic mixing still deviate from the effective mixing results offered by chaotic mixing results such as those seen in turbulent flows. However, recent discoveries of a mixing phenomenon that is generally observed under turbulent flows are found within electro-osmosis micromixers under low Reynolds number conditions. Zhao 

(99) experimentally discovered a rapid mixing process in an AC applied micromixer, where the power spectrum of concentration under an applied voltage of 20 V

p-p induces a −5/3 slope within a frequency range. This value of the slope is considered as the O–C spectrum in macroflows, which is often visible under relatively high Re conditions, such as the Taylor microscale Reynolds number Re > 500 in turbulent flows. 

(100) However, the Re value in the studied system is less than 1 at the specific location and applied voltage. A secondary flow is also suggested to occur close to microchannel walls, being attributed to the increase of convective instability within the system.Despite the experimental phenomenon proposed by Zhao et al., 

(99) the range of effects induced by vital parameters of an EOF mixing system on the enhanced mixing results and mechanisms of disturbance generated by the turbulent-like flow instability is not further characterized. Such a gap in knowledge may hinder the adaptability and commercialization of the discovery of micromixers. One of the parameters for further evaluation is the conductivity gradient of the fluid flow. A relatively strong conductivity gradient (5000:1) was adopted in the system due to the conductive properties of the two fluids. The high conductivity gradients may contribute to the relatively large Rayleigh number and differences in EDL layer thickness, resulting in an unusual disturbance in laminar flow conditions and enhanced mixing results. However, high conductivity gradients are not always achievable by the working fluids due to diverse fluid properties. The reliance on turbulent-like phenomena and rapid mixing results in a large conductivity gradient should be established to prevent the limited application of fluids for the mixing system. In addition, the proposed system utilizes distinct zeta potential distributions at the top and bottom walls due to their difference in material choices, which may be attributed to the flow instability phenomena. Further studies should be made on varying zeta potential magnitude and distribution to evaluate their effect on the slip boundary conditions of the flow and the large shear rate condition close to the channel wall of EOF. Such a study can potentially offer an optimized condition in zeta potential magnitude through material choices and geometrical layout of the zeta potential for better mixing results and manipulation of mixing fluid dynamics. The two vital parameters mentioned above can be varied with the aid of numerical simulation to understand the effect of parameters on the interaction between electro-osmotic forces and electroviscous forces. At the same time, the relationship of developed streamlines of the simulated velocity and concentration field, following their relationship with the mixing results, under the impact of these key parameters can foster more insight into the range of impact that the two parameters have on the proposed phenomena and the microfluidic dynamic principles of disturbances.

In addition, many of the current investigations of electrokinetic mixers commonly emphasize the fluid dynamics of mixing for Newtonian fluids, while the utilization of biofluids, primarily viscoelastic fluids such as blood, and their distinctive response under shear forces in these novel mixing processes of LOC systems are significantly less studied. To develop more compatible microdevice designs and efficient mixing outcomes for the biomedical industry, it is necessary to fill the knowledge gaps in the literature on electro-osmotic mixing for biofluids, where properties of elasticity, dynamic viscosity, and intricate relationship with shear flow from the fluid are further considered.

5.2.2. Electro-osmosis Separation in LOC Systems

Particle separation in LOC devices, particularly in biological research and diagnostics, is another area where disturbances may play a significant role in optimization. 

(101) Plasma analysis in LOC systems under precise control of blood flow phenomena and blood/plasma separation procedures can detect vital information about infectious diseases from particular antibodies and foreign nucleic acids for medical treatments, diagnostics, and research, 

(102) offering more efficient results and simple operating procedures compared to that of the traditional centrifugation method for blood and plasma separation. However, the adaptability of LOC devices for blood and plasma separation is often hindered by microchannel clogging, where flow velocity and plasma yield from LOC devices is reduced due to occasional RBC migration and aggregation at the filtration entrance of microdevices. 

(103)It is important to note that the EOF induces flow instability close to microchannel walls, which may provide further solutions to clogging for the separation process of the LOC systems. Mohammadi et al. 

(104) offered an anti-clogging effect of RBCs at the blood and plasma separating device filtration entry, adjacent to the surface wall, through RBC disaggregation under high shear rate conditions generated by a forward and reverse EOF direction.

Further theoretical and numerical research can be conducted to characterize the effect of high shear rate conditions near microchannel walls toward the detachment of binding blood cells on surfaces and the reversibility of aggregation. Through numerical modeling with varying electrokinetic parameters to induce different degrees of disturbances or shear conditions at channel walls, it may be possible to optimize and better understand the process of disrupting the forces that bind cells to surface walls and aggregated cells at filtration pores. RBCs that migrate close to microchannel walls are often attracted by the adhesion force between the RBC and the solid surface originating from the van der Waals forces. Following RBC migration and attachment by adhesive forces adjacent to the microchannel walls as shown in Figure 7, the increase in viscosity at the region causes a lower shear condition and encourages RBC aggregation (cell–cell interaction), which clogs filtering pores or microchannels and reduces flow velocity at filtration region. Both the impact that shear forces and disturbances may induce on cell binding forces with surface walls and other cells leading to aggregation may suggest further characterization. Kinetic parameters such as activation energy and the rate-determining step for cell binding composition attachment and detachment should be considered for modeling the dynamics of RBCs and blood flows under external forces in LOC separation devices.

Figure 7. Schematic representations of clogging at a microchannel pore following the sequence of RBC migration, cell attachment to channel walls, and aggregation. (105) Reproduced with permission from ref (105). Copyright 2018 The Authors under the terms of the Creative Commons (CC BY 4.0) License https://creativecommons.org/licenses/by/4.0/.

5.2.3. Relationship between External Forces and Microfluidic Systems

In blood flow, a thicker CFL suggests a lower blood viscosity, suggesting a complex relationship between shear stress and shear rate, affecting the blood viscosity and blood flow. Despite some experimental and numerical studies on electro-osmotic non-Newtonian fluid flow, limited literature has performed an in-depth investigation of the role that applied electric forces and other external forces could play in the process of CFL formation. Additional studies on how shear rates from external forces affect CFL formation and microfluidic flow dynamics can shed light on the mechanism of the contribution induced by external driving forces to the development of a separate phase of layer, similar to CFL, close to the microchannel walls and distinct from the surrounding fluid within the system, then influencing microfluidic flow dynamics.One of the mechanisms of phenomena to be explored is the formation of the Exclusion Zone (EZ) region following a “Self-Induced Flow” (SIF) phenomenon discovered by Li and Pollack, 

(106) as shown in Figure 8(a) and (b), respectively. A spontaneous sustained axial flow is observed when hydrophilic materials are immersed in water, resulting in the buildup of a negative layer of charges, defined as the EZ, after water molecules absorb infrared radiation (IR) energy and break down into H and OH

+.

Figure 8. Schematic representations of (a) the Exclusion Zone region and (b) the Self Induced Flow through visualization of microsphere movement within a microchannel. (106) Reproduced with permission from ref (106). Copyright 2020 The Authors under the terms of the Creative Commons (CC BY 4.0) License https://creativecommons.org/licenses/by/4.0/.

Despite the finding of such a phenomenon, the specific mechanism and role of IR energy have yet to be defined for the process of EZ development. To further develop an understanding of the role of IR energy in such phenomena, a feasible study may be seen through the lens of the relationships between external forces and microfluidic flow. In the phenomena, the increase of SIF velocity under a rise of IR radiation resonant characteristics is shown in the participation of the external electric field near the microchannel walls under electro-osmotic viscoelastic fluid flow systems. The buildup of negative charges at the hydrophilic surfaces in EZ is analogous to the mechanism of electrical double layer formation. Indeed, research has initiated the exploration of the core mechanisms for EZ formation through the lens of the electrokinetic phenomena. 

(107) Such a similarity of the role of IR energy and the transport phenomena of SIF with electrokinetic phenomena paves the way for the definition of the unknown SIF phenomena and EZ formation. Furthermore, Li and Pollack 

(106) suggest whether CFL formation might contribute to a SIF of blood using solely IR radiation, a commonly available source of energy in nature, as an external driving force. The proposition may be proven feasible with the presence of the CFL region next to the negatively charged hydrophilic endothelial glycocalyx layer, coating the luminal side of blood vessels. 

(108) Further research can dive into the resonating characteristics between the formation of the CFL region next to the hydrophilic endothelial glycocalyx layer and that of the EZ formation close to hydrophilic microchannel walls. Indeed, an increase in IR energy is known to rapidly accelerate EZ formation and SIF velocity, depicting similarity to the increase in the magnitude of electric field forces and greater shear rates at microchannel walls affecting CFL formation and EOF velocity. Such correlation depicts a future direction in whether SIF blood flow can be observed and characterized theoretically further through the lens of the relationship between blood flow and shear forces exhibited by external energy.

The intricate link between the CFL and external forces, more specifically the externally applied electric field, can receive further attention to provide a more complete framework for the mechanisms between IR radiation and EZ formation. Such characterization may also contribute to a greater comprehension of the role IR can play in CFL formation next to the endothelial glycocalyx layer as well as its role as a driving force to propel blood flow, similar to the SIF, but without the commonly assumed pressure force from heart contraction as a source of driving force.

5.3. Challenges

Although there have been significant improvements in blood flow modeling under LOC systems over the past decade, there are still notable constraints that may require special attention for numerical simulation applications to benefit the adaptability of the designs and functionalities of LOC devices. Several points that require special attention are mentioned below:

1.The majority of CFD models operate under the relationship between the viscoelasticity of blood and the shear rate conditions of flow. The relative effect exhibited by the presence of highly populated RBCs in whole blood and their forces amongst the cells themselves under complex flows often remains unclearly defined. Furthermore, the full range of cell populations in whole blood requires a much more computational load for numerical modeling. Therefore, a vital goal for future research is to evaluate a reduced modeling method where the impact of cell–cell interaction on the viscoelastic property of blood is considered.
2.Current computational methods on hemodynamics rely on continuum models based upon non-Newtonian rheology at the macroscale rather than at molecular and cellular levels. Careful considerations should be made for the development of a constructive framework for the physical and temporal scales of micro/nanoscale systems to evaluate the intricate relationship between fluid driving forces, dynamic viscosity, and elasticity.
3.Viscoelastic fluids under the impact of externally applied electric forces often deviate from the assumptions of no-slip boundary conditions due to the unique flow conditions induced by externally applied forces. Furthermore, the mechanism of vortex formation and viscoelastic flow instability at laminar flow conditions should be better defined through the lens of the microfluidic flow phenomenon to optimize the prediction of viscoelastic flow across different geometrical layouts. Mathematical models and numerical methods are needed to better predict such disturbance caused by external forces and the viscoelasticity of fluids at such a small scale.
4.Under practical situations, zeta potential distribution at channel walls frequently deviates from the common assumption of a constant distribution because of manufacturing faults or inherent surface charges prior to the introduction of electrokinetic influence. These discrepancies frequently lead to inconsistent surface potential distribution, such as excess positive ions at relatively more negatively charged walls. Accordingly, unpredicted vortex formation and flow instability may occur. Therefore, careful consideration should be given to these discrepancies and how they could trigger the transport process and unexpected results of a microdevice.

Author Information

ARTICLE SECTIONS

Jump To


  • Corresponding Authors
    • Zhe Chen – Department of Chemical Engineering, School of Chemistry and Chemical Engineering, State Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai 200240, P. R. China;  Email: zaccooky@sjtu.edu.cn
    • Bo Ouyang – Department of Chemical Engineering, School of Chemistry and Chemical Engineering, State Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai 200240, P. R. China;  Email: bouy93@sjtu.edu.cn
    • Zheng-Hong Luo – Department of Chemical Engineering, School of Chemistry and Chemical Engineering, State Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai 200240, P. R. China;  Orcidhttps://orcid.org/0000-0001-9011-6020; Email: luozh@sjtu.edu.cn
  • Authors
    • Bin-Jie Lai – Department of Chemical Engineering, School of Chemistry and Chemical Engineering, State Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai 200240, P. R. China;  Orcidhttps://orcid.org/0009-0002-8133-5381
    • Li-Tao Zhu – Department of Chemical Engineering, School of Chemistry and Chemical Engineering, State Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai 200240, P. R. China;  Orcidhttps://orcid.org/0000-0001-6514-8864
  • NotesThe authors declare no competing financial interest.

Acknowledgments

ARTICLE SECTIONS

Jump To


This work was supported by the National Natural Science Foundation of China (No. 22238005) and the Postdoctoral Research Foundation of China (No. GZC20231576).

Vocabulary

ARTICLE SECTIONS

Jump To


Microfluidicsthe field of technological and scientific study that investigates fluid flow in channels with dimensions between 1 and 1000 μm
Lab-on-a-Chip Technologythe field of research and technological development aimed at integrating the micro/nanofluidic characteristics to conduct laboratory processes on handheld devices
Computational Fluid Dynamics (CFD)the method utilizing computational abilities to predict physical fluid flow behaviors mathematically through solving the governing equations of corresponding fluid flows
Shear Ratethe rate of change in velocity where one layer of fluid moves past the adjacent layer
Viscoelasticitythe property holding both elasticity and viscosity characteristics relying on the magnitude of applied shear stress and time-dependent strain
Electro-osmosisthe flow of fluid under an applied electric field when charged solid surface is in contact with the bulk fluid
Vortexthe rotating motion of a fluid revolving an axis line

References

ARTICLE SECTIONS

Jump To


This article references 108 other publications.

  1. 1Neethirajan, S.; Kobayashi, I.; Nakajima, M.; Wu, D.; Nandagopal, S.; Lin, F. Microfluidics for food, agriculture and biosystems industries. Lab Chip 201111 (9), 1574– 1586,  DOI: 10.1039/c0lc00230eViewGoogle Scholar
  2. 2Whitesides, G. M. The origins and the future of microfluidics. Nature 2006442 (7101), 368– 373,  DOI: 10.1038/nature05058ViewGoogle Scholar
  3. 3Burklund, A.; Tadimety, A.; Nie, Y.; Hao, N.; Zhang, J. X. J. Chapter One – Advances in diagnostic microfluidics; Elsevier, 2020; DOI:  DOI: 10.1016/bs.acc.2019.08.001 .ViewGoogle Scholar
  4. 4Abdulbari, H. A. Chapter 12 – Lab-on-a-chip for analysis of blood. In Nanotechnology for Hematology, Blood Transfusion, and Artificial Blood; Denizli, A., Nguyen, T. A., Rajan, M., Alam, M. F., Rahman, K., Eds.; Elsevier, 2022; pp 265– 283.ViewGoogle Scholar
  5. 5Vladisavljević, G. T.; Khalid, N.; Neves, M. A.; Kuroiwa, T.; Nakajima, M.; Uemura, K.; Ichikawa, S.; Kobayashi, I. Industrial lab-on-a-chip: Design, applications and scale-up for drug discovery and delivery. Advanced Drug Delivery Reviews 201365 (11), 1626– 1663,  DOI: 10.1016/j.addr.2013.07.017ViewGoogle Scholar
  6. 6Kersaudy-Kerhoas, M.; Dhariwal, R.; Desmulliez, M. P. Y.; Jouvet, L. Hydrodynamic blood plasma separation in microfluidic channels. Microfluid. Nanofluid. 20108 (1), 105– 114,  DOI: 10.1007/s10404-009-0450-5ViewGoogle Scholar
  7. 7Popel, A. S.; Johnson, P. C. Microcirculation and Hemorheology. Annu. Rev. Fluid Mech. 200537 (1), 43– 69,  DOI: 10.1146/annurev.fluid.37.042604.133933ViewGoogle Scholar
  8. 8Fedosov, D. A.; Peltomäki, M.; Gompper, G. Deformation and dynamics of red blood cells in flow through cylindrical microchannels. Soft Matter 201410 (24), 4258– 4267,  DOI: 10.1039/C4SM00248BViewGoogle Scholar
  9. 9Chakraborty, S. Dynamics of capillary flow of blood into a microfluidic channel. Lab Chip 20055 (4), 421– 430,  DOI: 10.1039/b414566fViewGoogle Scholar
  10. 10Tomaiuolo, G.; Guido, S. Start-up shape dynamics of red blood cells in microcapillary flow. Microvascular Research 201182 (1), 35– 41,  DOI: 10.1016/j.mvr.2011.03.004ViewGoogle Scholar
  11. 11Sherwood, J. M.; Dusting, J.; Kaliviotis, E.; Balabani, S. The effect of red blood cell aggregation on velocity and cell-depleted layer characteristics of blood in a bifurcating microchannel. Biomicrofluidics 20126 (2), 24119,  DOI: 10.1063/1.4717755ViewGoogle Scholar
  12. 12Nader, E.; Skinner, S.; Romana, M.; Fort, R.; Lemonne, N.; Guillot, N.; Gauthier, A.; Antoine-Jonville, S.; Renoux, C.; Hardy-Dessources, M.-D. Blood Rheology: Key Parameters, Impact on Blood Flow, Role in Sickle Cell Disease and Effects of Exercise. Frontiers in Physiology 201910, 01329,  DOI: 10.3389/fphys.2019.01329ViewGoogle Scholar
  13. 13Trejo-Soto, C.; Lázaro, G. R.; Pagonabarraga, I.; Hernández-Machado, A. Microfluidics Approach to the Mechanical Properties of Red Blood Cell Membrane and Their Effect on Blood Rheology. Membranes 202212 (2), 217,  DOI: 10.3390/membranes12020217ViewGoogle Scholar
  14. 14Wagner, C.; Steffen, P.; Svetina, S. Aggregation of red blood cells: From rouleaux to clot formation. Comptes Rendus Physique 201314 (6), 459– 469,  DOI: 10.1016/j.crhy.2013.04.004ViewGoogle Scholar
  15. 15Kim, H.; Zhbanov, A.; Yang, S. Microfluidic Systems for Blood and Blood Cell Characterization. Biosensors 202313 (1), 13,  DOI: 10.3390/bios13010013ViewGoogle Scholar
  16. 16Fåhræus, R.; Lindqvist, T. THE VISCOSITY OF THE BLOOD IN NARROW CAPILLARY TUBES. American Journal of Physiology-Legacy Content 193196 (3), 562– 568,  DOI: 10.1152/ajplegacy.1931.96.3.562ViewGoogle Scholar
  17. 17Ascolese, M.; Farina, A.; Fasano, A. The Fåhræus-Lindqvist effect in small blood vessels: how does it help the heart?. J. Biol. Phys. 201945 (4), 379– 394,  DOI: 10.1007/s10867-019-09534-4ViewGoogle Scholar
  18. 18Bento, D.; Fernandes, C. S.; Miranda, J. M.; Lima, R. In vitro blood flow visualizations and cell-free layer (CFL) measurements in a microchannel network. Experimental Thermal and Fluid Science 2019109, 109847,  DOI: 10.1016/j.expthermflusci.2019.109847ViewGoogle Scholar
  19. 19Namgung, B.; Ong, P. K.; Wong, Y. H.; Lim, D.; Chun, K. J.; Kim, S. A comparative study of histogram-based thresholding methods for the determination of cell-free layer width in small blood vessels. Physiological Measurement 201031 (9), N61,  DOI: 10.1088/0967-3334/31/9/N01ViewGoogle Scholar
  20. 20Hymel, S. J.; Lan, H.; Fujioka, H.; Khismatullin, D. B. Cell trapping in Y-junction microchannels: A numerical study of the bifurcation angle effect in inertial microfluidics. Phys. Fluids (1994) 201931 (8), 082003,  DOI: 10.1063/1.5113516ViewGoogle Scholar
  21. 21Li, X.; Popel, A. S.; Karniadakis, G. E. Blood-plasma separation in Y-shaped bifurcating microfluidic channels: a dissipative particle dynamics simulation study. Phys. Biol. 20129 (2), 026010,  DOI: 10.1088/1478-3975/9/2/026010ViewGoogle Scholar
  22. 22Yin, X.; Thomas, T.; Zhang, J. Multiple red blood cell flows through microvascular bifurcations: Cell free layer, cell trajectory, and hematocrit separation. Microvascular Research 201389, 47– 56,  DOI: 10.1016/j.mvr.2013.05.002ViewGoogle Scholar
  23. 23Shibeshi, S. S.; Collins, W. E. The Rheology of Blood Flow in a Branched Arterial System. Appl. Rheol 200515 (6), 398– 405,  DOI: 10.1515/arh-2005-0020ViewGoogle Scholar
  24. 24Sequeira, A.; Janela, J. An Overview of Some Mathematical Models of Blood Rheology. In A Portrait of State-of-the-Art Research at the Technical University of Lisbon; Pereira, M. S., Ed.; Springer Netherlands: Dordrecht, 2007; pp 65– 87.ViewGoogle Scholar
  25. 25Walburn, F. J.; Schneck, D. J. A constitutive equation for whole human blood. Biorheology 197613, 201– 210,  DOI: 10.3233/BIR-1976-13307ViewGoogle Scholar
  26. 26Quemada, D. A rheological model for studying the hematocrit dependence of red cell-red cell and red cell-protein interactions in blood. Biorheology 198118, 501– 516,  DOI: 10.3233/BIR-1981-183-615ViewGoogle Scholar
  27. 27Varchanis, S.; Dimakopoulos, Y.; Wagner, C.; Tsamopoulos, J. How viscoelastic is human blood plasma?. Soft Matter 201814 (21), 4238– 4251,  DOI: 10.1039/C8SM00061AViewGoogle Scholar
  28. 28Apostolidis, A. J.; Moyer, A. P.; Beris, A. N. Non-Newtonian effects in simulations of coronary arterial blood flow. J. Non-Newtonian Fluid Mech. 2016233, 155– 165,  DOI: 10.1016/j.jnnfm.2016.03.008ViewGoogle Scholar
  29. 29Luo, X. Y.; Kuang, Z. B. A study on the constitutive equation of blood. J. Biomech. 199225 (8), 929– 934,  DOI: 10.1016/0021-9290(92)90233-QViewGoogle Scholar
  30. 30Oldroyd, J. G.; Wilson, A. H. On the formulation of rheological equations of state. Proceedings of the Royal Society of London. Series A. Mathematical and Physical Sciences 1950200 (1063), 523– 541,  DOI: 10.1098/rspa.1950.0035ViewGoogle Scholar
  31. 31Prado, G.; Farutin, A.; Misbah, C.; Bureau, L. Viscoelastic transient of confined red blood cells. Biophys J. 2015108 (9), 2126– 2136,  DOI: 10.1016/j.bpj.2015.03.046ViewGoogle Scholar
  32. 32Huang, C. R.; Pan, W. D.; Chen, H. Q.; Copley, A. L. Thixotropic properties of whole blood from healthy human subjects. Biorheology 198724 (6), 795– 801,  DOI: 10.3233/BIR-1987-24630ViewGoogle Scholar
  33. 33Anand, M.; Kwack, J.; Masud, A. A new generalized Oldroyd-B model for blood flow in complex geometries. International Journal of Engineering Science 201372, 78– 88,  DOI: 10.1016/j.ijengsci.2013.06.009ViewGoogle Scholar
  34. 34Horner, J. S.; Armstrong, M. J.; Wagner, N. J.; Beris, A. N. Investigation of blood rheology under steady and unidirectional large amplitude oscillatory shear. J. Rheol. 201862 (2), 577– 591,  DOI: 10.1122/1.5017623ViewGoogle Scholar
  35. 35Horner, J. S.; Armstrong, M. J.; Wagner, N. J.; Beris, A. N. Measurements of human blood viscoelasticity and thixotropy under steady and transient shear and constitutive modeling thereof. J. Rheol. 201963 (5), 799– 813,  DOI: 10.1122/1.5108737ViewGoogle Scholar
  36. 36Armstrong, M.; Tussing, J. A methodology for adding thixotropy to Oldroyd-8 family of viscoelastic models for characterization of human blood. Phys. Fluids 202032 (9), 094111,  DOI: 10.1063/5.0022501ViewGoogle Scholar
  37. 37Crank, J.; Nicolson, P. A practical method for numerical evaluation of solutions of partial differential equations of the heat-conduction type. Mathematical Proceedings of the Cambridge Philosophical Society 194743 (1), 50– 67,  DOI: 10.1017/S0305004100023197ViewGoogle Scholar
  38. 38Clough, R. W. Original formulation of the finite element method. Finite Elements in Analysis and Design 19907 (2), 89– 101,  DOI: 10.1016/0168-874X(90)90001-UViewGoogle Scholar
  39. 39Liu, W. K.; Liu, Y.; Farrell, D.; Zhang, L.; Wang, X. S.; Fukui, Y.; Patankar, N.; Zhang, Y.; Bajaj, C.; Lee, J.Immersed finite element method and its applications to biological systems. Computer Methods in Applied Mechanics and Engineering 2006195 (13), 1722– 1749,  DOI: 10.1016/j.cma.2005.05.049ViewGoogle Scholar
  40. 40Lopes, D.; Agujetas, R.; Puga, H.; Teixeira, J.; Lima, R.; Alejo, J. P.; Ferrera, C. Analysis of finite element and finite volume methods for fluid-structure interaction simulation of blood flow in a real stenosed artery. International Journal of Mechanical Sciences 2021207, 106650,  DOI: 10.1016/j.ijmecsci.2021.106650ViewGoogle Scholar
  41. 41Favero, J. L.; Secchi, A. R.; Cardozo, N. S. M.; Jasak, H. Viscoelastic flow analysis using the software OpenFOAM and differential constitutive equations. J. Non-Newtonian Fluid Mech. 2010165 (23), 1625– 1636,  DOI: 10.1016/j.jnnfm.2010.08.010ViewGoogle Scholar
  42. 42Pimenta, F.; Alves, M. A. Stabilization of an open-source finite-volume solver for viscoelastic fluid flows. J. Non-Newtonian Fluid Mech. 2017239, 85– 104,  DOI: 10.1016/j.jnnfm.2016.12.002ViewGoogle Scholar
  43. 43Chee, C. Y.; Lee, H. P.; Lu, C. Using 3D fluid-structure interaction model to analyse the biomechanical properties of erythrocyte. Phys. Lett. A 2008372 (9), 1357– 1362,  DOI: 10.1016/j.physleta.2007.09.067ViewGoogle Scholar
  44. 44Xu, D.; Kaliviotis, E.; Munjiza, A.; Avital, E.; Ji, C.; Williams, J. Large scale simulation of red blood cell aggregation in shear flows. J. Biomech. 201346 (11), 1810– 1817,  DOI: 10.1016/j.jbiomech.2013.05.010ViewGoogle Scholar
  45. 45Johnson, K. L.; Kendall, K.; Roberts, A. Surface energy and the contact of elastic solids. Proceedings of the royal society of London. A. mathematical and physical sciences 1971324 (1558), 301– 313,  DOI: 10.1098/rspa.1971.0141ViewGoogle Scholar
  46. 46Shi, L.; Pan, T.-W.; Glowinski, R. Deformation of a single red blood cell in bounded Poiseuille flows. Phys. Rev. E 201285 (1), 016307,  DOI: 10.1103/PhysRevE.85.016307ViewGoogle Scholar
  47. 47Yoon, D.; You, D. Continuum modeling of deformation and aggregation of red blood cells. J. Biomech. 201649 (11), 2267– 2279,  DOI: 10.1016/j.jbiomech.2015.11.027ViewGoogle Scholar
  48. 48Mainardi, F.; Spada, G. Creep, relaxation and viscosity properties for basic fractional models in rheology. European Physical Journal Special Topics 2011193 (1), 133– 160,  DOI: 10.1140/epjst/e2011-01387-1ViewGoogle Scholar
  49. 49Gracka, M.; Lima, R.; Miranda, J. M.; Student, S.; Melka, B.; Ostrowski, Z. Red blood cells tracking and cell-free layer formation in a microchannel with hyperbolic contraction: A CFD model validation. Computer Methods and Programs in Biomedicine 2022226, 107117,  DOI: 10.1016/j.cmpb.2022.107117ViewGoogle Scholar
  50. 50Aryan, H.; Beigzadeh, B.; Siavashi, M. Euler-Lagrange numerical simulation of improved magnetic drug delivery in a three-dimensional CT-based carotid artery bifurcation. Computer Methods and Programs in Biomedicine 2022219, 106778,  DOI: 10.1016/j.cmpb.2022.106778ViewGoogle Scholar
  51. 51Czaja, B.; Závodszky, G.; Azizi Tarksalooyeh, V.; Hoekstra, A. G. Cell-resolved blood flow simulations of saccular aneurysms: effects of pulsatility and aspect ratio. J. R Soc. Interface 201815 (146), 20180485,  DOI: 10.1098/rsif.2018.0485ViewGoogle Scholar
  52. 52Rydquist, G.; Esmaily, M. A cell-resolved, Lagrangian solver for modeling red blood cell dynamics in macroscale flows. J. Comput. Phys. 2022461, 111204,  DOI: 10.1016/j.jcp.2022.111204ViewGoogle Scholar
  53. 53Dadvand, A.; Baghalnezhad, M.; Mirzaee, I.; Khoo, B. C.; Ghoreishi, S. An immersed boundary-lattice Boltzmann approach to study the dynamics of elastic membranes in viscous shear flows. Journal of Computational Science 20145 (5), 709– 718,  DOI: 10.1016/j.jocs.2014.06.006ViewGoogle Scholar
  54. 54Krüger, T.; Holmes, D.; Coveney, P. V. Deformability-based red blood cell separation in deterministic lateral displacement devices─A simulation study. Biomicrofluidics 20148 (5), 054114,  DOI: 10.1063/1.4897913ViewGoogle Scholar
  55. 55Takeishi, N.; Ito, H.; Kaneko, M.; Wada, S. Deformation of a Red Blood Cell in a Narrow Rectangular Microchannel. Micromachines 201910 (3), 199,  DOI: 10.3390/mi10030199ViewGoogle Scholar
  56. 56Krüger, T.; Varnik, F.; Raabe, D. Efficient and accurate simulations of deformable particles immersed in a fluid using a combined immersed boundary lattice Boltzmann finite element method. Computers & Mathematics with Applications 201161 (12), 3485– 3505,  DOI: 10.1016/j.camwa.2010.03.057ViewGoogle Scholar
  57. 57Balachandran Nair, A. N.; Pirker, S.; Umundum, T.; Saeedipour, M. A reduced-order model for deformable particles with application in bio-microfluidics. Computational Particle Mechanics 20207 (3), 593– 601,  DOI: 10.1007/s40571-019-00283-8ViewGoogle Scholar
  58. 58Balachandran Nair, A. N.; Pirker, S.; Saeedipour, M. Resolved CFD-DEM simulation of blood flow with a reduced-order RBC model. Computational Particle Mechanics 20229 (4), 759– 774,  DOI: 10.1007/s40571-021-00441-xViewGoogle Scholar
  59. 59Mittal, R.; Iaccarino, G. IMMERSED BOUNDARY METHODS. Annu. Rev. Fluid Mech. 200537 (1), 239– 261,  DOI: 10.1146/annurev.fluid.37.061903.175743ViewGoogle Scholar
  60. 60Piquet, A.; Roussel, O.; Hadjadj, A. A comparative study of Brinkman penalization and direct-forcing immersed boundary methods for compressible viscous flows. Computers & Fluids 2016136, 272– 284,  DOI: 10.1016/j.compfluid.2016.06.001ViewGoogle Scholar
  61. 61Akerkouch, L.; Le, T. B. A Hybrid Continuum-Particle Approach for Fluid-Structure Interaction Simulation of Red Blood Cells in Fluid Flows. Fluids 20216 (4), 139,  DOI: 10.3390/fluids6040139ViewGoogle Scholar
  62. 62Barker, A. T.; Cai, X.-C. Scalable parallel methods for monolithic coupling in fluid-structure interaction with application to blood flow modeling. J. Comput. Phys. 2010229 (3), 642– 659,  DOI: 10.1016/j.jcp.2009.10.001ViewGoogle Scholar
  63. 63Cetin, A.; Sahin, M. A monolithic fluid-structure interaction framework applied to red blood cells. International Journal for Numerical Methods in Biomedical Engineering 201935 (2), e3171  DOI: 10.1002/cnm.3171ViewGoogle Scholar
  64. 64Freund, J. B. Numerical Simulation of Flowing Blood Cells. Annu. Rev. Fluid Mech. 201446 (1), 67– 95,  DOI: 10.1146/annurev-fluid-010313-141349ViewGoogle Scholar
  65. 65Ye, T.; Phan-Thien, N.; Lim, C. T. Particle-based simulations of red blood cells─A review. J. Biomech. 201649 (11), 2255– 2266,  DOI: 10.1016/j.jbiomech.2015.11.050ViewGoogle Scholar
  66. 66Arabghahestani, M.; Poozesh, S.; Akafuah, N. K. Advances in Computational Fluid Mechanics in Cellular Flow Manipulation: A Review. Applied Sciences 20199 (19), 4041,  DOI: 10.3390/app9194041ViewGoogle Scholar
  67. 67Rathnayaka, C. M.; From, C. S.; Geekiyanage, N. M.; Gu, Y. T.; Nguyen, N. T.; Sauret, E. Particle-Based Numerical Modelling of Liquid Marbles: Recent Advances and Future Perspectives. Archives of Computational Methods in Engineering 202229 (5), 3021– 3039,  DOI: 10.1007/s11831-021-09683-7ViewGoogle Scholar
  68. 68Li, X.; Vlahovska, P. M.; Karniadakis, G. E. Continuum- and particle-based modeling of shapes and dynamics of red blood cells in health and disease. Soft Matter 20139 (1), 28– 37,  DOI: 10.1039/C2SM26891DViewGoogle Scholar
  69. 69Beris, A. N.; Horner, J. S.; Jariwala, S.; Armstrong, M. J.; Wagner, N. J. Recent advances in blood rheology: a review. Soft Matter 202117 (47), 10591– 10613,  DOI: 10.1039/D1SM01212FViewGoogle Scholar
  70. 70Arciero, J.; Causin, P.; Malgaroli, F. Mathematical methods for modeling the microcirculation. AIMS Biophysics 20174 (3), 362– 399,  DOI: 10.3934/biophy.2017.3.362ViewGoogle Scholar
  71. 71Maria, M. S.; Chandra, T. S.; Sen, A. K. Capillary flow-driven blood plasma separation and on-chip analyte detection in microfluidic devices. Microfluid. Nanofluid. 201721 (4), 72,  DOI: 10.1007/s10404-017-1907-6ViewGoogle Scholar
  72. 72Huhtamäki, T.; Tian, X.; Korhonen, J. T.; Ras, R. H. A. Surface-wetting characterization using contact-angle measurements. Nat. Protoc. 201813 (7), 1521– 1538,  DOI: 10.1038/s41596-018-0003-zViewGoogle Scholar
  73. 73Young, T., III. An essay on the cohesion of fluids. Philosophical Transactions of the Royal Society of London 180595, 65– 87,  DOI: 10.1098/rstl.1805.0005ViewGoogle Scholar
  74. 74Kim, Y. C.; Kim, S.-H.; Kim, D.; Park, S.-J.; Park, J.-K. Plasma extraction in a capillary-driven microfluidic device using surfactant-added poly(dimethylsiloxane). Sens. Actuators, B 2010145 (2), 861– 868,  DOI: 10.1016/j.snb.2010.01.017ViewGoogle Scholar
  75. 75Washburn, E. W. The Dynamics of Capillary Flow. Physical Review 192117 (3), 273– 283,  DOI: 10.1103/PhysRev.17.273ViewGoogle Scholar
  76. 76Cito, S.; Ahn, Y. C.; Pallares, J.; Duarte, R. M.; Chen, Z.; Madou, M.; Katakis, I. Visualization and measurement of capillary-driven blood flow using spectral domain optical coherence tomography. Microfluid Nanofluidics 201213 (2), 227– 237,  DOI: 10.1007/s10404-012-0950-6ViewGoogle Scholar
  77. 77Berthier, E.; Dostie, A. M.; Lee, U. N.; Berthier, J.; Theberge, A. B. Open Microfluidic Capillary Systems. Anal Chem. 201991 (14), 8739– 8750,  DOI: 10.1021/acs.analchem.9b01429ViewGoogle Scholar
  78. 78Berthier, J.; Brakke, K. A.; Furlani, E. P.; Karampelas, I. H.; Poher, V.; Gosselin, D.; Cubizolles, M.; Pouteau, P. Whole blood spontaneous capillary flow in narrow V-groove microchannels. Sens. Actuators, B 2015206, 258– 267,  DOI: 10.1016/j.snb.2014.09.040ViewGoogle Scholar
  79. 79Hirt, C. W.; Nichols, B. D. Volume of fluid (VOF) method for the dynamics of free boundaries. J. Comput. Phys. 198139 (1), 201– 225,  DOI: 10.1016/0021-9991(81)90145-5ViewGoogle Scholar
  80. 80Chen, J.-L.; Shih, W.-H.; Hsieh, W.-H. AC electro-osmotic micromixer using a face-to-face, asymmetric pair of planar electrodes. Sens. Actuators, B 2013188, 11– 21,  DOI: 10.1016/j.snb.2013.07.012ViewGoogle Scholar
  81. 81Zhao, C.; Yang, C. Electrokinetics of non-Newtonian fluids: A review. Advances in Colloid and Interface Science 2013201-202, 94– 108,  DOI: 10.1016/j.cis.2013.09.001ViewGoogle Scholar
  82. 82Oh, K. W. 6 – Lab-on-chip (LOC) devices and microfluidics for biomedical applications. In MEMS for Biomedical Applications; Bhansali, S., Vasudev, A., Eds.; Woodhead Publishing, 2012; pp 150– 171.ViewGoogle Scholar
  83. 83Bello, M. S.; De Besi, P.; Rezzonico, R.; Righetti, P. G.; Casiraghi, E. Electroosmosis of polymer solutions in fused silica capillaries. ELECTROPHORESIS 199415 (1), 623– 626,  DOI: 10.1002/elps.1150150186ViewGoogle Scholar
  84. 84Park, H. M.; Lee, W. M. Effect of viscoelasticity on the flow pattern and the volumetric flow rate in electroosmotic flows through a microchannel. Lab Chip 20088 (7), 1163– 1170,  DOI: 10.1039/b800185eViewGoogle Scholar
  85. 85Afonso, A. M.; Alves, M. A.; Pinho, F. T. Analytical solution of mixed electro-osmotic/pressure driven flows of viscoelastic fluids in microchannels. J. Non-Newtonian Fluid Mech. 2009159 (1), 50– 63,  DOI: 10.1016/j.jnnfm.2009.01.006ViewGoogle Scholar
  86. 86Sousa, J. J.; Afonso, A. M.; Pinho, F. T.; Alves, M. A. Effect of the skimming layer on electro-osmotic─Poiseuille flows of viscoelastic fluids. Microfluid. Nanofluid. 201110 (1), 107– 122,  DOI: 10.1007/s10404-010-0651-yViewGoogle Scholar
  87. 87Zhao, C.; Yang, C. Electro-osmotic mobility of non-Newtonian fluids. Biomicrofluidics 20115 (1), 014110,  DOI: 10.1063/1.3571278ViewGoogle Scholar
  88. 88Pimenta, F.; Alves, M. A. Electro-elastic instabilities in cross-shaped microchannels. J. Non-Newtonian Fluid Mech. 2018259, 61– 77,  DOI: 10.1016/j.jnnfm.2018.04.004ViewGoogle Scholar
  89. 89Bezerra, W. S.; Castelo, A.; Afonso, A. M. Numerical Study of Electro-Osmotic Fluid Flow and Vortex Formation. Micromachines (Basel) 201910 (12), 796,  DOI: 10.3390/mi10120796ViewGoogle Scholar
  90. 90Ji, J.; Qian, S.; Liu, Z. Electroosmotic Flow of Viscoelastic Fluid through a Constriction Microchannel. Micromachines (Basel) 202112 (4), 417,  DOI: 10.3390/mi12040417ViewGoogle Scholar
  91. 91Zhao, C.; Yang, C. Exact solutions for electro-osmotic flow of viscoelastic fluids in rectangular micro-channels. Applied Mathematics and Computation 2009211 (2), 502– 509,  DOI: 10.1016/j.amc.2009.01.068ViewGoogle Scholar
  92. 92Gerum, R.; Mirzahossein, E.; Eroles, M.; Elsterer, J.; Mainka, A.; Bauer, A.; Sonntag, S.; Winterl, A.; Bartl, J.; Fischer, L. Viscoelastic properties of suspended cells measured with shear flow deformation cytometry. Elife 202211, e78823,  DOI: 10.7554/eLife.78823ViewGoogle Scholar
  93. 93Sadek, S. H.; Pinho, F. T.; Alves, M. A. Electro-elastic flow instabilities of viscoelastic fluids in contraction/expansion micro-geometries. J. Non-Newtonian Fluid Mech. 2020283, 104293,  DOI: 10.1016/j.jnnfm.2020.104293ViewGoogle Scholar
  94. 94Spanjaards, M.; Peters, G.; Hulsen, M.; Anderson, P. Numerical Study of the Effect of Thixotropy on Extrudate Swell. Polymers 202113 (24), 4383,  DOI: 10.3390/polym13244383ViewGoogle Scholar
  95. 95Rashidi, S.; Bafekr, H.; Valipour, M. S.; Esfahani, J. A. A review on the application, simulation, and experiment of the electrokinetic mixers. Chemical Engineering and Processing – Process Intensification 2018126, 108– 122,  DOI: 10.1016/j.cep.2018.02.021ViewGoogle Scholar
  96. 96Matsubara, K.; Narumi, T. Microfluidic mixing using unsteady electroosmotic vortices produced by a staggered array of electrodes. Chemical Engineering Journal 2016288, 638– 647,  DOI: 10.1016/j.cej.2015.12.013ViewGoogle Scholar
  97. 97Qaderi, A.; Jamaati, J.; Bahiraei, M. CFD simulation of combined electroosmotic-pressure driven micro-mixing in a microchannel equipped with triangular hurdle and zeta-potential heterogeneity. Chemical Engineering Science 2019199, 463– 477,  DOI: 10.1016/j.ces.2019.01.034ViewGoogle Scholar
  98. 98Cho, C.-C.; Chen, C.-L.; Chen, C. o.-K. Mixing enhancement in crisscross micromixer using aperiodic electrokinetic perturbing flows. International Journal of Heat and Mass Transfer 201255 (11), 2926– 2933,  DOI: 10.1016/j.ijheatmasstransfer.2012.02.006ViewGoogle Scholar
  99. 99Zhao, W.; Yang, F.; Wang, K.; Bai, J.; Wang, G. Rapid mixing by turbulent-like electrokinetic microflow. Chemical Engineering Science 2017165, 113– 121,  DOI: 10.1016/j.ces.2017.02.027ViewGoogle Scholar
  100. 100Tran, T.; Chakraborty, P.; Guttenberg, N.; Prescott, A.; Kellay, H.; Goldburg, W.; Goldenfeld, N.; Gioia, G. Macroscopic effects of the spectral structure in turbulent flows. Nat. Phys. 20106 (6), 438– 441,  DOI: 10.1038/nphys1674ViewGoogle Scholar
  101. 101Toner, M.; Irimia, D. Blood-on-a-chip. Annu. Rev. Biomed Eng. 20057, 77– 103,  DOI: 10.1146/annurev.bioeng.7.011205.135108ViewGoogle Scholar
  102. 102Maria, M. S.; Rakesh, P. E.; Chandra, T. S.; Sen, A. K. Capillary flow of blood in a microchannel with differential wetting for blood plasma separation and on-chip glucose detection. Biomicrofluidics 201610 (5), 054108,  DOI: 10.1063/1.4962874ViewGoogle Scholar
  103. 103Tripathi, S.; Varun Kumar, Y. V. B.; Prabhakar, A.; Joshi, S. S.; Agrawal, A. Passive blood plasma separation at the microscale: a review of design principles and microdevices. Journal of Micromechanics and Microengineering 201525 (8), 083001,  DOI: 10.1088/0960-1317/25/8/083001ViewGoogle Scholar
  104. 104Mohammadi, M.; Madadi, H.; Casals-Terré, J. Microfluidic point-of-care blood panel based on a novel technique: Reversible electroosmotic flow. Biomicrofluidics 20159 (5), 054106,  DOI: 10.1063/1.4930865ViewGoogle Scholar
  105. 105Kang, D. H.; Kim, K.; Kim, Y. J. An anti-clogging method for improving the performance and lifespan of blood plasma separation devices in real-time and continuous microfluidic systems. Sci. Rep 20188 (1), 17015,  DOI: 10.1038/s41598-018-35235-4ViewGoogle Scholar
  106. 106Li, Z.; Pollack, G. H. Surface-induced flow: A natural microscopic engine using infrared energy as fuel. Science Advances 20206 (19), eaba0941  DOI: 10.1126/sciadv.aba0941ViewGoogle Scholar
  107. 107Mercado-Uribe, H.; Guevara-Pantoja, F. J.; García-Muñoz, W.; García-Maldonado, J. S.; Méndez-Alcaraz, J. M.; Ruiz-Suárez, J. C. On the evolution of the exclusion zone produced by hydrophilic surfaces: A contracted description. J. Chem. Phys. 2021154 (19), 194902,  DOI: 10.1063/5.0043084ViewGoogle Scholar
  108. 108Yalcin, O.; Jani, V. P.; Johnson, P. C.; Cabrales, P. Implications Enzymatic Degradation of the Endothelial Glycocalyx on the Microvascular Hemodynamics and the Arteriolar Red Cell Free Layer of the Rat Cremaster Muscle. Front Physiol 20189, 168,  DOI: 10.3389/fphys.2018.00168ViewGoogle Scholar
Figure 1. (a) Top view of the microfluidic-magnetophoretic device, (b) Schematic representation of the channel cross-sections studied in this work, and (c) the magnet position relative to the channel location (Sepy and Sepz are the magnet separation distances in y and z, respectively).

Continuous-Flow Separation of Magnetic Particles from Biofluids: How Does the Microdevice Geometry Determine the Separation Performance?

1Department of Chemical and Biomolecular Engineering, ETSIIT, University of Cantabria, Avda. Los Castros s/n, 39005 Santander, Spain
2William G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, 151 W. Woodruff Ave., Columbus, OH 43210, USA
*Author to whom correspondence should be addressed.
Sensors 202020(11), 3030; https://doi.org/10.3390/s20113030
Received: 16 April 2020 / Revised: 21 May 2020 / Accepted: 25 May 2020 / Published: 27 May 2020
(This article belongs to the Special Issue Lab-on-a-Chip and Microfluidic Sensors)

Abstract

The use of functionalized magnetic particles for the detection or separation of multiple chemicals and biomolecules from biofluids continues to attract significant attention. After their incubation with the targeted substances, the beads can be magnetically recovered to perform analysis or diagnostic tests. Particle recovery with permanent magnets in continuous-flow microdevices has gathered great attention in the last decade due to the multiple advantages of microfluidics. As such, great efforts have been made to determine the magnetic and fluidic conditions for achieving complete particle capture; however, less attention has been paid to the effect of the channel geometry on the system performance, although it is key for designing systems that simultaneously provide high particle recovery and flow rates. Herein, we address the optimization of Y-Y-shaped microchannels, where magnetic beads are separated from blood and collected into a buffer stream by applying an external magnetic field. The influence of several geometrical features (namely cross section shape, thickness, length, and volume) on both bead recovery and system throughput is studied. For that purpose, we employ an experimentally validated Computational Fluid Dynamics (CFD) numerical model that considers the dominant forces acting on the beads during separation. Our results indicate that rectangular, long devices display the best performance as they deliver high particle recovery and high throughput. Thus, this methodology could be applied to the rational design of lab-on-a-chip devices for any magnetically driven purification, enrichment or isolation.

Keywords: particle magnetophoresisCFDcross sectionchip fabrication

Korea Abstract

생체 유체에서 여러 화학 물질과 생체 분자의 검출 또는 분리를위한 기능화 된 자성 입자의 사용은 계속해서 상당한 관심을 받고 있습니다. 표적 물질과 함께 배양 한 후 비드를 자기 적으로 회수하여 분석 또는 진단 테스트를 수행 할 수 있습니다. 연속 흐름 마이크로 장치에서 영구 자석을 사용한 입자 회수는 마이크로 유체의 여러 장점으로 인해 지난 10 년 동안 큰 관심을 모았습니다. 

따라서 완전한 입자 포획을 달성하기 위한 자기 및 유체 조건을 결정하기 위해 많은 노력을 기울였습니다. 그러나 높은 입자 회수율과 유속을 동시에 제공하는 시스템을 설계하는 데있어 핵심이기는 하지만 시스템 성능에 대한 채널 형상의 영향에 대해서는 덜주의를 기울였습니다. 

여기에서 우리는 자기 비드가 혈액에서 분리되고 외부 자기장을 적용하여 버퍼 스트림으로 수집되는 YY 모양의 마이크로 채널의 최적화를 다룹니다. 비드 회수 및 시스템 처리량에 대한 여러 기하학적 특징 (즉, 단면 형상, 두께, 길이 및 부피)의 영향을 연구합니다. 

이를 위해 분리 중에 비드에 작용하는 지배적인 힘을 고려하는 실험적으로 검증 된 CFD (Computational Fluid Dynamics) 수치 모델을 사용합니다. 우리의 결과는 직사각형의 긴 장치가 높은 입자 회수율과 높은 처리량을 제공하기 때문에 최고의 성능을 보여줍니다. 

따라서 이 방법론은 자기 구동 정제, 농축 또는 분리를 위한 랩온어 칩 장치의 합리적인 설계에 적용될 수 있습니다.

Figure 1. (a) Top view of the microfluidic-magnetophoretic device, (b) Schematic representation of the channel cross-sections studied in this work, and (c) the magnet position relative to the channel location (Sepy and Sepz are the magnet separation distances in y and z, respectively).
Figure 1. (a) Top view of the microfluidic-magnetophoretic device, (b) Schematic representation of the channel cross-sections studied in this work, and (c) the magnet position relative to the channel location (Sepy and Sepz are the magnet separation distances in y and z, respectively).
Figure 2. (a) Channel-magnet configuration and (b–d) magnetic force distribution in the channel midplane for 2 mm, 5 mm and 10 mm long rectangular (left) and U-shaped (right) devices.
Figure 2. (a) Channel-magnet configuration and (b–d) magnetic force distribution in the channel midplane for 2 mm, 5 mm and 10 mm long rectangular (left) and U-shaped (right) devices.
Figure 3. (a) Velocity distribution in a section perpendicular to the flow for rectangular (left) and U-shaped (right) cross section channels, and (b) particle location in these cross sections.
Figure 3. (a) Velocity distribution in a section perpendicular to the flow for rectangular (left) and U-shaped (right) cross section channels, and (b) particle location in these cross sections.
Figure 4. Influence of fluid flow rate on particle recovery when the applied magnetic force is (a) different and (b) equal in U-shaped and rectangular cross section microdevices.
Figure 4. Influence of fluid flow rate on particle recovery when the applied magnetic force is (a) different and (b) equal in U-shaped and rectangular cross section microdevices.
Figure 5. Magnetic bead capture as a function of fluid flow rate for all of the studied geometries.
Figure 5. Magnetic bead capture as a function of fluid flow rate for all of the studied geometries.
Figure 6. Influence of (a) magnetic and fluidic forces (J parameter) and (b) channel geometry (θ parameter) on particle recovery. Note that U-2mm does not accurately fit a line.
Figure 6. Influence of (a) magnetic and fluidic forces (J parameter) and (b) channel geometry (θ parameter) on particle recovery. Note that U-2mm does not accurately fit a line.
Figure 7. Dependence of bead capture on the (a) functional channel volume and (b) particle residence time (tres). Note that in the curve fitting expressions V represents the functional channel volume and that U-2mm does not accurately fit a line.
Figure 7. Dependence of bead capture on the (a) functional channel volume and (b) particle residence time (tres). Note that in the curve fitting expressions V represents the functional channel volume and that U-2mm does not accurately fit a line.

References

  1. Gómez-Pastora, J.; Xue, X.; Karampelas, I.H.; Bringas, E.; Furlani, E.P.; Ortiz, I. Analysis of separators for magnetic beads recovery: From large systems to multifunctional microdevices. Sep. Purif. Technol. 2017172, 16–31. [Google Scholar] [CrossRef]
  2. Wise, N.; Grob, T.; Morten, K.; Thompson, I.; Sheard, S. Magnetophoretic velocities of superparamagnetic particles, agglomerates and complexes. J. Magn. Magn. Mater. 2015384, 328–334. [Google Scholar] [CrossRef]
  3. Khashan, S.A.; Elnajjar, E.; Haik, Y. CFD simulation of the magnetophoretic separation in a microchannel. J. Magn. Magn. Mater. 2011323, 2960–2967. [Google Scholar] [CrossRef]
  4. Khashan, S.A.; Furlani, E.P. Scalability analysis of magnetic bead separation in a microchannel with an array of soft magnetic elements in a uniform magnetic field. Sep. Purif. Technol. 2014125, 311–318. [Google Scholar] [CrossRef]
  5. Furlani, E.P. Magnetic biotransport: Analysis and applications. Materials 20103, 2412–2446. [Google Scholar] [CrossRef]
  6. Gómez-Pastora, J.; Bringas, E.; Ortiz, I. Design of novel adsorption processes for the removal of arsenic from polluted groundwater employing functionalized magnetic nanoparticles. Chem. Eng. Trans. 201647, 241–246. [Google Scholar]
  7. Gómez-Pastora, J.; Bringas, E.; Lázaro-Díez, M.; Ramos-Vivas, J.; Ortiz, I. The reverse of controlled release: Controlled sequestration of species and biotoxins into nanoparticles (NPs). In Drug Delivery Systems; Stroeve, P., Mahmoudi, M., Eds.; World Scientific: Hackensack, NJ, USA, 2017; pp. 207–244. ISBN 9789813201057. [Google Scholar]
  8. Ruffert, C. Magnetic bead-magic bullet. Micromachines 20167, 21. [Google Scholar] [CrossRef]
  9. Yáñez-Sedeño, P.; Campuzano, S.; Pingarrón, J.M. Magnetic particles coupled to disposable screen printed transducers for electrochemical biosensing. Sensors 201616, 1585. [Google Scholar] [CrossRef]
  10. Schrittwieser, S.; Pelaz, B.; Parak, W.J.; Lentijo-Mozo, S.; Soulantica, K.; Dieckhoff, J.; Ludwig, F.; Guenther, A.; Tschöpe, A.; Schotter, J. Homogeneous biosensing based on magnetic particle labels. Sensors 201616, 828. [Google Scholar] [CrossRef]
  11. He, J.; Huang, M.; Wang, D.; Zhang, Z.; Li, G. Magnetic separation techniques in sample preparation for biological analysis: A review. J. Pharm. Biomed. Anal. 2014101, 84–101. [Google Scholar] [CrossRef]
  12. Ha, Y.; Ko, S.; Kim, I.; Huang, Y.; Mohanty, K.; Huh, C.; Maynard, J.A. Recent advances incorporating superparamagnetic nanoparticles into immunoassays. ACS Appl. Nano Mater. 20181, 512–521. [Google Scholar] [CrossRef]
  13. Gómez-Pastora, J.; González-Fernández, C.; Fallanza, M.; Bringas, E.; Ortiz, I. Flow patterns and mass transfer performance of miscible liquid-liquid flows in various microchannels: Numerical and experimental studies. Chem. Eng. J. 2018344, 487–497. [Google Scholar] [CrossRef]
  14. Gale, B.K.; Jafek, A.R.; Lambert, C.J.; Goenner, B.L.; Moghimifam, H.; Nze, U.C.; Kamarapu, S.K. A review of current methods in microfluidic device fabrication and future commercialization prospects. Inventions 20183, 60. [Google Scholar] [CrossRef]
  15. Nanobiotechnology; Concepts, Applications and Perspectives; Niemeyer, C.M.; Mirkin, C.A. (Eds.) Wiley-VCH: Weinheim, Germany, 2004; ISBN 3527305068. [Google Scholar]
  16. Khashan, S.A.; Dagher, S.; Alazzam, A.; Mathew, B.; Hilal-Alnaqbi, A. Microdevice for continuous flow magnetic separation for bioengineering applications. J. Micromech. Microeng. 201727, 055016. [Google Scholar] [CrossRef]
  17. Basauri, A.; Gomez-Pastora, J.; Fallanza, M.; Bringas, E.; Ortiz, I. Predictive model for the design of reactive micro-separations. Sep. Purif. Technol. 2019209, 900–907. [Google Scholar] [CrossRef]
  18. Abdollahi, P.; Karimi-Sabet, J.; Moosavian, M.A.; Amini, Y. Microfluidic solvent extraction of calcium: Modeling and optimization of the process variables. Sep. Purif. Technol. 2020231, 115875. [Google Scholar] [CrossRef]
  19. Khashan, S.A.; Alazzam, A.; Furlani, E. A novel design for a microfluidic magnetophoresis system: Computational study. In Proceedings of the 12th International Symposium on Fluid Control, Measurement and Visualization (FLUCOME2013), Nara, Japan, 18–23 November 2013. [Google Scholar]
  20. Pamme, N. Magnetism and microfluidics. Lab Chip 20066, 24–38. [Google Scholar] [CrossRef]
  21. Gómez-Pastora, J.; Amiri Roodan, V.; Karampelas, I.H.; Alorabi, A.Q.; Tarn, M.D.; Iles, A.; Bringas, E.; Paunov, V.N.; Pamme, N.; Furlani, E.P.; et al. Two-step numerical approach to predict ferrofluid droplet generation and manipulation inside multilaminar flow chambers. J. Phys. Chem. C 2019123, 10065–10080. [Google Scholar] [CrossRef]
  22. Gómez-Pastora, J.; Karampelas, I.H.; Bringas, E.; Furlani, E.P.; Ortiz, I. Numerical analysis of bead magnetophoresis from flowing blood in a continuous-flow microchannel: Implications to the bead-fluid interactions. Sci. Rep. 20199, 7265. [Google Scholar] [CrossRef]
  23. Tarn, M.D.; Pamme, N. On-Chip Magnetic Particle-Based Immunoassays Using Multilaminar Flow for Clinical Diagnostics. In Microchip Diagnostics Methods and Protocols; Taly, V., Viovy, J.L., Descroix, S., Eds.; Humana Press: New York, NY, USA, 2017; pp. 69–83. [Google Scholar]
  24. Phurimsak, C.; Tarn, M.D.; Peyman, S.A.; Greenman, J.; Pamme, N. On-chip determination of c-reactive protein using magnetic particles in continuous flow. Anal. Chem. 201486, 10552–10559. [Google Scholar] [CrossRef]
  25. Wu, X.; Wu, H.; Hu, Y. Enhancement of separation efficiency on continuous magnetophoresis by utilizing L/T-shaped microchannels. Microfluid. Nanofluid. 201111, 11–24. [Google Scholar] [CrossRef]
  26. Vojtíšek, M.; Tarn, M.D.; Hirota, N.; Pamme, N. Microfluidic devices in superconducting magnets: On-chip free-flow diamagnetophoresis of polymer particles and bubbles. Microfluid. Nanofluid. 201213, 625–635. [Google Scholar] [CrossRef]
  27. Gómez-Pastora, J.; González-Fernández, C.; Real, E.; Iles, A.; Bringas, E.; Furlani, E.P.; Ortiz, I. Computational modeling and fluorescence microscopy characterization of a two-phase magnetophoretic microsystem for continuous-flow blood detoxification. Lab Chip 201818, 1593–1606. [Google Scholar] [CrossRef] [PubMed]
  28. Forbes, T.P.; Forry, S.P. Microfluidic magnetophoretic separations of immunomagnetically labeled rare mammalian cells. Lab Chip 201212, 1471–1479. [Google Scholar] [CrossRef]
  29. Nandy, K.; Chaudhuri, S.; Ganguly, R.; Puri, I.K. Analytical model for the magnetophoretic capture of magnetic microspheres in microfluidic devices. J. Magn. Magn. Mater. 2008320, 1398–1405. [Google Scholar] [CrossRef]
  30. Plouffe, B.D.; Lewis, L.H.; Murthy, S.K. Computational design optimization for microfluidic magnetophoresis. Biomicrofluidics 20115, 013413. [Google Scholar] [CrossRef] [PubMed]
  31. Hale, C.; Darabi, J. Magnetophoretic-based microfluidic device for DNA isolation. Biomicrofluidics 20148, 044118. [Google Scholar] [CrossRef] [PubMed]
  32. Becker, H.; Gärtner, C. Polymer microfabrication methods for microfluidic analytical applications. Electrophoresis 200021, 12–26. [Google Scholar] [CrossRef]
  33. Pekas, N.; Zhang, Q.; Nannini, M.; Juncker, D. Wet-etching of structures with straight facets and adjustable taper into glass substrates. Lab Chip 201010, 494–498. [Google Scholar] [CrossRef]
  34. Wang, T.; Chen, J.; Zhou, T.; Song, L. Fabricating microstructures on glass for microfluidic chips by glass molding process. Micromachines 20189, 269. [Google Scholar] [CrossRef]
  35. Castaño-Álvarez, M.; Pozo Ayuso, D.F.; García Granda, M.; Fernández-Abedul, M.T.; Rodríguez García, J.; Costa-García, A. Critical points in the fabrication of microfluidic devices on glass substrates. Sens. Actuators B Chem. 2008130, 436–448. [Google Scholar] [CrossRef]
  36. Prakash, S.; Kumar, S. Fabrication of microchannels: A review. Proc. Inst. Mech. Eng. Part B J. Eng. Manuf. 2015229, 1273–1288. [Google Scholar] [CrossRef]
  37. Leester-Schädel, M.; Lorenz, T.; Jürgens, F.; Ritcher, C. Fabrication of Microfluidic Devices. In Microsystems for Pharmatechnology: Manipulation of Fluids, Particles, Droplets, and Cells; Dietzel, A., Ed.; Springer: Basel, Switzerland, 2016; pp. 23–57. ISBN 9783319269207. [Google Scholar]
  38. Bartlett, N.W.; Wood, R.J. Comparative analysis of fabrication methods for achieving rounded microchannels in PDMS. J. Micromech. Microeng. 201626, 115013. [Google Scholar] [CrossRef]
  39. Ng, P.F.; Lee, K.I.; Yang, M.; Fei, B. Fabrication of 3D PDMS microchannels of adjustable cross-sections via versatile gel templates. Polymers 201911, 64. [Google Scholar] [CrossRef] [PubMed]
  40. Furlani, E.P.; Sahoo, Y.; Ng, K.C.; Wortman, J.C.; Monk, T.E. A model for predicting magnetic particle capture in a microfluidic bioseparator. Biomed. Microdevices 20079, 451–463. [Google Scholar] [CrossRef]
  41. Tarn, M.D.; Peyman, S.A.; Robert, D.; Iles, A.; Wilhelm, C.; Pamme, N. The importance of particle type selection and temperature control for on-chip free-flow magnetophoresis. J. Magn. Magn. Mater. 2009321, 4115–4122. [Google Scholar] [CrossRef]
  42. Furlani, E.P. Permanent Magnet and Electromechanical Devices; Materials, Analysis and Applications; Academic Press: Waltham, MA, USA, 2001. [Google Scholar]
  43. White, F.M. Viscous Fluid Flow; McGraw-Hill: New York, NY, USA, 1974. [Google Scholar]
  44. Mathew, B.; Alazzam, A.; El-Khasawneh, B.; Maalouf, M.; Destgeer, G.; Sung, H.J. Model for tracing the path of microparticles in continuous flow microfluidic devices for 2D focusing via standing acoustic waves. Sep. Purif. Technol. 2015153, 99–107. [Google Scholar] [CrossRef]
  45. Furlani, E.J.; Furlani, E.P. A model for predicting magnetic targeting of multifunctional particles in the microvasculature. J. Magn. Magn. Mater. 2007312, 187–193. [Google Scholar] [CrossRef]
  46. Furlani, E.P.; Ng, K.C. Analytical model of magnetic nanoparticle transport and capture in the microvasculature. Phys. Rev. E 200673, 061919. [Google Scholar] [CrossRef]
  47. Eibl, R.; Eibl, D.; Pörtner, R.; Catapano, G.; Czermak, P. Cell and Tissue Reaction Engineering; Springer: Berlin/Heidelberg, Germany, 2009. [Google Scholar]
  48. Pamme, N.; Eijkel, J.C.T.; Manz, A. On-chip free-flow magnetophoresis: Separation and detection of mixtures of magnetic particles in continuous flow. J. Magn. Magn. Mater. 2006307, 237–244. [Google Scholar] [CrossRef]
  49. Alorabi, A.Q.; Tarn, M.D.; Gómez-Pastora, J.; Bringas, E.; Ortiz, I.; Paunov, V.N.; Pamme, N. On-chip polyelectrolyte coating onto magnetic droplets-Towards continuous flow assembly of drug delivery capsules. Lab Chip 201717, 3785–3795. [Google Scholar] [CrossRef]
  50. Zhang, H.; Guo, H.; Chen, Z.; Zhang, G.; Li, Z. Application of PECVD SiC in glass micromachining. J. Micromech. Microeng. 200717, 775–780. [Google Scholar] [CrossRef]
  51. Mourzina, Y.; Steffen, A.; Offenhäusser, A. The evaporated metal masks for chemical glass etching for BioMEMS. Microsyst. Technol. 200511, 135–140. [Google Scholar] [CrossRef]
  52. Mata, A.; Fleischman, A.J.; Roy, S. Fabrication of multi-layer SU-8 microstructures. J. Micromech. Microeng. 200616, 276–284. [Google Scholar] [CrossRef]
  53. Su, N. 8 2000 Negative Tone Photoresist Formulations 2002–2025; MicroChem Corporation: Newton, MA, USA, 2002. [Google Scholar]
  54. Su, N. 8 2000 Negative Tone Photoresist Formulations 2035–2100; MicroChem Corporation: Newton, MA, USA, 2002. [Google Scholar]
  55. Fu, C.; Hung, C.; Huang, H. A novel and simple fabrication method of embedded SU-8 micro channels by direct UV lithography. J. Phys. Conf. Ser. 200634, 330–335. [Google Scholar] [CrossRef]
  56. Kazoe, Y.; Yamashiro, I.; Mawatari, K.; Kitamori, T. High-pressure acceleration of nanoliter droplets in the gas phase in a microchannel. Micromachines 20167, 142. [Google Scholar] [CrossRef]
  57. Sharp, K.V.; Adrian, R.J.; Santiago, J.G.; Molho, J.I. Liquid flows in microchannels. In MEMS: Introduction and Fundamentals; Gad-el-Hak, M., Ed.; CRC Press: Boca Raton, FL, USA, 2006; pp. 10-1–10-46. ISBN 9781420036572. [Google Scholar]
  58. Oh, K.W.; Lee, K.; Ahn, B.; Furlani, E.P. Design of pressure-driven microfluidic networks using electric circuit analogy. Lab Chip 201212, 515–545. [Google Scholar] [CrossRef]
  59. Bruus, H. Theoretical Microfluidics; Oxford University Press: New York, NY, USA, 2008; ISBN 9788578110796. [Google Scholar]
  60. Beebe, D.J.; Mensing, G.A.; Walker, G.M. Physics and applications of microfluidics in biology. Annu. Rev. Biomed. Eng. 20024, 261–286. [Google Scholar] [CrossRef] [PubMed]
  61. Yalikun, Y.; Tanaka, Y. Large-scale integration of all-glass valves on a microfluidic device. Micromachines 20167, 83. [Google Scholar] [CrossRef] [PubMed]
  62. Van Heeren, H.; Verhoeven, D.; Atkins, T.; Tzannis, A.; Becker, H.; Beusink, W.; Chen, P. Design Guideline for Microfluidic Device and Component Interfaces (Part 2), Version 3; Available online: http://www.makefluidics.com/en/design-guideline?id=7 (accessed on 9 March 2020).
  63. Scheuble, N.; Iles, A.; Wootton, R.C.R.; Windhab, E.J.; Fischer, P.; Elvira, K.S. Microfluidic technique for the simultaneous quantification of emulsion instabilities and lipid digestion kinetics. Anal. Chem. 201789, 9116–9123. [Google Scholar] [CrossRef] [PubMed]
  64. Lynch, E.C. Red blood cell damage by shear stress. Biophys. J. 197212, 257–273. [Google Scholar]
  65. Paul, R.; Apel, J.; Klaus, S.; Schügner, F.; Schwindke, P.; Reul, H. Shear stress related blood damage in laminar Couette flow. Artif. Organs 200327, 517–529. [Google Scholar] [CrossRef] [PubMed]
  66. Gómez-Pastora, J.; Karampelas, I.H.; Xue, X.; Bringas, E.; Furlani, E.P.; Ortiz, I. Magnetic bead separation from flowing blood in a two-phase continuous-flow magnetophoretic microdevice: Theoretical analysis through computational fluid dynamics simulation. J. Phys. Chem. C 2017121, 7466–7477. [Google Scholar] [CrossRef]
  67. Lim, J.; Yeap, S.P.; Leow, C.H.; Toh, P.Y.; Low, S.C. Magnetophoresis of iron oxide nanoparticles at low field gradient: The role of shape anisotropy. J. Colloid Interface Sci. 2014421, 170–177. [Google Scholar] [CrossRef] [PubMed]
  68. Culbertson, C.T.; Sibbitts, J.; Sellens, K.; Jia, S. Fabrication of Glass Microfluidic Devices. In Microfluidic Electrophoresis: Methods and Protocols; Dutta, D., Ed.; Humana Press: New York, NY, USA, 2019; pp. 1–12. ISBN 978-1-4939-8963-8. [Google Scholar]
Fluid velocity magnitude including velocity vectors and blood volumetric fraction contours for scenario 3: (a,b) Magnet distance d = 0; (c,d) Magnet distance d = 1 mm.

Numerical Analysis of Bead Magnetophoresis from Flowing Blood in a Continuous-Flow Microchannel: Implications to the Bead-Fluid Interactions

Scientific Reports volume 9, Article number: 7265 (2019) Cite this article

Abstract

이 연구에서는 비드 운동과 유체 흐름에 미치는 영향에 대한 자세한 분석을 제공하기 위해 연속 흐름 마이크로 채널 내부의 비드 자기 영동에 대한 수치 흐름 중심 연구를 보고합니다.

수치 모델은 Lagrangian 접근 방식을 포함하며 영구 자석에 의해 생성 된 자기장의 적용에 의해 혈액에서 비드 분리 및 유동 버퍼로의 수집을 예측합니다.

다음 시나리오가 모델링됩니다. (i) 운동량이 유체에서 점 입자로 처리되는 비드로 전달되는 단방향 커플 링, (ii) 비드가 점 입자로 처리되고 운동량이 다음으로부터 전달되는 양방향 결합 비드를 유체로 또는 그 반대로, (iii) 유체 변위에서 비드 체적의 영향을 고려한 양방향 커플 링.

결과는 세 가지 시나리오에서 비드 궤적에 약간의 차이가 있지만 특히 높은 자기력이 비드에 적용될 때 유동장에 상당한 변화가 있음을 나타냅니다.

따라서 높은 자기력을 사용할 때 비드 운동과 유동장의 체적 효과를 고려한 정확한 전체 유동 중심 모델을 해결해야 합니다. 그럼에도 불구하고 비드가 중간 또는 낮은 자기력을 받을 때 계산적으로 저렴한 모델을 안전하게 사용하여 자기 영동을 모델링 할 수 있습니다.

Sketch of the magnetophoresis process in the continuous-flow microdevice.
Sketch of the magnetophoresis process in the continuous-flow microdevice.
Schematic view of the microdevice showing the working conditions set in the simulations.
Schematic view of the microdevice showing the working conditions set in the simulations.
Bead trajectories for different magnetic field conditions, magnet placed at different distances “d” from the channel: (a) d = 0; (b) d = 1 mm; (c) d = 1.5 mm; (d) d = 2 mm
Bead trajectories for different magnetic field conditions, magnet placed at different distances “d” from the channel: (a) d = 0; (b) d = 1 mm; (c) d = 1.5 mm; (d) d = 2 mm
Separation efficacy as a function of the magnet distance. Comparison between one-way and two-way coupling.
Separation efficacy as a function of the magnet distance. Comparison between one-way and two-way coupling.
(a) Fluid velocity magnitude including velocity vectors and (b) blood volumetric fraction contours with magnet distance d = 0 mm for scenario 1 (t = 0.25 s).
(a) Fluid velocity magnitude including velocity vectors and (b) blood volumetric fraction contours with magnet distance d = 0 mm for scenario 1 (t = 0.25 s).
luid velocity magnitude including velocity vectors and blood volumetric fraction contours for scenario 2: (a,b) Magnet distance d = 0 mm at t = 0.4 s; (c,d) Magnet distance d = 1 mm at t = 0.4 s.
luid velocity magnitude including velocity vectors and blood volumetric fraction contours for scenario 2: (a,b) Magnet distance d = 0 mm at t = 0.4 s; (c,d) Magnet distance d = 1 mm at t = 0.4 s.
Fluid velocity magnitude including velocity vectors and blood volumetric fraction contours for scenario 3: (a,b) Magnet distance d = 0; (c,d) Magnet distance d = 1 mm.
Fluid velocity magnitude including velocity vectors and blood volumetric fraction contours for scenario 3: (a,b) Magnet distance d = 0; (c,d) Magnet distance d = 1 mm.
Blood volumetric fraction contours. Scenario 1: (a) Magnet distance d = 0 and (b) Magnet distance d = 1 mm; Scenario 2: (c) Magnet distance d = 0 and (d) Magnet distance d = 1 mm; and Scenario 3: (e) Magnet distance d = 0 and (f) Magnet distance d = 1 mm.
Blood volumetric fraction contours. Scenario 1: (a) Magnet distance d = 0 and (b) Magnet distance d = 1 mm; Scenario 2: (c) Magnet distance d = 0 and (d) Magnet distance d = 1 mm; and Scenario 3: (e) Magnet distance d = 0 and (f) Magnet distance d = 1 mm.

References

  1. 1.Keshipour, S. & Khalteh, N. K. Oxidation of ethylbenzene to styrene oxide in the presence of cellulose-supported Pd magnetic nanoparticles. Appl. Organometal. Chem. 30, 653–656 (2016).CAS Article Google Scholar 
  2. 2.Neamtu, M. et al. Functionalized magnetic nanoparticles: synthesis, characterization, catalytic application and assessment of toxicity. Sci. Rep. 8(1), 6278 (2018).ADS MathSciNet Article Google Scholar 
  3. 3.Gómez-Pastora, J., Bringas, E. & Ortiz, I. Recent progress and future challenges on the use of high performance magnetic nano-adsorbents in environmental applications. Chem. Eng. J. 256, 187–204 (2014).Article Google Scholar 
  4. 4.Gómez-Pastora, J., Bringas, E. & Ortiz, I. Design of novel adsorption processes for the removal of arsenic from polluted groundwater employing functionalized magnetic nanoparticles. Chem. Eng. Trans. 47, 241–246 (2016).Google Scholar 
  5. 5.Bagbi, Y., Sarswat, A., Mohan, D., Pandey, A. & Solanki, P. R. Lead and chromium adsorption from water using L-Cysteine functionalized magnetite (Fe3O4) nanoparticles. Sci. Rep. 7(1), 7672 (2017).ADS Article Google Scholar 
  6. 6.Gómez-Pastora, J. et al. Review and perspectives on the use of magnetic nanophotocatalysts (MNPCs) in water treatment. Chem. Eng. J. 310, 407–427 (2017).Article Google Scholar 
  7. 7.Lee, H. Y. et al. A selective fluoroionophore based on BODIPY-functionalized magnetic silica nanoparticles: removal of Pb2+ from human blood. Angew. Chem. Int. Ed. 48, 1239–1243 (2009).CAS Article Google Scholar 
  8. 8.Buzea, C., Pacheco, I. I. & Robbie, K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2, MR17–MR71 (2007).Article Google Scholar 
  9. 9.Roux, S. et al. Multifunctional nanoparticles: from the detection of biomolecules to the therapy. Int. J. Nanotechnol. 7, 781–801 (2010).ADS CAS Article Google Scholar 
  10. 10.Gómez-Pastora, J., Bringas, E., Lázaro-Díez, M., Ramos-Vivas, J. & Ortiz, I. In Drug Delivery Systems (Stroeve, P. & Mahmoudi, M. ed) 207–244 (World Scientific, 2017).
  11. 11.Selmi, M., Gazzah, M. H. & Belmabrouk, H. Optimization of microfluidic biosensor efficiency by means of fluid flow engineering. Sci. Rep. 7(1), 5721 (2017).ADS Article Google Scholar 
  12. 12.Gómez-Pastora, J., González-Fernández, C., Fallanza, M., Bringas, E. & Ortiz, I. Flow patterns and mass transfer performance of miscible liquid-liquid flows in various microchannels: Numerical and experimental studies. Chem. Eng. J. 344, 487–497 (2018).Article Google Scholar 
  13. 13.Pamme, N. Magnetism and microfluidics. Lab Chip 6, 24–38 (2006).CAS Article Google Scholar 
  14. 14.Alorabi, A. Q. et al. On-chip polyelectrolyte coating onto magnetic droplets – towards continuous flow assembly of drug delivery capsules. Lab Chip 17, 3785–3795 (2017).CAS Article Google Scholar 
  15. 15.Gómez-Pastora, J. et al. Analysis of separators for magnetic beads recovery: from large systems to multifunctional microdevices. Sep. Purif. Technol. 172, 16–31 (2017).Article Google Scholar 
  16. 16.Tarn, M. D. & Pamme, N. On-chip magnetic particle-based immunoassays using multilaminar flow for clinical diagnosis. Methods Mol. Biol. 1547, 69–83 (2017).CAS Article Google Scholar 
  17. 17.Lv, C. et al. Integrated optofluidic-microfluidic twin channels: toward diverse application of lab-on-a-chip systems. Sci. Rep. 6, 19801 (2016).ADS CAS Article Google Scholar 
  18. 18.Gómez-Pastora, J. et al. Magnetic bead separation from flowing blood in a two-phase continuous-flow magnetophoretic microdevice: theoretical analysis through computational fluid dynamics simulation. J. Phys. Chem. C 121, 7466–7477 (2017).Article Google Scholar 
  19. 19.Furlani, E. P. Magnetic biotransport: analysis and applications. Materials 3, 2412–2446 (2010).ADS CAS Article Google Scholar 
  20. 20.Khashan, S. A. & Furlani, E. P. Effects of particle–fluid coupling on particle transport and capture in a magnetophoretic microsystem. Microfluid. Nanofluid. 12, 565–580 (2012).Article Google Scholar 
  21. 21.Modak, N., Datta, A. & Ganguly, R. Cell separation in a microfluidic channel using magnetic microspheres. Microfluid. Nanofluid. 6, 647–660 (2009).CAS Article Google Scholar 
  22. 22.Furlani, E. P., Sahoo, Y., Ng, K. C., Wortman, J. C. & Monk, T. E. A model for predicting magnetic particle capture in a microfluidic bioseparator. Biomed. Microdevices 9, 451–463 (2007).CAS Article Google Scholar 
  23. 23.Furlani, E. P. & Sahoo, Y. Analytical model for the magnetic field and force in a magnetophoretic microsystem. J. Phys. D: Appl. Phys. 39, 1724–1732 (2006).ADS CAS Article Google Scholar 
  24. 24.Tarn, M. D. et al. The importance of particle type selection and temperature control for on-chip free-flow magnetophoresis. J. Magn. Magn. Mater. 321, 4115–4122 (2009).ADS CAS Article Google Scholar 
  25. 25.Fonnum, G., Johansson, C., Molteberg, A., Morup, S. & Aksnes, E. Characterisation of Dynabeads® by magnetization measurements and Mössbauer spectroscopy. J. Magn. Magn. Mater. 293, 41–47 (2005).ADS CAS Article Google Scholar 
  26. 26.Xue, W., Moore, L. R., Nakano, N., Chalmers, J. J. & Zborowski, M. Single cell magnetometry by magnetophoresis vs. bulk cell suspension magnetometry by SQUID-MPMS – A comparison. J. Magn. Magn. Mater. 474, 152–160 (2019).ADS CAS Article Google Scholar 
  27. 27.Moore, L. R. et al. Continuous, intrinsic magnetic depletion of erythrocytes from whole blood with a quadrupole magnet and annular flow channel; pilot scale study. Biotechnol. Bioeng. 115, 1521–1530 (2018).CAS Article Google Scholar 
  28. 28.Furlani, E. P. & Xue, X. Field, force and transport analysis for magnetic particle-based gene delivery. Microfluid Nanofluid. 13, 589–602 (2012).CAS Article Google Scholar 
  29. 29.Furlani, E. P. & Xue, X. A model for predicting field-directed particle transport in the magnetofection process. Pharm. Res. 29, 1366–1379 (2012).CAS Article Google Scholar 
  30. 30.Furlani, E. P. Permanent Magnet and Electromechanical Devices; MaterialsAnalysis and Applications, (Academic Press, 2001).
  31. 31.Balachandar, S. & Eaton, J. K. Turbulent dispersed multiphase flow. Annu. Rev. Fluid Mech. 42, 111–133 (2010).ADS Article Google Scholar 
  32. 32.Wakaba, L. & Balachandar, S. On the added mass force at finite Reynolds and acceleration number. Theor. Comput. Fluid. Dyn. 21, 147–153 (2007).Article Google Scholar 
  33. 33.White, F. M. Viscous Fluid Flow, (McGraw-Hill, 1974).
  34. 34.Rietema, K. & Van Den Akker, H. E. A. On the momentum equations in dispersed two-phase systems. Int. J. Multiphase Flow 9, 21–36 (1983).Article Google Scholar 
  35. 35.Furlani, E. P. & Ng, K. C. Analytical model of magnetic nanoparticle transport and capture in the microvasculature. Phys. Rev. E 73, 1–10 (2006).Article Google Scholar 
  36. 36.Eibl, R., Eibl, D., Pörtner, R., Catapano, G. & Czermak, P. Cell and Tissue Reaction Engineering, (Springer, 2009).
  37. 37.Gómez-Pastora, J. et al. Computational modeling and fluorescence microscopy characterization of a two-phase magnetophoretic microsystem for continuous-flow blood detoxification. Lab Chip 18, 1593–1606 (2018).Article Google Scholar 
  38. 38.Khashan, S. A. & Furlani, E. P. Scalability analysis of magnetic bead separation in a microchannel with an array of soft magnetic elements in a uniform magnetic field. Sep. Purif. Technol. 125, 311–318 (2014).CAS Article Google Scholar 
  39. 39.Hirt, C. W. & Sicilian, J. M. A porosity technique for the definition of obstacles in rectangular cell meshes. ProcFourth International ConfShip Hydro., National Academic of Science, Washington, DC., (1985).
  40. 40.Crank, J. Free and Moving Boundary Problems, (Oxford University Press, 1984).
  41. 41.Bruus, H. Theoretical Microfluidics, (Oxford University Press, 2008).
  42. 42.Liang, L. & Xuan, X. Diamagnetic particle focusing using ferromicrofluidics with a single magnet. Microfluid. Nanofluid. 13, 637–643 (2012).

Author information

  1. Edward P. Furlani is deceased.

Affiliations

  1. Department of Chemical and Biomolecular Engineering, ETSIIT, University of Cantabria, Avda. Los Castros s/n, 39005, Santander, SpainJenifer Gómez-Pastora, Eugenio Bringas & Inmaculada Ortiz
  2. Flow Science, Inc, Santa Fe, New Mexico, 87505, USAIoannis H. Karampelas
  3. Department of Chemical and Biological Engineering, University at Buffalo (SUNY), Buffalo, New York, 14260, USAEdward P. Furlani
  4. Department of Electrical Engineering, University at Buffalo (SUNY), Buffalo, New York, 14260, USAEdward P. Furlani
Modeling of contactless bubble–bubble interactions in microchannels with integrated inertial pumps

Modeling of contactless bubble–bubble interactions in microchannels with integrated inertial pumps

통합 관성 펌프를 사용하여 마이크로 채널에서 비접촉식 기포-기포 상호 작용 모델링

Physics of Fluids 33, 042002 (2021); https://doi.org/10.1063/5.0041924 B. Hayesa) G. L. Whitingb), and  R. MacCurdyc)

ABSTRACT

In this study, the nonlinear effect of contactless bubble–bubble interactions in inertial micropumps is characterized via reduced parameter one-dimensional and three-dimensional computational fluid dynamics (3D CFD) modeling. A one-dimensional pump model is developed to account for contactless bubble-bubble interactions, and the accuracy of the developed one-dimensional model is assessed via the commercial volume of fluid CFD software, FLOW-3D. The FLOW-3D CFD model is validated against experimental bubble dynamics images as well as experimental pump data. Precollapse and postcollapse bubble and flow dynamics for two resistors in a channel have been successfully explained by the modified one-dimensional model. The net pumping effect design space is characterized as a function of resistor placement and firing time delay. The one-dimensional model accurately predicts cumulative flow for simultaneous resistor firing with inner-channel resistor placements (0.2L < x < 0.8L where L is the channel length) as well as delayed resistor firing with inner-channel resistor placements when the time delay is greater than the time required for the vapor bubble to fill the channel cross section. In general, one-dimensional model accuracy suffers at near-reservoir resistor placements and short time delays which we propose is a result of 3D bubble-reservoir interactions and transverse bubble growth interactions, respectively, that are not captured by the one-dimensional model. We find that the one-dimensional model accuracy improves for smaller channel heights. We envision the developed one-dimensional model as a first-order rapid design tool for inertial pump-based microfluidic systems operating in the contactless bubble–bubble interaction nonlinear regime

이 연구에서 관성 마이크로 펌프에서 비접촉 기포-기포 상호 작용의 비선형 효과는 감소 된 매개 변수 1 차원 및 3 차원 전산 유체 역학 (3D CFD) 모델링을 통해 특성화됩니다. 비접촉식 기포-버블 상호 작용을 설명하기 위해 1 차원 펌프 모델이 개발되었으며, 개발 된 1 차원 모델의 정확도는 유체 CFD 소프트웨어 인 FLOW-3D의 상용 볼륨을 통해 평가됩니다.

FLOW-3D CFD 모델은 실험적인 거품 역학 이미지와 실험적인 펌프 데이터에 대해 검증되었습니다. 채널에 있는 두 저항기의 붕괴 전 및 붕괴 후 기포 및 유동 역학은 수정 된 1 차원 모델에 의해 성공적으로 설명되었습니다. 순 펌핑 효과 설계 공간은 저항 배치 및 발사 시간 지연의 기능으로 특징 지어집니다.

1 차원 모델은 내부 채널 저항 배치 (0.2L <x <0.8L, 여기서 L은 채널 길이)로 동시 저항 발생에 대한 누적 흐름과 시간 지연시 내부 채널 저항 배치로 지연된 저항 발생을 정확하게 예측합니다. 증기 방울이 채널 단면을 채우는 데 필요한 시간보다 큽니다.

일반적으로 1 차원 모델 정확도는 저수지 근처의 저항 배치와 1 차원 모델에 의해 포착되지 않는 3D 기포-저수지 상호 작용 및 가로 기포 성장 상호 작용의 결과 인 짧은 시간 지연에서 어려움을 겪습니다. 채널 높이가 작을수록 1 차원 모델 정확도가 향상됩니다. 우리는 개발 된 1 차원 모델을 비접촉 기포-기포 상호 작용 비선형 영역에서 작동하는 관성 펌프 기반 미세 유체 시스템을 위한 1 차 빠른 설계 도구로 생각합니다.

REFERENCES

1.S. Hassan and X. Zhang, “ Design and fabrication of capillary-driven flow device for point-of-care diagnostics,” Biosensors 10, 39 (2020). https://doi.org/10.3390/bios10040039, Google ScholarCrossref
2.Q. Shizhi and H. Bau, “ Magneto-hydrodynamics based microfluidics,” Mech. Res. Commun. 36, 10 (2009). https://doi.org/10.1016/j.mechrescom.2008.06.013, Google ScholarCrossref
3.N. Mishchuk, T. Heldal, T. Volden, J. Auerswald, and H. Knapp, “ Micropump based on electroosmosis of the second kind,” Electrophoresis 30, 3499 (2009). https://doi.org/10.1002/elps.200900271, Google ScholarCrossref
4.J. Snyder, J. Getpreecharsawas, D. Fang, T. Gaborski, C. Striemer, P. Fauchet, D. Borkholder, and J. McGrath, “ High-performance, low-voltage electroosmotic pumps with molecularly thin silicon nanomembranes,” Proc. Nat. Acad. Sci. U. S. A. 110, 18425–18430 (2013). https://doi.org/10.1073/pnas.1308109110, Google ScholarCrossref
5.K. Vinayakumar, G. Nadiger, V. Shetty, S. Dinesh, M. Nayak, and K. Rajanna, “ Packaged peristaltic micropump for controlled drug delivery application,” Rev. Sci. Instrum. 88, 015102 (2017). https://doi.org/10.1063/1.4973513, Google ScholarScitation, ISI
6.D. Duffy, H. Gillis, J. Lin, N. Sheppard, and G. Kellogg, “ Microfabricated centrifugal microfluidic systems: Characterization and multiple enzymatic assays,” Anal. Chem. 71, 4669 (1999). https://doi.org/10.1021/ac990682c, Google ScholarCrossref
7.V. Gnyawali, M. Saremi, M. Kolios, and S. Tsai, “ Stable microfluidic flow focusing using hydrostatics,” Biomicrofluidics 11, 034104 (2017). https://doi.org/10.1063/1.4983147, Google ScholarScitation, ISI
8.J. Lake, K. Heyde, and W. Ruder, “ Low-cost feedback-controlled syringe pressure pumps for microfluidics applications,” PLoS One 12, e0175089 (2017). https://doi.org/10.1371/journal.pone.0175089, Google ScholarCrossref
9.M. I. Mohammed, S. Haswell, and I. Gibson, “ Lab-on-a-chip or chip-in-a-lab: Challenges of commercialization lost in translation,” Procedia Technology 20, 54–59 (2015), proceedings of The 1st International Design Technology Conference, DESTECH2015, Geelong. Google ScholarCrossref
10.E. Torniainen, A. Govyadinov, D. Markel, and P. Kornilovitch, “ Bubble-driven inertial micropump,” Phys. Fluids 24, 122003 (2012). https://doi.org/10.1063/1.4769755, Google ScholarScitation, ISI
11.H. Hoefemann, S. Wadle, N. Bakhtina, V. Kondrashov, N. Wangler, and R. Zengerle, “ Sorting and lysis of single cells by bubblejet technology,” Sens. Actuators, B 168, 442–445 (2012). https://doi.org/10.1016/j.snb.2012.04.005, Google ScholarCrossref
12.B. Hayes, A. Hayes, M. Rolleston, A. Ferreira, and J. Kirsher, “ Pulsatory mixing of laminar flow using bubble-driven micro-pumps,” in Proceedings of the ASME 2018 International Mechanical Engineering Congress and Exposition (2018), Vol. 7. Google ScholarCrossref
13.E. Ory, H. Yuan, A. Prosperetti, S. Popinet, and S. Zaleski, “ Growth and collapse of a vapor bubble in a narrow tube,” Phys. Fluids 12, 1268 (2000). https://doi.org/10.1063/1.870381, Google ScholarScitation, ISI
14.Z. Yin and A. Prosperetti, “‘ Blinking bubble’ micropump with microfabricated heaters,” J. Micromech. Microeng. 15, 1683 (2005). https://doi.org/10.1088/0960-1317/15/9/010, Google ScholarCrossref
15.M. Einat and M. Grajower, “ Microboiling measurements of thermal-inkjet heaters,” J. Microelectromech. Syst. 19, 391 (2010). https://doi.org/10.1109/JMEMS.2010.2040946, Google ScholarCrossref
16.A. Govyadinov, P. Kornilovitch, D. Markel, and E. Torniainen, “ Single-pulse dynamics and flow rates of inertial micropumps,” Microfluid. Nanofluid. 20, 73 (2016). https://doi.org/10.1007/s10404-016-1738-x, Google ScholarCrossref
17.E. Sourtiji and Y. Peles, “ A micro-synthetic jet in a microchannel using bubble growth and collapse,” Appl. Therm. Eng. 160, 114084 (2019). https://doi.org/10.1016/j.applthermaleng.2019.114084, Google ScholarCrossref
18.B. Hayes, A. Govyadinov, and P. Kornilovitch, “ Microfluidic switchboards with integrated inertial pumps,” Microfluid. Nanofluid. 22, 15 (2018). https://doi.org/10.1007/s10404-017-2032-2, Google ScholarCrossref
19.P. Kornilovitch, A. Govyadinov, D. Markel, and E. Torniainen, “ One-dimensional model of inertial pumping,” Phys. Rev. E 87, 023012 (2013). https://doi.org/10.1103/PhysRevE.87.023012, Google ScholarCrossref
20.H. Yuan and A. Prosperetti, “ The pumping effect of growing and collapsing bubbles in a tube,” J. Micromech. Microeng. 9, 402–413 (1999). https://doi.org/10.1088/0960-1317/9/4/318, Google ScholarCrossref
21.J. Zou, B. Li, and C. Ji, “ Interactions between two oscillating bubbles in a rigid tube,” Exp. Therm. Fluid Sci. 61, 105 (2015). https://doi.org/10.1016/j.expthermflusci.2014.10.021, Google ScholarCrossref
22.C. Hirt and B. Nichols, “ Volume of fluid (vof) method for the dynamics of free boundaries,” J. Comput. Phys. 39, 201–225 (1981). https://doi.org/10.1016/0021-9991(81)90145-5, Google ScholarCrossref
23.C. Borgnakke and R. E. Sonntag, Fundamentals of Thermodynamics, 8th ed. ( Wiley, 1999). Google Scholar
24.O. E. Ruiz, “ CFD model of the thermal inkjet droplet ejection process,” in Proceeding of Heat Transfer Summer Conference (2007), Vol. 3. Google ScholarCrossref
25.T. Theofanous, L. Biasi, H. Isbin, and H. Fauske, “ A theoretical study on bubble growth in constant and time-dependent pressure fields,” Chem. Eng. Sci. 24, 885–897 (1969). https://doi.org/10.1016/0009-2509(69)85008-6, Google ScholarCrossref
26.S. Timoshenko and J. Goodier, Theory of Elasticity, 3rd ed. ( McGaw-Hill, Inc., 1970). Google Scholar

Figure 1 (A) A schematic of ovarian cancer metastases involving tumor cells or clusters (yellow) shedding from a primary site and disseminating along ascitic currents of peritoneal fluid (green arrows) in the abdominal cavity. Ovarian cancer typically disseminates in four common abdomino-pelvic sites: (1) cul-de-sac (an extension of the peritoneal cavity between the rectum and back wall of the uterus); (2) right infracolic space (the apex formed by the termination of the small intestine of the small bowel mesentery at the ileocecal junction); (3) left infracolic space (superior site of the sigmoid colon); (4) Right paracolic gutter (communication between the upper and lower abdomen defined by the ascending colon and peritoneal wall). (B) The schematic of a perfusion model used to study the impact of sustained fluid flow on treatment resistance and molecular features of 3D ovarian cancer nodules (Top left). A side view of the perfusion model and growth of ovarian cancer nodules to a stromal bed (Top right). The photograph of a perfusion model used in the experiments (Bottom left) and depth-informed confocal imaging of ovarian cancer nodules in channels with and without carboplatin treatment (Bottom right). The perfusion model is 24 × 40 mm, with three channels that are 4 × 30 mm each and a height of 254 μm. The inlet and outlet ports of channels are 2.2 mm in diameter and positioned 5 mm from the edge of the chip. (C) A schematic of a 24-well plate model used to study the treatment resistance and molecular features of 3D ovarian cancer nodules under static conditions (without flow) (Top left). A side view of the static models and growth of ovarian cancer nodules on a stromal bed (Top right). Confocal imaging of 3D ovarian cancer nodules in a 24-well plate without and with carboplatin treatment (Bottom). Scale bars: 1 mm.

Flow-induced Shear Stress Confers Resistance to Carboplatin in an Adherent Three-Dimensional Model for Ovarian Cancer: A Role for EGFR-Targeted Photoimmunotherapy Informed by Physical Stress

난소암에 대한 일관된 3차원 모델에서 카보플라틴에 대한 유동에 의한 전단응력변화에 관한 연구

Abstract

A key reason for the persistently grim statistics associated with metastatic ovarian cancer is resistance to conventional agents, including platinum-based chemotherapies. A major source of treatment failure is the high degree of genetic and molecular heterogeneity, which results from significant underlying genomic instability, as well as stromal and physical cues in the microenvironment. Ovarian cancer commonly disseminates via transcoelomic routes to distant sites, which is associated with the frequent production of malignant ascites, as well as the poorest prognosis. In addition to providing a cell and protein-rich environment for cancer growth and progression, ascitic fluid also confers physical stress on tumors. An understudied area in ovarian cancer research is the impact of fluid shear stress on treatment failure. Here, we investigate the effect of fluid shear stress on response to platinum-based chemotherapy and the modulation of molecular pathways associated with aggressive disease in a perfusion model for adherent 3D ovarian cancer nodules. Resistance to carboplatin is observed under flow with a concomitant increase in the expression and activation of the epidermal growth factor receptor (EGFR) as well as downstream signaling members mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK) and extracellular signal-regulated kinase (ERK). The uptake of platinum by the 3D ovarian cancer nodules was significantly higher in flow cultures compared to static cultures. A downregulation of phospho-focal adhesion kinase (p-FAK), vinculin, and phospho-paxillin was observed following carboplatin treatment in both flow and static cultures. Interestingly, low-dose anti-EGFR photoimmunotherapy (PIT), a targeted photochemical modality, was found to be equally effective in ovarian tumors grown under flow and static conditions. These findings highlight the need to further develop PIT-based combinations that target the EGFR, and sensitize ovarian cancers to chemotherapy in the context of flow-induced shear stress.

전이성 난소 암과 관련된 지속적으로 암울한 통계의 주요 이유는 백금 기반 화학 요법을 포함한 기존 약제에 대한 내성 때문입니다. 치료 실패의 주요 원인은 높은 수준의 유전적 및 분자적 이질성이며, 이는 중요한 기본 게놈 불안정성과 미세 환경의 기질 및 물리적 단서로 인해 발생합니다.

난소 암은 흔히 transcoelomic 경로를 통해 먼 부위로 전파되며, 이는 악성 복수의 빈번한 생산과 가장 나쁜 예후와 관련이 있습니다. 암 성장 및 진행을위한 세포 및 단백질이 풍부한 환경을 제공하는 것 외에도 복수 액은 종양에 물리적 스트레스를 부여합니다. 난소 암 연구에서 잘 연구되지 않은 분야는 유체 전단 응력이 치료 실패에 미치는 영향입니다.

여기, 우리는 백금 기반 화학 요법에 대한 반응과 부착 3D 난소 암 결절에 대한 관류 모델에서 공격적인 질병과 관련된 분자 경로의 변조에 대한 유체 전단 응력의 효과를 조사합니다.

카르보플라틴에 대한 내성은 상피 성장 인자 수용체 (EGFR)의 발현 및 활성화의 수반되는 증가 뿐만 아니라 다운 스트림 신호 구성원인 미토겐 활성화 단백질 키나제/세포 외 신호 조절 키나제 (MEK) 및 세포 외 신호 조절과 함께 관찰됩니다. 키나아제 (ERK). 3D 난소 암 결절에 의한 백금 흡수는 정적 배양에 비해 유동 배양에서 상당히 높았습니다.

포스 포-포컬 접착 키나제 (p-FAK), 빈 쿨린 및 포스 포-팍 실린의 하향 조절은 유동 및 정적 배양 모두에서 카보 플 라틴 처리 후 관찰되었습니다. 흥미롭게도, 표적 광 화학적 양식 인 저용량 항 EGFR 광 면역 요법 (PIT)은 유동 및 정적 조건에서 성장한 난소 종양에서 똑같이 효과적인 것으로 밝혀졌습니다.

이러한 발견은 EGFR을 표적으로하는 PIT 기반 조합을 추가로 개발하고 흐름 유도 전단 응력의 맥락에서 화학 요법에 난소 암을 민감하게 할 필요성을 강조합니다.

Keywords: ovarian cancer, epidermal growth factor receptor (EGFR), mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK), extracellular signal-regulated kinase (ERK), chemoresistance, fluid shear stress, ascites, perfusion model, photoimmunotherapy (PIT), photodynamic therapy (PDT), carboplatin

Figure 1 (A) A schematic of ovarian cancer metastases involving tumor cells or clusters (yellow) shedding from a primary site and disseminating along ascitic currents of peritoneal fluid (green arrows) in the abdominal cavity. Ovarian cancer typically disseminates in four common abdomino-pelvic sites: (1) cul-de-sac (an extension of the peritoneal cavity between the rectum and back wall of the uterus); (2) right infracolic space (the apex formed by the termination of the small intestine of the small bowel mesentery at the ileocecal junction); (3) left infracolic space (superior site of the sigmoid colon); (4) Right paracolic gutter (communication between the upper and lower abdomen defined by the ascending colon and peritoneal wall). (B) The schematic of a perfusion model used to study the impact of sustained fluid flow on treatment resistance and molecular features of 3D ovarian cancer nodules (Top left). A side view of the perfusion model and growth of ovarian cancer nodules to a stromal bed (Top right). The photograph of a perfusion model used in the experiments (Bottom left) and depth-informed confocal imaging of ovarian cancer nodules in channels with and without carboplatin treatment (Bottom right). The perfusion model is 24 × 40 mm, with three channels that are 4 × 30 mm each and a height of 254 μm. The inlet and outlet ports of channels are 2.2 mm in diameter and positioned 5 mm from the edge of the chip. (C) A schematic of a 24-well plate model used to study the treatment resistance and molecular features of 3D ovarian cancer nodules under static conditions (without flow) (Top left). A side view of the static models and growth of ovarian cancer nodules on a stromal bed (Top right). Confocal imaging of 3D ovarian cancer nodules in a 24-well plate without and with carboplatin treatment (Bottom). Scale bars: 1 mm.
Figure 1 (A) A schematic of ovarian cancer metastases involving tumor cells or clusters (yellow) shedding from a primary site and disseminating along ascitic currents of peritoneal fluid (green arrows) in the abdominal cavity. Ovarian cancer typically disseminates in four common abdomino-pelvic sites: (1) cul-de-sac (an extension of the peritoneal cavity between the rectum and back wall of the uterus); (2) right infracolic space (the apex formed by the termination of the small intestine of the small bowel mesentery at the ileocecal junction); (3) left infracolic space (superior site of the sigmoid colon); (4) Right paracolic gutter (communication between the upper and lower abdomen defined by the ascending colon and peritoneal wall). (B) The schematic of a perfusion model used to study the impact of sustained fluid flow on treatment resistance and molecular features of 3D ovarian cancer nodules (Top left). A side view of the perfusion model and growth of ovarian cancer nodules to a stromal bed (Top right). The photograph of a perfusion model used in the experiments (Bottom left) and depth-informed confocal imaging of ovarian cancer nodules in channels with and without carboplatin treatment (Bottom right). The perfusion model is 24 × 40 mm, with three channels that are 4 × 30 mm each and a height of 254 μm. The inlet and outlet ports of channels are 2.2 mm in diameter and positioned 5 mm from the edge of the chip. (C) A schematic of a 24-well plate model used to study the treatment resistance and molecular features of 3D ovarian cancer nodules under static conditions (without flow) (Top left). A side view of the static models and growth of ovarian cancer nodules on a stromal bed (Top right). Confocal imaging of 3D ovarian cancer nodules in a 24-well plate without and with carboplatin treatment (Bottom). Scale bars: 1 mm.
Figure 2 (A) Geometry of the micronodule located at the center of the microchannel. The flow velocity is in the X-direction. The nodule is modeled as an ellipse with a semi-minor axis of 40 μm in the Z-direction. The semi-major axis varies from 40-100 μm in the X-direction. The section over which the fluid dynamics are studied is the middle part of the channel with dimensions 4 mm along the Y-axis and 250 μm along the Z-axis. The nodule is located at (0, 20 μm). The black dotted line shows the centerline of the largest nodule. (B) Shear stress distribution over the surface of the solid micro-nodule on the XZ-plane. (C) Shear stress distribution over the surface of the porous micro-nodule on the XZ-plane. (D) Flow flux distribution over the centerline of the porous micro-nodule on the XZ-plane. The flux enters the surface at the left and leaves at the right.
Figure 2 (A) Geometry of the micronodule located at the center of the microchannel. The flow velocity is in the X-direction. The nodule is modeled as an ellipse with a semi-minor axis of 40 μm in the Z-direction. The semi-major axis varies from 40-100 μm in the X-direction. The section over which the fluid dynamics are studied is the middle part of the channel with dimensions 4 mm along the Y-axis and 250 μm along the Z-axis. The nodule is located at (0, 20 μm). The black dotted line shows the centerline of the largest nodule. (B) Shear stress distribution over the surface of the solid micro-nodule on the XZ-plane. (C) Shear stress distribution over the surface of the porous micro-nodule on the XZ-plane. (D) Flow flux distribution over the centerline of the porous micro-nodule on the XZ-plane. The flux enters the surface at the left and leaves at the right.
Figure 3 Cytotoxic response in carboplatin-treated 3D OVCAR-5 cultures under static conditions. (A) Representative confocal images of 3D tumors treated with carboplatin (0-500 μM) for 96 h showing a dose-dependent reduction in viable tumor (calcein signal). (B) Image-based quantification of normalized viable tumor area in 3D OVCAR-5 cultures following treatment with increasing doses of carboplatin. A minimum nodule size cut-off of 2000 µm2 (clusters of ~15–20 cells) was applied to the fluorescence images for quantitative analysis of the normalized viable tumor area. (One-way ANOVA with Dunnett’s post hoc test; n.s., not significant; * p < 0.05; *** p < 0.001; N = 9) (C) Inductively coupled plasma mass spectrometry (ICP-MS)-based quantification of carboplatin uptake in static 3D OVCAR-5 tumors shows a dose-dependent increase in platinum levels, up to 9774 ± 3,052 ng/mg protein at an incubation concentration of 500 μM carboplatin. (One-way ANOVA with Dunn’s multiple comparisons test; n.s., not significant; * p < 0.05; ** p < 0.01; N = 3). Results are expressed as mean ± standard error of mean (SEM). Scale bars: 500 μm.
Figure 3 Cytotoxic response in carboplatin-treated 3D OVCAR-5 cultures under static conditions. (A) Representative confocal images of 3D tumors treated with carboplatin (0-500 μM) for 96 h showing a dose-dependent reduction in viable tumor (calcein signal). (B) Image-based quantification of normalized viable tumor area in 3D OVCAR-5 cultures following treatment with increasing doses of carboplatin. A minimum nodule size cut-off of 2000 µm2 (clusters of ~15–20 cells) was applied to the fluorescence images for quantitative analysis of the normalized viable tumor area. (One-way ANOVA with Dunnett’s post hoc test; n.s., not significant; * p < 0.05; *** p < 0.001; N = 9) (C) Inductively coupled plasma mass spectrometry (ICP-MS)-based quantification of carboplatin uptake in static 3D OVCAR-5 tumors shows a dose-dependent increase in platinum levels, up to 9774 ± 3,052 ng/mg protein at an incubation concentration of 500 μM carboplatin. (One-way ANOVA with Dunn’s multiple comparisons test; n.s., not significant; * p < 0.05; ** p < 0.01; N = 3). Results are expressed as mean ± standard error of mean (SEM). Scale bars: 500 μm.
Figure 4 flow-induced chemo-resistance
Figure 4 flow-induced chemo-resistance
Figure 5 The effects of flow-induced shear stress on 3D ovarian cancer biology. (A) Western blot analysis of OVCAR-5 tumors was performed 7 days after culture under static or flow conditions. A flow-induced increase in EGFR and p-ERK, compared to static cultures, was observed. Conversely, a reduction in p-FAK, p-Paxillin, and Vinculin was observed under flow, relative to static conditions. (B) Western blot analysis of 3D OVCAR-5 tumors was performed 11 days after culture under static or flow conditions, including 4 days of treatment with 500 µM carboplatin, and respective controls. In both static and flow 3D cultures, carboplatin treatment resulted in downregulation of EGFR, FAK, p-Paxillin, Paxillin, and Vinculin. Upregulation of p-ERK was observed after carboplatin treatment in both static and flow 3D cultures. (C) Baseline levels of EGFR activity and expression are maintained by a complex array of factors, including recycling and degradation of the activated receptor complex. Flow-induced shear stress has been shown to cause a posttranslational up-regulation of EGFR expression and activation, likely resulting from increased receptor recycling and decreased EGFR degradation. Activation of EGFR results in ERK phosphorylation to induce gene expression, ultimately leading to cell proliferation, survival, and chemoresistance. FAK and other tyrosine kinases are activated by the engagement of integrins with the ECM. Subsequent phosphorylation of paxillin by FAK not only influences the remodeling of the actin cytoskeleton, but also modulates vinculin activation to regulate mitogen-activated protein kinase (MAPK) cascades, thereby stimulating pro-survival gene expression.
Figure 5 The effects of flow-induced shear stress on 3D ovarian cancer biology. (A) Western blot analysis of OVCAR-5 tumors was performed 7 days after culture under static or flow conditions. A flow-induced increase in EGFR and p-ERK, compared to static cultures, was observed. Conversely, a reduction in p-FAK, p-Paxillin, and Vinculin was observed under flow, relative to static conditions. (B) Western blot analysis of 3D OVCAR-5 tumors was performed 11 days after culture under static or flow conditions, including 4 days of treatment with 500 µM carboplatin, and respective controls. In both static and flow 3D cultures, carboplatin treatment resulted in downregulation of EGFR, FAK, p-Paxillin, Paxillin, and Vinculin. Upregulation of p-ERK was observed after carboplatin treatment in both static and flow 3D cultures. (C) Baseline levels of EGFR activity and expression are maintained by a complex array of factors, including recycling and degradation of the activated receptor complex. Flow-induced shear stress has been shown to cause a posttranslational up-regulation of EGFR expression and activation, likely resulting from increased receptor recycling and decreased EGFR degradation. Activation of EGFR results in ERK phosphorylation to induce gene expression, ultimately leading to cell proliferation, survival, and chemoresistance. FAK and other tyrosine kinases are activated by the engagement of integrins with the ECM. Subsequent phosphorylation of paxillin by FAK not only influences the remodeling of the actin cytoskeleton, but also modulates vinculin activation to regulate mitogen-activated protein kinase (MAPK) cascades, thereby stimulating pro-survival gene expression.

References

  1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2019. CA Cancer J. Clin. 2019;69:7–34. doi: 10.3322/caac.21551. [PubMed] [CrossRef] [Google Scholar]
  2. Foley O.W., Rauh-Hain J.A., Del Carmen M.G. Recurrent epithelial ovarian cancer: An update on treatment. Oncology. 2013;27:288–294, 298. [PubMed] [Google Scholar]
  3. Kipps E., Tan D.S., Kaye S.B. Meeting the challenge of ascites in ovarian cancer: New avenues for therapy and research. Nat. Rev. Cancer. 2013;13:273–282. doi: 10.1038/nrc3432. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  4. Tan D.S., Agarwal R., Kaye S.B. Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol. 2006;7:925–934. doi: 10.1016/S1470-2045(06)70939-1. [PubMed] [CrossRef] [Google Scholar]
  5. Ahmed N., Stenvers K.L. Getting to know ovarian cancer ascites: Opportunities for targeted therapy-based translational research. Front. Oncol. 2013;3:256. doi: 10.3389/fonc.2013.00256. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  6. Shield K., Ackland M.L., Ahmed N., Rice G.E. Multicellular spheroids in ovarian cancer metastases: Biology and pathology. Gynecol. Oncol. 2009;113:143–148. doi: 10.1016/j.ygyno.2008.11.032. [PubMed] [CrossRef] [Google Scholar]
  7. Naora H., Montell D.J. Ovarian cancer metastasis: Integrating insights from disparate model organisms. Nat. Rev. Cancer. 2005;5:355–366. doi: 10.1038/nrc1611. [PubMed] [CrossRef] [Google Scholar]
  8. Lengyel E. Ovarian cancer development and metastasis. Am. J. Pathol. 2010;177:1053–1064. doi: 10.2353/ajpath.2010.100105. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  9. Javellana M., Hoppenot C., Lengyel E. The road to long-term survival: Surgical approach and longitudinal treatments of long-term survivors of advanced-stage serous ovarian cancer. Gynecol. Oncol. 2019;152:228–234. doi: 10.1016/j.ygyno.2018.11.007. [PubMed] [CrossRef] [Google Scholar]
  10. Al Habyan S., Kalos C., Szymborski J., McCaffrey L. Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer. Oncogene. 2018;37:5127–5135. doi: 10.1038/s41388-018-0317-x. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  11. Kim S., Kim B., Song Y.S. Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer. Cancer Sci. 2016;107:1173–1178. doi: 10.1111/cas.12987. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  12. Bowtell D.D., Bohm S., Ahmed A.A., Aspuria P.J., Bast R.C., Beral V., Berek J.S., Birrer M.J., Blagden S., Bookman M.A., et al. Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer. Nat. Rev. Cancer. 2015;15:668–679. doi: 10.1038/nrc4019. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  13. Hoppenot C., Eckert M.A., Tienda S.M., Lengyel E. Who are the long-term survivors of high grade serous ovarian cancer? Gynecol. Oncol. 2018;148:204–212. doi: 10.1016/j.ygyno.2017.10.032. [PubMed] [CrossRef] [Google Scholar]
  14. Zhao Y., Cao J., Melamed A., Worley M., Gockley A., Jones D., Nia H.T., Zhang Y., Stylianopoulos T., Kumar A.S., et al. Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma. Proc. Natl. Acad. Sci. USA. 2019;116:2210–2219. doi: 10.1073/pnas.1818357116. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  15. Ayantunde A.A., Parsons S.L. Pattern and prognostic factors in patients with malignant ascites: A retrospective study. Ann. Oncol. 2007;18:945–949. doi: 10.1093/annonc/mdl499. [PubMed] [CrossRef] [Google Scholar]
  16. Latifi A., Luwor R.B., Bilandzic M., Nazaretian S., Stenvers K., Pyman J., Zhu H., Thompson E.W., Quinn M.A., Findlay J.K., et al. Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: Molecular phenotype of chemoresistant ovarian tumors. PLoS ONE. 2012;7:e46858. doi: 10.1371/journal.pone.0046858. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  17. Ahmed N., Greening D., Samardzija C., Escalona R.M., Chen M., Findlay J.K., Kannourakis G. Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells. Sci. Rep. 2016;6:30061. doi: 10.1038/srep30061. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  18. Gjorevski N., Boghaert E., Nelson C.M. Regulation of Epithelial-Mesenchymal Transition by Transmission of Mechanical Stress through Epithelial Tissues. Cancer Microenviron. 2012;5:29–38. doi: 10.1007/s12307-011-0076-5. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  19. Polacheck W.J., Charest J.L., Kamm R.D. Interstitial flow influences direction of tumor cell migration through competing mechanisms. Proc. Natl. Acad. Sci. USA. 2011;108:11115–11120. doi: 10.1073/pnas.1103581108. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  20. Polacheck W.J., German A.E., Mammoto A., Ingber D.E., Kamm R.D. Mechanotransduction of fluid stresses governs 3D cell migration. Proc. Natl. Acad. Sci. USA. 2014;111:2447–2452. doi: 10.1073/pnas.1316848111. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  21. Polacheck W.J., Zervantonakis I.K., Kamm R.D. Tumor cell migration in complex microenvironments. Cell Mol. Life Sci. 2013;70:1335–1356. doi: 10.1007/s00018-012-1115-1. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  22. Swartz M.A., Lund A.W. Lymphatic and interstitial flow in the tumour microenvironment: Linking mechanobiology with immunity. Nat. Rev. Cancer. 2012;12:210–219. doi: 10.1038/nrc3186. [PubMed] [CrossRef] [Google Scholar]
  23. Pisano M., Triacca V., Barbee K.A., Swartz M.A. An in vitro model of the tumor-lymphatic microenvironment with simultaneous transendothelial and luminal flows reveals mechanisms of flow enhanced invasion. Integr. Biol. 2015;7:525–533. doi: 10.1039/C5IB00085H. [PubMed] [CrossRef] [Google Scholar]
  24. Follain G., Herrmann D., Harlepp S., Hyenne V., Osmani N., Warren S.C., Timpson P., Goetz J.G. Fluids and their mechanics in tumour transit: Shaping metastasis. Nat. Rev. Cancer. 2020;20:107–124. doi: 10.1038/s41568-019-0221-x. [PubMed] [CrossRef] [Google Scholar]
  25. Rizvi I., Gurkan U.A., Tasoglu S., Alagic N., Celli J.P., Mensah L.B., Mai Z., Demirci U., Hasan T. Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules. Proc. Natl. Acad. Sci. USA. 2013;110:E1974–E1983. doi: 10.1073/pnas.1216989110. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  26. Novak C., Horst E., Mehta G. Mechanotransduction in ovarian cancer: Shearing into the unknown. APL Bioeng. 2018;2 doi: 10.1063/1.5024386. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  27. Carmignani C.P., Sugarbaker T.A., Bromley C.M., Sugarbaker P.H. Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread. Cancer Metastasis Rev. 2003;22:465–472. doi: 10.1023/A:1023791229361. [PubMed] [CrossRef] [Google Scholar]
  28. Sugarbaker P.H. Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. Cancer Treatment Res. 1996;82:79–100. [PubMed] [Google Scholar]
  29. Feki A., Berardi P., Bellingan G., Major A., Krause K.H., Petignat P., Zehra R., Pervaiz S., Irminger-Finger I. Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model. Crit. Rev. Oncol./Hematol. 2009;72:1–9. doi: 10.1016/j.critrevonc.2008.12.003. [PubMed] [CrossRef] [Google Scholar]
  30. Holm-Nielsen P. Pathogenesis of ascites in peritoneal carcinomatosis. Acta Pathol. Microbiol. Scand. 1953;33:10–21. doi: 10.1111/j.1699-0463.1953.tb04805.x. [PubMed] [CrossRef] [Google Scholar]
  31. Ahmed N., Riley C., Oliva K., Rice G., Quinn M. Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma. Br. J. Cancer. 2005;92:1475–1485. doi: 10.1038/sj.bjc.6602495. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  32. Woodburn J.R. The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol. Ther. 1999;82:241–250. doi: 10.1016/S0163-7258(98)00045-X. [PubMed] [CrossRef] [Google Scholar]
  33. Servidei T., Riccardi A., Mozzetti S., Ferlini C., Riccardi R. Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib. Int. J. Cancer J. Int. Cancer. 2008;123:2939–2949. doi: 10.1002/ijc.23902. [PubMed] [CrossRef] [Google Scholar]
  34. Chen A.P., Zhang J., Liu H., Zhao S.P., Dai S.Z., Sun X.L. Association of EGFR expression with angiogenesis and chemoresistance in ovarian carcinoma. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2009;31:48–52. [PubMed] [Google Scholar]
  35. Alper O., Bergmann-Leitner E.S., Bennett T.A., Hacker N.F., Stromberg K., Stetler-Stevenson W.G. Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells. J. Natl. Cancer Inst. 2001;93:1375–1384. doi: 10.1093/jnci/93.18.1375. [PubMed] [CrossRef] [Google Scholar]
  36. Zeineldin R., Muller C.Y., Stack M.S., Hudson L.G. Targeting the EGF receptor for ovarian cancer therapy. J. Oncol. 2010;2010:414676. doi: 10.1155/2010/414676. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  37. Alper O., De Santis M.L., Stromberg K., Hacker N.F., Cho-Chung Y.S., Salomon D.S. Anti-sense suppression of epidermal growth factor receptor expression alters cellular proliferation, cell-adhesion and tumorigenicity in ovarian cancer cells. Int. J. Cancer. 2000;88:566–574. doi: 10.1002/1097-0215(20001115)88:4<566::AID-IJC8>3.0.CO;2-D. [PubMed] [CrossRef] [Google Scholar]
  38. Posadas E.M., Liel M.S., Kwitkowski V., Minasian L., Godwin A.K., Hussain M.M., Espina V., Wood B.J., Steinberg S.M., Kohn E.C. A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer. Cancer. 2007;109:1323–1330. doi: 10.1002/cncr.22545. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  39. Psyrri A., Kassar M., Yu Z., Bamias A., Weinberger P.M., Markakis S., Kowalski D., Camp R.L., Rimm D.L., Dimopoulos M.A. Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer. Clin. Cancer Res. 2005;11:8637–8643. doi: 10.1158/1078-0432.CCR-05-1436. [PubMed] [CrossRef] [Google Scholar]
  40. Dimou A., Agarwal S., Anagnostou V., Viray H., Christensen S., Gould Rothberg B., Zolota V., Syrigos K., Rimm D. Standardization of epidermal growth factor receptor (EGFR) measurement by quantitative immunofluorescence and impact on antibody-based mutation detection in non-small cell lung cancer. Am. J. Pathol. 2011;179:580–589. doi: 10.1016/j.ajpath.2011.04.031. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  41. Anagnostou V.K., Welsh A.W., Giltnane J.M., Siddiqui S., Liceaga C., Gustavson M., Syrigos K.N., Reiter J.L., Rimm D.L. Analytic variability in immunohistochemistry biomarker studies. Cancer Epidemiol Biomarkers Prev. 2010;19:982–991. doi: 10.1158/1055-9965.EPI-10-0097. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  42. Del Carmen M.G., Rizvi I., Chang Y., Moor A.C., Oliva E., Sherwood M., Pogue B., Hasan T. Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. J. Natl. Cancer Inst. 2005;97:1516–1524. doi: 10.1093/jnci/dji314. [PubMed] [CrossRef] [Google Scholar]
  43. Armstrong D.K., Bundy B., Wenzel L., Huang H.Q., Baergen R., Lele S., Copeland L.J., Walker J.L., Burger R.A., Gynecologic Oncology G. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N. Engl. J. Med. 2006;354:34–43. doi: 10.1056/NEJMoa052985. [PubMed] [CrossRef] [Google Scholar]
  44. Verwaal V.J., Van Ruth S., De Bree E., Van Sloothen G.W., Van Tinteren H., Boot H., Zoetmulder F.A. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J. Clin. Oncol. 2003;21:3737–3743. doi: 10.1200/JCO.2003.04.187. [PubMed] [CrossRef] [Google Scholar]
  45. Van Driel W.J., Koole S.N., Sikorska K., Schagen van Leeuwen J.H., Schreuder H.W.R., Hermans R.H.M., De Hingh I., Van der Velden J., Arts H.J., Massuger L., et al. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. N. Engl. J. Med. 2018;378:230–240. doi: 10.1056/NEJMoa1708618. [PubMed] [CrossRef] [Google Scholar]
  46. Verwaal V.J., Bruin S., Boot H., Van Slooten G., Van Tinteren H. 8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann. Surg. Oncol. 2008;15:2426–2432. doi: 10.1245/s10434-008-9966-2. [PubMed] [CrossRef] [Google Scholar]
  47. DeLaney T.F., Sindelar W.F., Tochner Z., Smith P.D., Friauf W.S., Thomas G., Dachowski L., Cole J.W., Steinberg S.M., Glatstein E. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int. J. Radiat. Oncol. Biol. Phys. 1993;25:445–457. doi: 10.1016/0360-3016(93)90066-5. [PubMed] [CrossRef] [Google Scholar]
  48. Celli J.P., Spring B.Q., Rizvi I., Evans C.L., Samkoe K.S., Verma S., Pogue B.W., Hasan T. Imaging and photodynamic therapy: Mechanisms, monitoring, and optimization. Chem. Rev. 2010;110:2795–2838. doi: 10.1021/cr900300p. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  49. Spring B.Q., Rizvi I., Xu N., Hasan T. The role of photodynamic therapy in overcoming cancer drug resistance. Photochem. Photobiol. Sci. 2015;14:1476–1491. doi: 10.1039/C4PP00495G. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  50. Liang B.J., Pigula M., Baglo Y., Najafali D., Hasan T., Huang H.C. Breaking the Selectivity-Uptake Trade-Off of Photoimmunoconjugates with Nanoliposomal Irinotecan for Synergistic Multi-Tier Cancer Targeting. J. Nanobiotechnol. 2020;18:1. doi: 10.1186/s12951-019-0560-5. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  51. Huang H.C., Rizvi I., Liu J., Anbil S., Kalra A., Lee H., Baglo Y., Paz N., Hayden D., Pereira S., et al. Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug Delivery. Cancer Res. 2018;78:558–571. doi: 10.1158/0008-5472.CAN-17-1700. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  52. Huang H.C., Mallidi S., Liu J., Chiang C.T., Mai Z., Goldschmidt R., Ebrahim-Zadeh N., Rizvi I., Hasan T. Photodynamic Therapy Synergizes with Irinotecan to Overcome Compensatory Mechanisms and Improve Treatment Outcomes in Pancreatic Cancer. Cancer Res. 2016;76:1066–1077. doi: 10.1158/0008-5472.CAN-15-0391. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  53. Cengel K.A., Glatstein E., Hahn S.M. Intraperitoneal photodynamic therapy. Cancer Treat. Res. 2007;134:493–514. [PubMed] [Google Scholar]
  54. Obaid G., Broekgaarden M., Bulin A.-L., Huang H.-C., Kuriakose J., Liu J., Hasan T. Photonanomedicine: A convergence of photodynamic therapy and nanotechnology. Nanoscale. 2016;8:12471–12503. doi: 10.1039/C5NR08691D. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  55. Ogata F., Nagaya T., Nakamura Y., Sato K., Okuyama S., Maruoka Y., Choyke P.L., Kobayashi H. Near-infrared photoimmunotherapy: A comparison of light dosing schedules. Oncotarget. 2017;8:35069–35075. doi: 10.18632/oncotarget.17047. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  56. Mitsunaga M., Ogawa M., Kosaka N., Rosenblum L.T., Choyke P.L., Kobayashi H. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat. Med. 2011;17:1685–1691. doi: 10.1038/nm.2554. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  57. Inglut C.T., Baglo Y., Liang B.J., Cheema Y., Stabile J., Woodworth G.F., Huang H.-C. Systematic Evaluation of Light-Activatable Biohybrids for Anti-Glioma Photodynamic Therapy. J. Clin. Med. 2019;8:1269. doi: 10.3390/jcm8091269. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  58. Huang H.C., Pigula M., Fang Y., Hasan T. Immobilization of Photo-Immunoconjugates on Nanoparticles Leads to Enhanced Light-Activated Biological Effects. Small. 2018:e1800236. doi: 10.1002/smll.201800236. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  59. Spring B.Q., Abu-Yousif A.O., Palanisami A., Rizvi I., Zheng X., Mai Z., Anbil S., Sears R.B., Mensah L.B., Goldschmidt R., et al. Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates. Proc. Natl. Acad. Sci. USA. 2014;111:E933–E942. doi: 10.1073/pnas.1319493111. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  60. Abu-Yousif A.O., Moor A.C., Zheng X., Savellano M.D., Yu W., Selbo P.K., Hasan T. Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells. Cancer Lett. 2012;321:120–127. doi: 10.1016/j.canlet.2012.01.014. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  61. Rizvi I., Dinh T.A., Yu W., Chang Y., Sherwood M.E., Hasan T. Photoimmunotherapy and irradiance modulation reduce chemotherapy cycles and toxicity in a murine model for ovarian carcinomatosis: Perspective and results. Israel J. Chem. 2012;52:776–787. doi: 10.1002/ijch.201200016. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  62. Quirk B.J., Brandal G., Donlon S., Vera J.C., Mang T.S., Foy A.B., Lew S.M., Girotti A.W., Jogal S., LaViolette P.S., et al. Photodynamic therapy (PDT) for malignant brain tumors–where do we stand? Photodiagnosis Photodyn. Ther. 2015;12:530–544. doi: 10.1016/j.pdpdt.2015.04.009. [PubMed] [CrossRef] [Google Scholar]
  63. Eljamel M.S., Goodman C., Moseley H. ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: A single centre Phase III randomised controlled trial. Lasers Med. Sci. 2008;23:361–367. doi: 10.1007/s10103-007-0494-2. [PubMed] [CrossRef] [Google Scholar]
  64. Varma A.K., Muller P.J. Cranial neuropathies after intracranial Photofrin-photodynamic therapy for malignant supratentorial gliomas-a report on 3 cases. Surg. Neurol. 2008;70:190–193. doi: 10.1016/j.surneu.2007.01.060. [PubMed] [CrossRef] [Google Scholar]
  65. Akimoto J. Photodynamic Therapy for Malignant Brain Tumors. Neurol. Medico-Chirurgica. 2016;56:151–157. doi: 10.2176/nmc.ra.2015-0296. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  66. Kercher E.M., Nath S., Rizvi I., Spring B.Q. Cancer Cell-targeted and Activatable Photoimmunotherapy Spares T Cells in a 3D Coculture Model. Photochem. Photobiol. 2019 doi: 10.1111/php.13153. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  67. Savellano M.D., Hasan T. Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates. Photochem. Photobiol. 2003;77:431–439. doi: 10.1562/0031-8655(2003)077<0431:TCTOTE>2.0.CO;2. [PubMed] [CrossRef] [Google Scholar]
  68. Molpus K.L., Hamblin M.R., Rizvi I., Hasan T. Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photoimmunoconjugates. Gynecol. Oncol. 2000;76:397–404. doi: 10.1006/gyno.1999.5705. [PubMed] [CrossRef] [Google Scholar]
  69. Savellano M.D., Hasan T. Photochemical targeting of epidermal growth factor receptor: A mechanistic study. Clin. Cancer Res. 2005;11:1658–1668. doi: 10.1158/1078-0432.CCR-04-1902. [PubMed] [CrossRef] [Google Scholar]
  70. Nath S., Saad M.A., Pigula M., Swain J.W.R., Hasan T. Photoimmunotherapy of Ovarian Cancer: A Unique Niche in the Management of Advanced Disease. Cancers. 2019;11:1887. doi: 10.3390/cancers11121887. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  71. Calibasi Kocal G., Guven S., Foygel K., Goldman A., Chen P., Sengupta S., Paulmurugan R., Baskin Y., Demirci U. Dynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow. Sci. Rep. 2016;6:38221. doi: 10.1038/srep38221. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  72. Tasoglu S., Gurkan U.A., Wang S., Demirci U. Manipulating biological agents and cells in micro-scale volumes for applications in medicine. Chem. Soc. Rev. 2013;42:5788–5808. doi: 10.1039/c3cs60042d. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  73. Moon S., Gurkan U.A., Blander J., Fawzi W.W., Aboud S., Mugusi F., Kuritzkes D.R., Demirci U. Enumeration of CD4+ T-cells using a portable microchip count platform in Tanzanian HIV-infected patients. PLoS ONE. 2011;6:e21409. doi: 10.1371/journal.pone.0021409. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  74. White F.M. Fluid Mechanics. McGraw-Hill; Boston, MA, USA: 2011. [Google Scholar]
  75. Luo Q., Kuang D., Zhang B., Song G. Cell stiffness determined by atomic force microscopy and its correlation with cell motility. Biochim Biophys Acta. 2016;1860:1953–1960. doi: 10.1016/j.bbagen.2016.06.010. [PubMed] [CrossRef] [Google Scholar]
  76. Sarntinoranont M., Rooney F., Ferrari M. Interstitial Stress and Fluid Pressure Within a Growing Tumor. Ann. Biomed. Eng. 2003;31:327–335. doi: 10.1114/1.1554923. [PubMed] [CrossRef] [Google Scholar]
  77. Baxter L.T., Jain R.K. Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. Microvasc. Res. 1989;37:77–104. doi: 10.1016/0026-2862(89)90074-5. [PubMed] [CrossRef] [Google Scholar]
  78. Malik R., Khan A.P., Asangani I.A., Cieślik M., Prensner J.R., Wang X., Iyer M.K., Jiang X., Borkin D., Escara-Wilke J., et al. Targeting the MLL complex in castration-resistant prostate cancer. Nat. Med. 2015;21:344. doi: 10.1038/nm.3830. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  79. Nath S., Christian L., Tan S.Y., Ki S., Ehrlich L.I., Poenie M. Dynein Separately Partners with NDE1 and Dynactin To Orchestrate T Cell Focused Secretion. J. Immunol. 2016;197:2090–2101. doi: 10.4049/jimmunol.1600180. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  80. Celli J.P., Rizvi I., Evans C.L., Abu-Yousif A.O., Hasan T. Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model. J. Biomed. Opt. 2010;15:051603. doi: 10.1117/1.3483903. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  81. Rizvi I., Celli J.P., Evans C.L., Abu-Yousif A.O., Muzikansky A., Pogue B.W., Finkelstein D., Hasan T. Synergistic Enhancement of Carboplatin Efficacy with Photodynamic Therapy in a Three-Dimensional Model for Micrometastatic Ovarian Cancer. Cancer Res. 2010;70:9319–9328. doi: 10.1158/0008-5472.CAN-10-1783. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  82. Glidden M.D., Celli J.P., Massodi I., Rizvi I., Pogue B.W., Hasan T. Image-Based Quantification of Benzoporphyrin Derivative Uptake, Localization, and Photobleaching in 3D Tumor Models, for Optimization of PDT Parameters. Theranostics. 2012;2:827–839. doi: 10.7150/thno.4334. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  83. Celli J.P., Rizvi I., Blanden A.R., Massodi I., Glidden M.D., Pogue B.W., Hasan T. An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models. Sci. Rep. 2014;4:3751. doi: 10.1038/srep03751. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  84. Bulin A.L., Broekgaarden M., Hasan T. Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids. Sci. Rep. 2017;7:16645. doi: 10.1038/s41598-017-16622-9. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  85. Rahmanzadeh R., Rai P., Celli J.P., Rizvi I., Baron-Luhr B., Gerdes J., Hasan T. Ki-67 as a molecular target for therapy in an in vitro three-dimensional model for ovarian cancer. Cancer Res. 2010;70:9234–9242. doi: 10.1158/0008-5472.CAN-10-1190. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  86. Anbil S., Rizvi I., Celli J.P., Alagic N., Pogue B.W., Hasan T. Impact of treatment response metrics on photodynamic therapy planning and outcomes in a three-dimensional model of ovarian cancer. J. Biomed. Opt. 2013;18:098004. doi: 10.1117/1.JBO.18.9.098004. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  87. Di Pasqua A.J., Goodisman J., Dabrowiak J.C. Understanding how the platinum anticancer drug carboplatin works: From the bottle to the cell. Inorg. Chim. Acta. 2012;389:29–35. doi: 10.1016/j.ica.2012.01.028. [CrossRef] [Google Scholar]
  88. Rabik C.A., Dolan M.E. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat. Rev. 2007;33:9–23. doi: 10.1016/j.ctrv.2006.09.006. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  89. Ozols R.F. Carboplatin and paclitaxel in ovarian cancer. Semin. Oncol. 1995;22:78–83. [PubMed] [Google Scholar]
  90. Neijt J.P., Lund B. Paclitaxel with carboplatin for the treatment of ovarian cancer. Semin. Oncol. 1996;23:2–4. [PubMed] [Google Scholar]
  91. Subauste C.M., Pertz O., Adamson E.D., Turner C.E., Junger S., Hahn K.M. Vinculin modulation of paxillin–FAK interactions regulates ERK to control survival and motility. J. Cell Biol. 2004;165:371–381. doi: 10.1083/jcb.200308011. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  92. Eke I., Cordes N. Focal adhesion signaling and therapy resistance in cancer. Semin. Cancer Biol. 2015;31:65–75. [PubMed] [Google Scholar]
  93. McCubrey J.A., Steelman L.S., Chappell W.H., Abrams S.L., Wong E.W., Chang F., Lehmann B., Terrian D.M., Milella M., Tafuri A., et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim. Biophys. Acta. 2007;1773:1263–1284. doi: 10.1016/j.bbamcr.2006.10.001. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  94. Duska L.R., Hamblin M.R., Miller J.L., Hasan T. Combination photoimmunotherapy and cisplatin: Effects on human ovarian cancer ex vivo. J. Natl. Cancer Inst. 1999;91:1557–1563. doi: 10.1093/jnci/91.18.1557. [PubMed] [CrossRef] [Google Scholar]
  95. Spring B., Mai Z., Rai P., Chang S., Hasan T. Theranostic nanocells for simultaneous imaging and photodynamic therapy of pancreatic cancer. Proc. SPIE. 2010;7551:755104. [Google Scholar]
  96. Kessel D., Oleinick N.L. Photodynamic therapy and cell death pathways. Methods Mol. Biol. 2010;635:35–46. doi: 10.1007/978-1-60761-697-9_3. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  97. Van Dongen G.A., Visser G.W., Vrouenraets M.B. Photosensitizer-antibody conjugates for detection and therapy of cancer. Adv. Drug Deliv. Rev. 2004;56:31–52. doi: 10.1016/j.addr.2003.09.003. [PubMed] [CrossRef] [Google Scholar]
  98. Ayhan A., Gultekin M., Taskiran C., Dursun P., Firat P., Bozdag G., Celik N.Y., Yuce K. Ascites and epithelial ovarian cancers: A reappraisal with respect to different aspects. Int. J. Gynecol. Cancer. 2007;17:68–75. doi: 10.1111/j.1525-1438.2006.00777.x. [PubMed] [CrossRef] [Google Scholar]
  99. Shen-Gunther J., Mannel R.S. Ascites as a predictor of ovarian malignancy. Gynecol. Oncol. 2002;87:77–83. doi: 10.1006/gyno.2002.6800. [PubMed] [CrossRef] [Google Scholar]
  100. Pourgholami M.H., Ataie-Kachoie P., Badar S., Morris D.L. Minocycline inhibits malignant ascites of ovarian cancer through targeting multiple signaling pathways. Gynecol. Oncol. 2013;129:113–119. doi: 10.1016/j.ygyno.2012.12.031. [PubMed] [CrossRef] [Google Scholar]
  101. Shender V., Arapidi G., Butenko I., Anikanov N., Ivanova O., Govorun V. Peptidome profiling dataset of ovarian cancer and non-cancer proximal fluids: Ascites and blood sera. Data Brief. 2019;22:557–562. doi: 10.1016/j.dib.2018.12.056. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  102. Parsons S.L., Watson S.A., Steele R.J.C. Malignant ascites. Br. J. Surg. 1996;83:6–14. doi: 10.1002/bjs.1800830104. [PubMed] [CrossRef] [Google Scholar]
  103. Becker G., Galandi D., Blum H.E. Malignant ascites: Systematic review and guideline for treatment. Eur. J. Cancer. 2006;42:589–597. doi: 10.1016/j.ejca.2005.11.018. [PubMed] [CrossRef] [Google Scholar]
  104. Huang H., Li Y.J., Lan C.Y., Huang Q.D., Feng Y.L., Huang Y.W., Liu J.H. Clinical significance of ascites in epithelial ovarian cancer. Neoplasma. 2013;60:546–552. doi: 10.4149/neo_2013_071. [PubMed] [CrossRef] [Google Scholar]
  105. Blagden S.P. Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian Cancer. Front. Oncol. 2015;5:149. doi: 10.3389/fonc.2015.00149. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  106. Ahmed N., Latifi A., Riley C.B., Findlay J.K., Quinn M.A. Neuronal transcription factor Brn-3a(l) is over expressed in high-grade ovarian carcinomas and tumor cells from ascites of patients with advanced-stage ovarian cancer. J. Ovarian Res. 2010;3:17. doi: 10.1186/1757-2215-3-17. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  107. Mahmood N., Mihalcioiu C., Rabbani S.A. Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications. Front. Oncol. 2018;8:24. doi: 10.3389/fonc.2018.00024. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  108. Jeffrey B., Udaykumar H.S., Schulze K.S. Flow fields generated by peristaltic reflex in isolated guinea pig ileum: Impact of contraction depth and shoulders. Am. J. Physiol. Gastrointest. Liver Physiol. 2003;285:G907–G918. doi: 10.1152/ajpgi.00062.2003. [PubMed] [CrossRef] [Google Scholar]
  109. Nagy J.A., Herzberg K.T., Dvorak J.M., Dvorak H.F. Pathogenesis of malignant ascites formation: Initiating events that lead to fluid accumulation. Cancer Res. 1993;53:2631–2643. [PubMed] [Google Scholar]
  110. Ahmed N., Abubaker K., Findlay J., Quinn M. Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. Curr. Cancer Drug Targets. 2010;10:268–278. doi: 10.2174/156800910791190175. [PubMed] [CrossRef] [Google Scholar]
  111. Latifi A., Abubaker K., Castrechini N., Ward A.C., Liongue C., Dobill F., Kumar J., Thompson E.W., Quinn M.A., Findlay J.K., et al. Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile. J. Cell Biochem. 2011;112:2850–2864. doi: 10.1002/jcb.23199. [PubMed] [CrossRef] [Google Scholar]
  112. Chan D.W., Hui W.W., Cai P.C., Liu M.X., Yung M.M., Mak C.S., Leung T.H., Chan K.K., Ngan H.Y. Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells. PLoS ONE. 2012;7:e52578. doi: 10.1371/journal.pone.0052578. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  113. Mebratu Y., Tesfaigzi Y. How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? Cell Cycle. 2009;8:1168–1175. doi: 10.4161/cc.8.8.8147. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  114. Zebisch A., Czernilofsky A.P., Keri G., Smigelskaite J., Sill H., Troppmair J. Signaling through RAS-RAF-MEK-ERK: From basics to bedside. Curr. Med. Chem. 2007;14:601–623. doi: 10.2174/092986707780059670. [PubMed] [CrossRef] [Google Scholar]
  115. Jo H., Sipos K., Go Y.M., Law R., Rong J., McDonald J.M. Differential effect of shear stress on extracellular signal-regulated kinase and N-terminal Jun kinase in endothelial cells. Gi2- and Gbeta/gamma-dependent signaling pathways. J. Biol. Chem. 1997;272:1395–1401. doi: 10.1074/jbc.272.2.1395. [PubMed] [CrossRef] [Google Scholar]
  116. Surapisitchat J., Hoefen R.J., Pi X., Yoshizumi M., Yan C., Berk B.C. Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: Inhibitory crosstalk among MAPK family members. Proc. Natl. Acad. Sci. USA. 2001;98:6476–6481. doi: 10.1073/pnas.101134098. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  117. Kim C.H., Jeung E.B., Yoo Y.M. Combined Fluid Shear Stress and Melatonin Enhances the ERK/Akt/mTOR Signal in Cilia-Less MC3T3-E1 Preosteoblast Cells. Int. J. Mol. Sci. 2018;19:2929. doi: 10.3390/ijms19102929. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  118. Persons D.L., Yazlovitskaya E.M., Cui W., Pelling J.C. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: Inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin. Cancer Res. 1999;5:1007–1014. [PubMed] [Google Scholar]
  119. Hayakawa J., Ohmichi M., Kurachi H., Ikegami H., Kimura A., Matsuoka T., Jikihara H., Mercola D., Murata Y. Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line. J. Biol. Chem. 1999;274:31648–31654. doi: 10.1074/jbc.274.44.31648. [PubMed] [CrossRef] [Google Scholar]
  120. Yeh P.Y., Chuang S.E., Yeh K.H., Song Y.C., Ea C.K., Cheng A.L. Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation. Biochem. Pharmacol. 2002;63:1423–1430. doi: 10.1016/S0006-2952(02)00908-5. [PubMed] [CrossRef] [Google Scholar]
  121. Wang X., Martindale J.L., Holbrook N.J. Requirement for ERK activation in cisplatin-induced apoptosis. J. Biol. Chem. 2000;275:39435–39443. doi: 10.1074/jbc.M004583200. [PubMed] [CrossRef] [Google Scholar]
  122. Qin X., Liu C., Zhou Y., Wang G. Cisplatin induces programmed death-1-ligand 1(PD-L1) over-expression in hepatoma H22 cells via Erk /MAPK signaling pathway. Cell Mol. Biol. 2010;56:OL1366-72. doi: 10.1170/156. [PubMed] [CrossRef] [Google Scholar]
  123. Basu A., Tu H. Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cdelta. Biochem. Biophys. Res. Commun. 2005;334:1068–1073. doi: 10.1016/j.bbrc.2005.06.199. [PubMed] [CrossRef] [Google Scholar]
  124. Nowak G. Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells. J. Biol. Chem. 2002;277:43377–43388. doi: 10.1074/jbc.M206373200. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  125. Chaudhury A., Tan B.J., Das S., Chiu G.N. Increased ERK activation and cellular drug accumulation in the enhanced cytotoxicity of folate receptor-targeted liposomal carboplatin. Int. J. Oncol. 2012;40:703–710. doi: 10.3892/ijo.2011.1262. [PubMed] [CrossRef] [Google Scholar]
  126. Lok G.T., Chan D.W., Liu V.W., Hui W.W., Leung T.H., Yao K.M., Ngan H.Y. Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells. PLoS ONE. 2011;6:e23790. doi: 10.1371/journal.pone.0023790. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  127. Lafky J.M., Wilken J.A., Baron A.T., Maihle N.J. Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochim. Biophys. Acta. 2008;1785:232–265. doi: 10.1016/j.bbcan.2008.01.001. [PubMed] [CrossRef] [Google Scholar]
  128. Secord A.A., Blessing J.A., Armstrong D.K., Rodgers W.H., Miner Z., Barnes M.N., Lewandowski G., Mannel R.S., Gynecologic Oncology G. Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: A Gynecologic Oncology Group study. Gynecol. Oncol. 2008;108:493–499. doi: 10.1016/j.ygyno.2007.11.029. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  129. Bae G.-Y., Choi S.-J., Lee J.-S., Jo J., Lee J., Kim J., Cha H.-J. Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer. Oncotarget. 2013;4:2512. doi: 10.18632/oncotarget.1463. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  130. Pece S., Gutkind J.S. Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J. Biol. Chem. 2000;275:41227–41233. doi: 10.1074/jbc.M006578200. [PubMed] [CrossRef] [Google Scholar]
  131. Lifschitz-Mercer B., Czernobilsky B., Feldberg E., Geiger B. Expression of the adherens junction protein vinculin in human basal and squamous cell tumors: Relationship to invasiveness and metastatic potential. Hum. Pathol. 1997;28:1230–1236. doi: 10.1016/S0046-8177(97)90195-7. [PubMed] [CrossRef] [Google Scholar]
  132. Raz A., Geiger B. Altered organization of cell-substrate contacts and membrane-associated cytoskeleton in tumor cell variants exhibiting different metastatic capabilities. Cancer Res. 1982;42:5183–5190. [PubMed] [Google Scholar]
  133. Fukada T., Sakajiri H., Kuroda M., Kioka N., Sugimoto K. Fluid shear stress applied by orbital shaking induces MG-63 osteosarcoma cells to activate ERK in two phases through distinct signaling pathways. Biochem. Biophys. Rep. 2017;9:257–265. doi: 10.1016/j.bbrep.2017.01.004. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  134. Wu D.W., Wu T.C., Wu J.Y., Cheng Y.W., Chen Y.C., Lee M.C., Chen C.Y., Lee H. Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression. Oncogene. 2014;33:4385–4395. doi: 10.1038/onc.2013.389. [PubMed] [CrossRef] [Google Scholar]
  135. Kessel D. Apoptosis and associated phenomena as a determinants of the efficacy of photodynamic therapy. Photochem. Photobiol. Sci. 2015;14:1397–1402. doi: 10.1039/C4PP00413B. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  136. Agostinis P., Berg K., Cengel K.A., Foster T.H., Girotti A.W., Gollnick S.O., Hahn S.M., Hamblin M.R., Juzeniene A., Kessel D., et al. Photodynamic therapy of cancer: An update. CA Cancer J. Clin. 2011;61:250–281. doi: 10.3322/caac.20114. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  137. Sorrin A.J., Ruhi M.K., Ferlic N.A., Karimnia V., Polacheck W.J., Celli J.P., Huang H.C., Rizvi I. Photodynamic Therapy and the Biophysics of the Tumor Microenvironment. Photochem. Photobiol. 2020 doi: 10.1111/php.13209. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  138. Niu C.J., Fisher C., Scheffler K., Wan R., Maleki H., Liu H., Sun Y., C A.S., Birngruber R., Lilge L. Polyacrylamide gel substrates that simulate the mechanical stiffness of normal and malignant neuronal tissues increase protoporphyin IX synthesis in glioma cells. J. Biomed. Opt. 2015;20:098002. doi: 10.1117/1.JBO.20.9.098002. [PubMed] [CrossRef] [Google Scholar]
  139. Perentes J.Y., Wang Y., Wang X., Abdelnour E., Gonzalez M., Decosterd L., Wagnieres G., Van den Bergh H., Peters S., Ris H.B., et al. Low-Dose Vascular Photodynamic Therapy Decreases Tumor Interstitial Fluid Pressure, which Promotes Liposomal Doxorubicin Distribution in a Murine Sarcoma Metastasis Model. Transl. Oncol. 2014;7 doi: 10.1016/j.tranon.2014.04.010. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  140. Leunig M., Goetz A.E., Gamarra F., Zetterer G., Messmer K., Jain R.K. Photodynamic therapy-induced alterations in interstitial fluid pressure, volume and water content of an amelanotic melanoma in the hamster. Br. J. Cancer. 1994;69:101–103. doi: 10.1038/bjc.1994.15. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  141. Foster T.H., Murant R.S., Bryant R.G., Knox R.S., Gibson S.L., Hilf R. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat Res. 1991;126:296–303. doi: 10.2307/3577919. [PubMed] [CrossRef] [Google Scholar]
  142. Foster T.H., Hartley D.F., Nichols M.G., Hilf R. Fluence rate effects in photodynamic therapy of multicell tumor spheroids. Cancer Res. 1993;53:1249–1254. [PubMed] [Google Scholar]
  143. Nichols M.G., Foster T.H. Oxygen diffusion and reaction kinetics in the photodynamic therapy of multicell tumour spheroids. Phys. Med. Biol. 1994;39:2161–2181. doi: 10.1088/0031-9155/39/12/003. [PubMed] [CrossRef] [Google Scholar]
  144. Cavin S., Wang X., Zellweger M., Gonzalez M., Bensimon M., Wagnieres G., Krueger T., Ris H.B., Gronchi F., Perentes J.Y. Interstitial fluid pressure: A novel biomarker to monitor photo-induced drug uptake in tumor and normal tissues. Lasers Surg. Med. 2017;49:773–780. doi: 10.1002/lsm.22687. [PubMed] [CrossRef] [Google Scholar]
  145. Garcia Calavia P., Chambrier I., Cook M.J., Haines A.H., Field R.A., Russell D.A. Targeted photodynamic therapy of breast cancer cells using lactose-phthalocyanine functionalized gold nanoparticles. J. Colloid Interface Sci. 2018;512:249–259. doi: 10.1016/j.jcis.2017.10.030. [PubMed] [CrossRef] [Google Scholar]
  146. Kato T., Jin C.S., Ujiie H., Lee D., Fujino K., Wada H., Hu H.P., Weersink R.A., Chen J., Kaji M., et al. Nanoparticle targeted folate receptor 1-enhanced photodynamic therapy for lung cancer. Lung Cancer. 2017;113:59–68. doi: 10.1016/j.lungcan.2017.09.002. [PubMed] [CrossRef] [Google Scholar]
  147. Sebak A.A., Gomaa I.E.O., ElMeshad A.N., AbdelKader M.H. Targeted photodynamic-induced singlet oxygen production by peptide-conjugated biodegradable nanoparticles for treatment of skin melanoma. Photodiagnosis Photodyn. Ther. 2018;23:181–189. doi: 10.1016/j.pdpdt.2018.05.017. [PubMed] [CrossRef] [Google Scholar]
  148. Fernandes S.R.G., Fernandes R., Sarmento B., Pereira P.M.R., Tome J.P.C. Photoimmunoconjugates: Novel synthetic strategies to target and treat cancer by photodynamic therapy. Org. Biomol. Chem. 2019;17:2579–2593. doi: 10.1039/C8OB02902D. [PubMed] [CrossRef] [Google Scholar]
  149. Hamblin M.R., Miller J.L., Hasan T. Effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells. Cancer Res. 1996;56:5205–5210. [PubMed] [Google Scholar]
  150. Flont M., Jastrzebska E., Brzozka Z. Synergistic effect of the combination therapy on ovarian cancer cells under microfluidic conditions. Anal. Chim. Acta. 2020;1100:138–148. doi: 10.1016/j.aca.2019.11.047. [PubMed] [CrossRef] [Google Scholar]
Figure 3. (a) Velocity distribution in a section perpendicular to the flow for rectangular (left) and Ushaped (right) cross section channels, and (b) particle location in these cross sections.

Continuous-Flow Separation of Magnetic Particles from Biofluids: How Does the Microdevice Geometry Determine the Separation Performance?

Cristina González Fernández,1 Jenifer Gómez Pastora,2 Arantza Basauri,1 Marcos Fallanza,1 Eugenio Bringas,1 Jeffrey J. Chalmers,2 and Inmaculada Ortiz1,*
Author information Article notes Copyright and License information Disclaimer

생체 유체에서 자성 입자의 연속 흐름 분리 : 마이크로 장치 형상이 분리 성능을 어떻게 결정합니까?

Abstract

The use of functionalized magnetic particles for the detection or separation of multiple chemicals and biomolecules from biofluids continues to attract significant attention. After their incubation with the targeted substances, the beads can be magnetically recovered to perform analysis or diagnostic tests. Particle recovery with permanent magnets in continuous-flow microdevices has gathered great attention in the last decade due to the multiple advantages of microfluidics. As such, great efforts have been made to determine the magnetic and fluidic conditions for achieving complete particle capture; however, less attention has been paid to the effect of the channel geometry on the system performance, although it is key for designing systems that simultaneously provide high particle recovery and flow rates. Herein, we address the optimization of Y-Y-shaped microchannels, where magnetic beads are separated from blood and collected into a buffer stream by applying an external magnetic field. The influence of several geometrical features (namely cross section shape, thickness, length, and volume) on both bead recovery and system throughput is studied. For that purpose, we employ an experimentally validated Computational Fluid Dynamics (CFD) numerical model that considers the dominant forces acting on the beads during separation. Our results indicate that rectangular, long devices display the best performance as they deliver high particle recovery and high throughput. Thus, this methodology could be applied to the rational design of lab-on-a-chip devices for any magnetically driven purification, enrichment or isolation.

생체 유체에서 여러 화학 물질과 생체 분자의 검출 또는 분리를 위한 기능화된 자성 입자의 사용은 계속해서 상당한 관심을 받고 있습니다. 표적 물질과 함께 배양 한 후 비드는 자기적으로 회수되어 분석 또는 진단 테스트를 수행 할 수 있습니다.

연속 흐름 마이크로 장치에서 영구 자석을 사용한 입자 회수는 마이크로 유체의 여러 장점으로 인해 지난 10 년 동안 큰 관심을 모았습니다. 따라서 완전한 입자 포획을 달성하기 위한 자기 및 유체 조건을 결정하기 위해 많은 노력을 기울였습니다.

그러나 높은 입자 회수율과 유속을 동시에 제공하는 시스템을 설계하는데 있어 핵심이기는 하지만 시스템 성능에 대한 채널 형상의 영향에 대해서는 덜 주의를 기울였습니다.

여기에서 우리는 자기 비드가 혈액에서 분리되어 외부 자기장을 적용하여 버퍼 스트림으로 수집되는 Y-Y 모양의 마이크로 채널의 최적화를 다룹니다. 비드 회수 및 시스템 처리량에 대한 여러 기하학적 특징 (즉, 단면 형상, 두께, 길이 및 부피)의 영향을 연구합니다.

이를 위해 분리 중에 비드에 작용하는 지배적인 힘을 고려하는 실험적으로 검증된 CFD (Computational Fluid Dynamics) 수치 모델을 사용합니다.

우리의 결과는 직사각형의 긴 장치가 높은 입자 회수율과 높은 처리량을 제공하기 때문에 최고의 성능을 보여줍니다. 따라서 이 방법론은 자기 구동 정제, 농축 또는 분리를 위한 랩 온어 칩 장치의 합리적인 설계에 적용될 수 있습니다.

Keywords: particle magnetophoresis, CFD, cross section, chip fabrication

Figure 1 (a) Top view of the microfluidic-magnetophoretic device, (b) Schematic representation of the channel cross-sections studied in this work, and (c) the magnet position relative to the channel location (Sepy and Sepz are the magnet separation distances in y and z, respectively).
Figure 1 (a) Top view of the microfluidic-magnetophoretic device, (b) Schematic representation of the channel cross-sections studied in this work, and (c) the magnet position relative to the channel location (Sepy and Sepz are the magnet separation distances in y and z, respectively).
Figure 2. (a) Channel-magnet configuration and (b–d) magnetic force distribution in the channel midplane for 2 mm, 5 mm and 10 mm long rectangular (left) and U-shaped (right) devices.
Figure 2. (a) Channel-magnet configuration and (b–d) magnetic force distribution in the channel midplane for 2 mm, 5 mm and 10 mm long rectangular (left) and U-shaped (right) devices.
Figure 3. (a) Velocity distribution in a section perpendicular to the flow for rectangular (left) and Ushaped (right) cross section channels, and (b) particle location in these cross sections.
Figure 3. (a) Velocity distribution in a section perpendicular to the flow for rectangular (left) and Ushaped (right) cross section channels, and (b) particle location in these cross sections.
Figure 4. Influence of fluid flow rate on particle recovery when the applied magnetic force is (a) different and (b) equal in U-shaped and rectangular cross section microdevices.
Figure 4. Influence of fluid flow rate on particle recovery when the applied magnetic force is (a) different and (b) equal in U-shaped and rectangular cross section microdevices.
Figure 5. Magnetic bead capture as a function of fluid flow rate for all of the studied geometries.
Figure 5. Magnetic bead capture as a function of fluid flow rate for all of the studied geometries.
Figure 6. Influence of (a) magnetic and fluidic forces (J parameter) and (b) channel geometry (θ parameter) on particle recovery. Note that U-2mm does not accurately fit a line.
Figure 6. Influence of (a) magnetic and fluidic forces (J parameter) and (b) channel geometry (θ parameter) on particle recovery. Note that U-2mm does not accurately fit a line.
Figure 7. Dependence of bead capture on the (a) functional channel volume, and (b) particle residence time (tres). Note that in the curve fitting expressions V represents the functional channel volume and that U-2mm does not accurately fit a line.
Figure 7. Dependence of bead capture on the (a) functional channel volume, and (b) particle residence time (tres). Note that in the curve fitting expressions V represents the functional channel volume and that U-2mm does not accurately fit a line.

References

  1. Gómez-Pastora J., Xue X., Karampelas I.H., Bringas E., Furlani E.P., Ortiz I. Analysis of separators for magnetic beads recovery: From large systems to multifunctional microdevices. Sep. Purif. Technol. 2017;172:16–31. doi: 10.1016/j.seppur.2016.07.050. [CrossRef] [Google Scholar]
  2. Wise N., Grob T., Morten K., Thompson I., Sheard S. Magnetophoretic velocities of superparamagnetic particles, agglomerates and complexes. J. Magn. Magn. Mater. 2015;384:328–334. doi: 10.1016/j.jmmm.2015.02.031. [CrossRef] [Google Scholar]
  3. Khashan S.A., Elnajjar E., Haik Y. CFD simulation of the magnetophoretic separation in a microchannel. J. Magn. Magn. Mater. 2011;323:2960–2967. doi: 10.1016/j.jmmm.2011.06.001. [CrossRef] [Google Scholar]
  4. Khashan S.A., Furlani E.P. Scalability analysis of magnetic bead separation in a microchannel with an array of soft magnetic elements in a uniform magnetic field. Sep. Purif. Technol. 2014;125:311–318. doi: 10.1016/j.seppur.2014.02.007. [CrossRef] [Google Scholar]
  5. Furlani E.P. Magnetic biotransport: Analysis and applications. Materials. 2010;3:2412–2446. doi: 10.3390/ma3042412. [CrossRef] [Google Scholar]
  6. Gómez-Pastora J., Bringas E., Ortiz I. Design of novel adsorption processes for the removal of arsenic from polluted groundwater employing functionalized magnetic nanoparticles. Chem. Eng. Trans. 2016;47:241–246. [Google Scholar]
  7. Gómez-Pastora J., Bringas E., Lázaro-Díez M., Ramos-Vivas J., Ortiz I. The reverse of controlled release: Controlled sequestration of species and biotoxins into nanoparticles (NPs) In: Stroeve P., Mahmoudi M., editors. Drug Delivery Systems. World Scientific; Hackensack, NJ, USA: 2017. pp. 207–244. [Google Scholar]
  8. Ruffert C. Magnetic bead-magic bullet. Micromachines. 2016;7:21. doi: 10.3390/mi7020021. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  9. Yáñez-Sedeño P., Campuzano S., Pingarrón J.M. Magnetic particles coupled to disposable screen printed transducers for electrochemical biosensing. Sensors. 2016;16:1585. doi: 10.3390/s16101585. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  10. Schrittwieser S., Pelaz B., Parak W.J., Lentijo-Mozo S., Soulantica K., Dieckhoff J., Ludwig F., Guenther A., Tschöpe A., Schotter J. Homogeneous biosensing based on magnetic particle labels. Sensors. 2016;16:828. doi: 10.3390/s16060828. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  11. He J., Huang M., Wang D., Zhang Z., Li G. Magnetic separation techniques in sample preparation for biological analysis: A review. J. Pharm. Biomed. Anal. 2014;101:84–101. doi: 10.1016/j.jpba.2014.04.017. [PubMed] [CrossRef] [Google Scholar]
  12. Ha Y., Ko S., Kim I., Huang Y., Mohanty K., Huh C., Maynard J.A. Recent advances incorporating superparamagnetic nanoparticles into immunoassays. ACS Appl. Nano Mater. 2018;1:512–521. doi: 10.1021/acsanm.7b00025. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  13. Gómez-Pastora J., González-Fernández C., Fallanza M., Bringas E., Ortiz I. Flow patterns and mass transfer performance of miscible liquid-liquid flows in various microchannels: Numerical and experimental studies. Chem. Eng. J. 2018;344:487–497. doi: 10.1016/j.cej.2018.03.110. [CrossRef] [Google Scholar]
  14. Gale B.K., Jafek A.R., Lambert C.J., Goenner B.L., Moghimifam H., Nze U.C., Kamarapu S.K. A review of current methods in microfluidic device fabrication and future commercialization prospects. Inventions. 2018;3:60. doi: 10.3390/inventions3030060. [CrossRef] [Google Scholar]
  15. Niemeyer C.M., Mirkin C.A., editors. Nanobiotechnology; Concepts, Applications and Perspectives. Wiley-VCH; Weinheim, Germany: 2004. [Google Scholar]
  16. Khashan S.A., Dagher S., Alazzam A., Mathew B., Hilal-Alnaqbi A. Microdevice for continuous flow magnetic separation for bioengineering applications. J. Micromech. Microeng. 2017;27:055016. doi: 10.1088/1361-6439/aa666d. [CrossRef] [Google Scholar]
  17. Basauri A., Gomez-Pastora J., Fallanza M., Bringas E., Ortiz I. Predictive model for the design of reactive micro-separations. Sep. Purif. Technol. 2019;209:900–907. doi: 10.1016/j.seppur.2018.09.028. [CrossRef] [Google Scholar]
  18. Abdollahi P., Karimi-Sabet J., Moosavian M.A., Amini Y. Microfluidic solvent extraction of calcium: Modeling and optimization of the process variables. Sep. Purif. Technol. 2020;231:115875. doi: 10.1016/j.seppur.2019.115875. [CrossRef] [Google Scholar]
  19. Khashan S.A., Alazzam A., Furlani E. A novel design for a microfluidic magnetophoresis system: Computational study; Proceedings of the 12th International Symposium on Fluid Control, Measurement and Visualization (FLUCOME2013); Nara, Japan. 18–23 November 2013. [Google Scholar]
  20. Pamme N. Magnetism and microfluidics. Lab Chip. 2006;6:24–38. doi: 10.1039/B513005K. [PubMed] [CrossRef] [Google Scholar]
  21. Gómez-Pastora J., Amiri Roodan V., Karampelas I.H., Alorabi A.Q., Tarn M.D., Iles A., Bringas E., Paunov V.N., Pamme N., Furlani E.P., et al. Two-step numerical approach to predict ferrofluid droplet generation and manipulation inside multilaminar flow chambers. J. Phys. Chem. C. 2019;123:10065–10080. doi: 10.1021/acs.jpcc.9b01393. [CrossRef] [Google Scholar]
  22. Gómez-Pastora J., Karampelas I.H., Bringas E., Furlani E.P., Ortiz I. Numerical analysis of bead magnetophoresis from flowing blood in a continuous-flow microchannel: Implications to the bead-fluid interactions. Sci. Rep. 2019;9:7265. doi: 10.1038/s41598-019-43827-x. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  23. Tarn M.D., Pamme N. On-Chip Magnetic Particle-Based Immunoassays Using Multilaminar Flow for Clinical Diagnostics. In: Taly V., Viovy J.L., Descroix S., editors. Microchip Diagnostics Methods and Protocols. Humana Press; New York, NY, USA: 2017. pp. 69–83. [Google Scholar]
  24. Phurimsak C., Tarn M.D., Peyman S.A., Greenman J., Pamme N. On-chip determination of c-reactive protein using magnetic particles in continuous flow. Anal. Chem. 2014;86:10552–10559. doi: 10.1021/ac5023265. [PubMed] [CrossRef] [Google Scholar]
  25. Wu X., Wu H., Hu Y. Enhancement of separation efficiency on continuous magnetophoresis by utilizing L/T-shaped microchannels. Microfluid. Nanofluid. 2011;11:11–24. doi: 10.1007/s10404-011-0768-7. [CrossRef] [Google Scholar]
  26. Vojtíšek M., Tarn M.D., Hirota N., Pamme N. Microfluidic devices in superconducting magnets: On-chip free-flow diamagnetophoresis of polymer particles and bubbles. Microfluid. Nanofluid. 2012;13:625–635. doi: 10.1007/s10404-012-0979-6. [CrossRef] [Google Scholar]
  27. Gómez-Pastora J., González-Fernández C., Real E., Iles A., Bringas E., Furlani E.P., Ortiz I. Computational modeling and fluorescence microscopy characterization of a two-phase magnetophoretic microsystem for continuous-flow blood detoxification. Lab Chip. 2018;18:1593–1606. doi: 10.1039/C8LC00396C. [PubMed] [CrossRef] [Google Scholar]
  28. Forbes T.P., Forry S.P. Microfluidic magnetophoretic separations of immunomagnetically labeled rare mammalian cells. Lab Chip. 2012;12:1471–1479. doi: 10.1039/c2lc40113d. [PubMed] [CrossRef] [Google Scholar]
  29. Nandy K., Chaudhuri S., Ganguly R., Puri I.K. Analytical model for the magnetophoretic capture of magnetic microspheres in microfluidic devices. J. Magn. Magn. Mater. 2008;320:1398–1405. doi: 10.1016/j.jmmm.2007.11.024. [CrossRef] [Google Scholar]
  30. Plouffe B.D., Lewis L.H., Murthy S.K. Computational design optimization for microfluidic magnetophoresis. Biomicrofluidics. 2011;5:013413. doi: 10.1063/1.3553239. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  31. Hale C., Darabi J. Magnetophoretic-based microfluidic device for DNA isolation. Biomicrofluidics. 2014;8:044118. doi: 10.1063/1.4893772. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  32. Becker H., Gärtner C. Polymer microfabrication methods for microfluidic analytical applications. Electrophoresis. 2000;21:12–26. doi: 10.1002/(SICI)1522-2683(20000101)21:1<12::AID-ELPS12>3.0.CO;2-7. [PubMed] [CrossRef] [Google Scholar]
  33. Pekas N., Zhang Q., Nannini M., Juncker D. Wet-etching of structures with straight facets and adjustable taper into glass substrates. Lab Chip. 2010;10:494–498. doi: 10.1039/B912770D. [PubMed] [CrossRef] [Google Scholar]
  34. Wang T., Chen J., Zhou T., Song L. Fabricating microstructures on glass for microfluidic chips by glass molding process. Micromachines. 2018;9:269. doi: 10.3390/mi9060269. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  35. Castaño-Álvarez M., Pozo Ayuso D.F., García Granda M., Fernández-Abedul M.T., Rodríguez García J., Costa-García A. Critical points in the fabrication of microfluidic devices on glass substrates. Sens. Actuators B Chem. 2008;130:436–448. doi: 10.1016/j.snb.2007.09.043. [CrossRef] [Google Scholar]
  36. Prakash S., Kumar S. Fabrication of microchannels: A review. Proc. Inst. Mech. Eng. Part B J. Eng. Manuf. 2015;229:1273–1288. doi: 10.1177/0954405414535581. [CrossRef] [Google Scholar]
  37. Leester-Schädel M., Lorenz T., Jürgens F., Ritcher C. Fabrication of Microfluidic Devices. In: Dietzel A., editor. Microsystems for Pharmatechnology: Manipulation of Fluids, Particles, Droplets, and Cells. Springer; Basel, Switzerland: 2016. pp. 23–57. [Google Scholar]
  38. Bartlett N.W., Wood R.J. Comparative analysis of fabrication methods for achieving rounded microchannels in PDMS. J. Micromech. Microeng. 2016;26:115013. doi: 10.1088/0960-1317/26/11/115013. [CrossRef] [Google Scholar]
  39. Ng P.F., Lee K.I., Yang M., Fei B. Fabrication of 3D PDMS microchannels of adjustable cross-sections via versatile gel templates. Polymers. 2019;11:64. doi: 10.3390/polym11010064. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  40. Furlani E.P., Sahoo Y., Ng K.C., Wortman J.C., Monk T.E. A model for predicting magnetic particle capture in a microfluidic bioseparator. Biomed. Microdevices. 2007;9:451–463. doi: 10.1007/s10544-007-9050-x. [PubMed] [CrossRef] [Google Scholar]
  41. Tarn M.D., Peyman S.A., Robert D., Iles A., Wilhelm C., Pamme N. The importance of particle type selection and temperature control for on-chip free-flow magnetophoresis. J. Magn. Magn. Mater. 2009;321:4115–4122. doi: 10.1016/j.jmmm.2009.08.016. [CrossRef] [Google Scholar]
  42. Furlani E.P. Permanent Magnet and Electromechanical Devices; Materials, Analysis and Applications. Academic Press; Waltham, MA, USA: 2001. [Google Scholar]
  43. White F.M. Viscous Fluid Flow. McGraw-Hill; New York, NY, USA: 1974. [Google Scholar]
  44. Mathew B., Alazzam A., El-Khasawneh B., Maalouf M., Destgeer G., Sung H.J. Model for tracing the path of microparticles in continuous flow microfluidic devices for 2D focusing via standing acoustic waves. Sep. Purif. Technol. 2015;153:99–107. doi: 10.1016/j.seppur.2015.08.026. [CrossRef] [Google Scholar]
  45. Furlani E.J., Furlani E.P. A model for predicting magnetic targeting of multifunctional particles in the microvasculature. J. Magn. Magn. Mater. 2007;312:187–193. doi: 10.1016/j.jmmm.2006.09.026. [CrossRef] [Google Scholar]
  46. Furlani E.P., Ng K.C. Analytical model of magnetic nanoparticle transport and capture in the microvasculature. Phys. Rev. E. 2006;73:061919. doi: 10.1103/PhysRevE.73.061919. [PubMed] [CrossRef] [Google Scholar]
  47. Eibl R., Eibl D., Pörtner R., Catapano G., Czermak P. Cell and Tissue Reaction Engineering. Springer; Berlin/Heidelberg, Germany: 2009. [Google Scholar]
  48. Pamme N., Eijkel J.C.T., Manz A. On-chip free-flow magnetophoresis: Separation and detection of mixtures of magnetic particles in continuous flow. J. Magn. Magn. Mater. 2006;307:237–244. doi: 10.1016/j.jmmm.2006.04.008. [CrossRef] [Google Scholar]
  49. Alorabi A.Q., Tarn M.D., Gómez-Pastora J., Bringas E., Ortiz I., Paunov V.N., Pamme N. On-chip polyelectrolyte coating onto magnetic droplets-Towards continuous flow assembly of drug delivery capsules. Lab Chip. 2017;17:3785–3795. doi: 10.1039/C7LC00918F. [PubMed] [CrossRef] [Google Scholar]
  50. Zhang H., Guo H., Chen Z., Zhang G., Li Z. Application of PECVD SiC in glass micromachining. J. Micromech. Microeng. 2007;17:775–780. doi: 10.1088/0960-1317/17/4/014. [CrossRef] [Google Scholar]
  51. Mourzina Y., Steffen A., Offenhäusser A. The evaporated metal masks for chemical glass etching for BioMEMS. Microsyst. Technol. 2005;11:135–140. doi: 10.1007/s00542-004-0430-3. [CrossRef] [Google Scholar]
  52. Mata A., Fleischman A.J., Roy S. Fabrication of multi-layer SU-8 microstructures. J. Micromech. Microeng. 2006;16:276–284. doi: 10.1088/0960-1317/16/2/012. [CrossRef] [Google Scholar]
  53. Su N. 8 2000 Negative Tone Photoresist Formulations 2002–2025. MicroChem Corporation; Newton, MA, USA: 2002. [Google Scholar]
  54. Su N. 8 2000 Negative Tone Photoresist Formulations 2035–2100. MicroChem Corporation; Newton, MA, USA: 2002. [Google Scholar]
  55. Fu C., Hung C., Huang H. A novel and simple fabrication method of embedded SU-8 micro channels by direct UV lithography. J. Phys. Conf. Ser. 2006;34:330–335. doi: 10.1088/1742-6596/34/1/054. [CrossRef] [Google Scholar]
  56. Kazoe Y., Yamashiro I., Mawatari K., Kitamori T. High-pressure acceleration of nanoliter droplets in the gas phase in a microchannel. Micromachines. 2016;7:142. doi: 10.3390/mi7080142. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  57. Sharp K.V., Adrian R.J., Santiago J.G., Molho J.I. Liquid flows in microchannels. In: Gad-el-Hak M., editor. MEMS: Introduction and Fundamentals. CRC Press; Boca Raton, FL, USA: 2006. pp. 10-1–10-46. [Google Scholar]
  58. Oh K.W., Lee K., Ahn B., Furlani E.P. Design of pressure-driven microfluidic networks using electric circuit analogy. Lab Chip. 2012;12:515–545. doi: 10.1039/C2LC20799K. [PubMed] [CrossRef] [Google Scholar]
  59. Bruus H. Theoretical Microfluidics. Oxford University Press; New York, NY, USA: 2008. [Google Scholar]
  60. Beebe D.J., Mensing G.A., Walker G.M. Physics and applications of microfluidics in biology. Annu. Rev. Biomed. Eng. 2002;4:261–286. doi: 10.1146/annurev.bioeng.4.112601.125916. [PubMed] [CrossRef] [Google Scholar]
  61. Yalikun Y., Tanaka Y. Large-scale integration of all-glass valves on a microfluidic device. Micromachines. 2016;7:83. doi: 10.3390/mi7050083. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  62. Van Heeren H., Verhoeven D., Atkins T., Tzannis A., Becker H., Beusink W., Chen P. [(accessed on 9 March 2020)];Design Guideline for Microfluidic Device and Component Interfaces (Part 2) Version 3. Available online: http://www.makefluidics.com/en/design-guideline?id=7.
  63. Scheuble N., Iles A., Wootton R.C.R., Windhab E.J., Fischer P., Elvira K.S. Microfluidic technique for the simultaneous quantification of emulsion instabilities and lipid digestion kinetics. Anal. Chem. 2017;89:9116–9123. doi: 10.1021/acs.analchem.7b01853. [PubMed] [CrossRef] [Google Scholar]
  64. Lynch E.C. Red blood cell damage by shear stress. Biophys. J. 1972;12:257–273. [PMC free article] [PubMed] [Google Scholar]
  65. Paul R., Apel J., Klaus S., Schügner F., Schwindke P., Reul H. Shear stress related blood damage in laminar Couette flow. Artif. Organs. 2003;27:517–529. doi: 10.1046/j.1525-1594.2003.07103.x. [PubMed] [CrossRef] [Google Scholar]
  66. Gómez-Pastora J., Karampelas I.H., Xue X., Bringas E., Furlani E.P., Ortiz I. Magnetic bead separation from flowing blood in a two-phase continuous-flow magnetophoretic microdevice: Theoretical analysis through computational fluid dynamics simulation. J. Phys. Chem. C. 2017;121:7466–7477. doi: 10.1021/acs.jpcc.6b12835. [CrossRef] [Google Scholar]
  67. Lim J., Yeap S.P., Leow C.H., Toh P.Y., Low S.C. Magnetophoresis of iron oxide nanoparticles at low field gradient: The role of shape anisotropy. J. Colloid Interface Sci. 2014;421:170–177. doi: 10.1016/j.jcis.2014.01.044. [PubMed] [CrossRef] [Google Scholar]
  68. Culbertson C.T., Sibbitts J., Sellens K., Jia S. Fabrication of Glass Microfluidic Devices. In: Dutta D., editor. Microfluidic Electrophoresis: Methods and Protocols. Humana Press; New York, NY, USA: 2019. pp. 1–12. [Google Scholar]
Mixing Tank with FLOW-3D

CFD Stirs Up Mixing 일반

CFD (전산 유체 역학) 전문가가 필요하고 때로는 실행하는데 몇 주가 걸리는 믹싱 시뮬레이션의 시대는 오래 전입니다. 컴퓨팅 및 관련 기술의 엄청난 도약에 힘 입어 Ansys, Comsol 및 Flow Science와 같은 회사는 엔지니어의 데스크톱에 사용하기 쉬운 믹싱 시뮬레이션을 제공하고 있습니다.

“병렬화 및 고성능 컴퓨팅의 발전과 템플릿화는 비전문 화학 엔지니어에게 정확한 CFD 시뮬레이션을 제공했습니다.”라고 펜실베이니아  피츠버그에있는 Ansys Inc.의 수석 제품 마케팅 관리자인 Bill Kulp는 말합니다 .

흐름 개선을위한 실용적인 지침이 필요하십니까? 다운로드 화학 처리의 eHandbook을 지금 흐름 도전 싸우는 방법!

예를 들어, 회사는 휴스턴에있는 Nalco Champion과 함께 프로젝트를 시작했습니다. 이 프로젝트는 시뮬레이션 전문가가 아닌 화학 엔지니어에게 Ansys Fluent 및 ACT (분석 제어 기술) 템플릿 기반 시뮬레이션 앱에 대한 액세스 권한을 부여합니다. 새로운 화학 물질을위한 프로세스를 빠르고 효율적으로 확장합니다.

Giving Mixing Its Due

“화학 산업은 CFD와 같은 계산 도구를 사용하여 많은 것을 얻을 수 있지만 혼합 프로세스는 단순하다고 가정하기 때문에 간과되는 경우가 있습니다. 그러나 최신 수치 기법을 사용하여 우수한 성능을 달성하는 흥미로운 방법이 많이 있습니다.”라고 Flow Science Inc. , Santa Fe, NM의 CFD 엔지니어인 Ioannis Karampelas는 말합니다 .

이러한 많은 기술이 회사의 Flow-3D Multiphysics 모델링 소프트웨어 패키지와 전용 포스트 프로세서 시각화 도구 인 FlowSight에 포함되어 있습니다.

“모든 상업용 CFD 패키지는 어떤 형태의 시각화 도구와 번들로 제공되지만 FlowSight는 매우 강력하고 사용하기 쉽고 이해하기 쉽게 설계되었습니다. 예를 들어, 프로세스를 재 설계하려는 엔지니어는 다양한 설계 변경의 효과를 평가하기 위해 매우 직관적인 시각화 도구가 필요합니다.”라고 그는 설명합니다.

이 접근 방식은 실험 측정을 얻기 어려운 공정 (예 : 쉽게 측정 할 수없는 매개 변수 및 독성 물질의 존재로 인해 본질적으로 위험한 공정)을 더 잘 이해하고 최적화하는데 특히 효과적입니다.

동일한 접근 방식은 또한 믹서 관련 장비 공급 업체가 고객 요구에 맞게 제품을보다 정확하게 개발하고 맞춤화하는 데 도움이되었습니다. “이는 불필요한 프로토 타이핑 비용이나 잠재적 인 과도한 엔지니어링을 방지합니다. 두 가지 모두 일부 공급 업체의 문제였습니다.”라고 Karampelas는 말합니다.

CFD 기술 자체는 계속해서 발전하고 있습니다. 예를 들어, 수치 알고리즘의 관점에서 볼 때 구형 입자의 상호 작용이 열 전달을 적절하게 모델링하는 데 중요한 다양한 문제에 대해 이산 요소 모델링을 쉽게 적용 할 수있는 반면, LES 난류 모델은 난류 흐름 패턴을 정확하게 시뮬레이션하는 데 이상적입니다.

컴퓨팅 리소스에 대한 비용과 수요에도 불구하고 Karampelas는 난류 모델의 전체 제품군을 제공 할 수있는 것이 중요하다고 생각합니다. 특히 LES는 이미 대부분의 학계와 일부 산업 (예 : 전력 공학)에서 선택하는 방법이기 때문입니다. .

그럼에도 불구하고 CFD의 사용이 제한적이거나 비실용적 일 수있는 경우는 확실히 있습니다. 여기에는 나노 입자에서 벌크 유체 증발을 모델링하는 것과 같이 관심의 규모가 다른 규모에 따라 달라질 수있는 문제와 중요한 물리적 현상이 아직 알려지지 않았거나 제대로 이해되지 않았거나 아마도 매우 복잡한 문제 (예 : 모델링)가 포함됩니다. 음 펨바 효과”라고 Karampelas는 경고합니다.

반면에 더욱 강력한 하드웨어와 업데이트 된 수치 알고리즘의 출현은 CFD 소프트웨어를 사용하여 과다한 설계 및 최적화 문제를 해결하기위한 최적의 접근 방식이 될 것이라고 그는 믿습니다.

“복잡한 열교환 시스템 및 새로운 혼합 기술과 같이 점점 더 복잡한 공정을 모델링 할 수있는 능력은 가까운 장래에 가능할 수있는 일을 간단히 보여줍니다. 수치적 방법 사용의 주요 이점은 설계자가 상상력에 의해서만 제한되어 소규모 믹서에서 대규모 반응기 및 증류 컬럼에 이르기까지 다양한 화학 플랜트 공정을 최적화 할 수있는 길을 열어 준다는 것입니다. 실험적 또는 경험적 접근 방식은 항상 관련성이 있지만 CFD가 미래의 엔지니어를위한 선택 도구가 될 것이라고 확신합니다.”라고 그는 결론을 내립니다.



Seán Ottewell은 Chemical Processing의 편집장입니다. sottewell@putman.net으로 이메일을 보낼 수 있습니다 .

기사 원문 : https://www.chemicalprocessing.com/articles/2017/cfd-stirs-up-mixing/

Micro/Biofluidics with FLOW-3D (미세/생명 유체공학)

미세/생명유체공학에 관한 모델링

  • In-Vitro Diagnostics(IVD) : 체외 진단
  • Drug Delivery : 약물 전달
  • Point of Care Devices : 현장 진료 장비
  • Microarrays : 마이크로어레이
  • Lab-on-a-chip : 랩온어칩
  • MEMS(MicroElectroMechanical Systems) : 미세전자기계시스템

미세/생명유체공학에 관한 개념

  • 대류/확산 효과
  • 표면 장력
  • 자유 표면 역학
  • 점도 효과
  • 관성 효과
  • 다공성 매체
  • 전기 역학
  • 미립자 역학
  • 반응 속도론

Particle Model(입자모델)

Lagrangian particle model(라그랑지안 입자 모델)

라그랑지안 입자 모델(Lagrangian particle model)은 서브 그리드(Sub-grid) 모델로 계산 셀보다 작은 속성과 크기가 다른 구형(Spherical) 입자의 움직임을 추적할 수 있는 계산 모델입니다.

해석 사례

  • Aeration tank modelling(산기 탱크 모델링)
  • Bubble diffuser system(버블디퓨저 시스템)
  • Drug delivery etc.

Particle options

  • Marker particles – Massless
  • Mass particles – Solid spheres
  • Fluid particles – Droplets of fluid
  • Gas particles – Bubbles of gas

가정 및 한계(Assumptions & Limitations)

  • 입자크기(Particle size) << 격자크기(Mesh size)
  • 입자간의 상호작용을 고려하지 않습니다.
  • 입자 갯수에 제한

Marker Particles(마커 입자)

마커 입자(Marker particles)는 흐름(Flow)에 영향을 미치지 않고 주변 유체의 속도에 따라 움직이지 않는 질량이 없는 상태의 입자입니다. 그러므로, 유체 분자의 시각화로 간주될 수 있습니다.

계산영역에 마커 입자(Marker particles)를 적용함으로써, 개별 유체 분자가 따르는 경로(Paths)를 시각화할 수 있습니다.

Mass Particles(질량 입자)

질량 입자(Mass particles)는 특정 직경과 밀도를 가진 고체 구체(Spheres)로 고려됩니다. 따라서, 질량 입자(Mass particles)는 계산 영역에서 현탁된 고체(Suspended solids)의 운동을 모델링하기 위해 사용됩니다.

Fluid particles(유체 입자)

유체 입자(Fluid particles)는 유체#1의 액적(Droplets of Fluid#1)으로 생각할 수 있습니다. 유체 입자(Fluid particles)는 유체 스프레이(Fluid sprays), 적층 제조(additive manufacturing), 용접(Welding) 등과 같은 계산 셀보다 작은 모델링 유체 부피를 포함하는 수많은 시뮬레이션에 사용될 수 있습니다.

Gas particles(가스 입자)

가스 입자(Gas particles)는 가스의 구형(Spherical) 버블과 유체, 공극(Void) 및 고체 물체와의 상호 작용을 시뮬레이션하는데 사용됩니다.

제품 소개 요청

FLOW-3D 소개 요청

    회사/기관명* :

    제목* :

    성명* :

    이메일 주소* :

    연락 전화번호* :

    내용 :

    산업 분야별 해석 사례

    FLOW-3D 를 이용한 각각의 산업분야 적용 가능성을 살펴보십시오.
    경험이 풍부한 당사 FLOW-3D  Engineer가 귀하의 궁금하신 사항에 대해 언제든지 답변해 드립니다.

    주조분야
    • Gravity Pour 중력 주조
    • High Pressure Die Casting 고압 다이캐스팅
    • Tilt Casting 경동 주조
    • Centrifugal Casting 원심 주조
    • Investment Casting 정밀 주조
    • Vacuum Casting 진공 주조
    • Continuous Casting 연속 주조
    • Lost Foam Casting 소실 모형 주조
    • Fill and Defects Tracking 용탕 주입 및 결함 추적
    • Solidification and Shrinkage 응고 및 수축 해석
    • Thermal Stress Evolution and Deformation 열응력 및 변형 해석
    물 및 환경 응용 분야
    • Wastewater Treatment and Recovery 폐수 처리 및 복구
    • Pump Stations 펌프장
    • Dams, Weirs, Spillways 댐, 위어, 여수로
    • River Hydraulics 강 유역
    • Inundation & Flooding 침수 및 범람
    • Open Channel Flow 개수로 흐름
    • Sediment and Scour 퇴적 및 세굴(쇄굴)
    • Plumes, Hydraulic Zones of Influence 기둥, 수리 영향 구역
    • Coastal and Critical Infrastructure Wave Run-Up 연안 및 핵심 인프라 웨이브 런업

    에너지 분야
    • Fuel/cargo sloshing in oceangoing containers 해양 컨테이너 용 연료 /화물 슬로싱
    • Offshore platform wave effects 근해 플랫폼 파 영향
    • Separation devices undergoing 6 DOF motion 6 자유도 운동을하는 분리 장치
    • Wave energy converters 파동 에너지 변환기
    미세유체
    • Continuous-Flow 연속 흐름
    • Droplet, Digital 물방울, 디지털
    • Molecular Biology 분자 생물학
    • Opto-Microfluidics 광 마이크로 유체
    • Cell Behavior 세포 행동
    • Fuel Cells 연료 전지들
    용접 제조
    • Laser Welding 레이저 용접
    • Laser Metal Deposition 레이저 금속 증착
    • Additive Manufacturing 첨가제 제조
    • Multi-Layer Build 다중 레이어 빌드
    • Polymer 3D Printing 폴리머 3D 프린팅
    코팅 분야
    • Curtain Coating 커튼 코팅
    • Dip Coating 딥 코팅
    • Gravure Printing 그라비아 코팅
    • Roll Coating 롤 코팅
    • Slide Coating 슬라이드 코팅
    • Slot Coating 슬롯 코팅
    • Contact Insights 접촉면 분석
    연안 / 해양분야
    • Breakwater Structures 방파제 구조물
    • Offshore Structures 항만 연안 구조물
    • Ship Hydrodynamics 선박 유체 역학
    • Sloshing & Slamming 슬로싱 & 슬래 밍
    • Tsunamis 쓰나미 해석
    생명공학 분야
    • Active Mixing 액티브 믹싱
    • Chemical Reactions 화학 반응
    • Dissolution 용해
    • Drug Delivery 약물 전달
    • Drug Particles 마약 입자
    • Microdispensers 마이크로 디스펜서
    • Passive Mixing 패시브 믹싱
    • Piezo Driven Pumps 피에조 구동 펌프
    자동차 분야
    • Fuel Tanks 연료 탱크
    • Early Fuel Shut-Off 초기 연료 차단
    • Gear Interaction 기어 상호 작용
    • Filters 필터
    • Degas Bottles 병의 가스제거

    Fuel Tank Simulation
    Fuel Tank Simulation
    우주 항공 분야
    • Sloshing Dynamics 슬로싱 동역학
    • Electric Charge Distribution 전기 충전 배분
    • PMDs PMD

    aerospace-sloshing-simulation
    aerospace-sloshing-simulation